0001432093-12-000494.txt : 20120619 0001432093-12-000494.hdr.sgml : 20120619 20120618191453 ACCESSION NUMBER: 0001432093-12-000494 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120619 DATE AS OF CHANGE: 20120618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Organic Alliance, Inc. CENTRAL INDEX KEY: 0001442634 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53545 FILM NUMBER: 12913510 BUSINESS ADDRESS: STREET 1: 1250 NE LOOP 410 STREET 2: SUITE 320 CITY: SAN ANTONIO STATE: TX ZIP: 78209 BUSINESS PHONE: 2108268900 MAIL ADDRESS: STREET 1: 1250 NE LOOP 410 STREET 2: SUITE 320 CITY: SAN ANTONIO STATE: TX ZIP: 78209 10-Q 1 organic10q033112.htm organic10q033112.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q
 
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2012

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Commission File Number
000-51119

ORGANIC ALLIANCE, INC.
(Exact name of registrant as specified in its charter)

Nevada
20-0853334
State of incorporation
I.R.S. Employer Identification No.
 
401 Monterey Street, Suite 202
Salinas, CA 93901
 (Address of principal executive offices)
 
(831) 240-0295
 (Issuer’s telephone number)
  
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes o  No x
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer  o
Accelerated filer  o
   
Non-accelerated filer  o
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class
 
Outstanding at  June 18, 2012
Common stock, $0.0001 par value
 
11,032,593
 
 
 

 
ORGANIC ALLIANCE, INC.

FORM 10-Q

TABLE OF CONTENTS
 
     
Page
PART I - FINANCIAL INFORMATION
 
 
       
ITEM 1.
FINANCIAL STATEMENTS
 
 
       
 
        Condensed Consolidated Balance Sheets as of March 31, 2012 (Unaudited) and December 31, 2011 (Audited)
 
F-1
       
 
        Condensed Consolidated Statements of Operations for the three months ended March 31, 2012 and 2011 (Unaudited)
 
F-2
       
 
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and 2011 (Unaudited)
 
F-3
       
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
F-4
       
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
3
       
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  10
       
ITEM 4.
CONTROLS AND PROCEDURES
 
10
       
PART II - OTHER INFORMATION
 
 
 
ITEM 1.
LEGAL PROCEEDINGS
 
12
       
ITEM 2.
UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS
 
13
       
TEM 3.
DEFAULTS UPON SENIOR SECURITIES
 
13
       
ITEM 4.
MINE SAFETY DISCLOSURE
 
13
       
ITEM 5.
OTHER INFORMATION
 
13
       
ITEM 6.
EXHIBITS
 
13
       
SIGNATURES
   
14
 
 
 

 
PART I - FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS
 
Organic Alliance Inc.
           
Condensed Consolidated Balance Sheet
           
             
   
March 31, 2012
   
December 31, 2011
 
   
unaudited
   
audited
 
Assets
           
Current assets:
           
Cash
  $ 101,819     $ 5,852  
Accounts receivable, net of allowance for doubtful accounts of $77,968
               
at March 31, 2012 and December 31, 2011
    195,322       128,886  
Inventory
    19,073       -  
Prepaid expenses and other current assets
    32,494       23,527  
Total current assets
    348,708       158,265  
                 
Total Assets
  $ 348,708     $ 158,265  
                 
Liabilities and Stockholders' Deficiency
               
                 
Current liabilities:
               
Accounts payable
  $ 1,196,146     $ 1,179,753  
Due to factor
    50,929       82,087  
Accrued expenses and other current liabilities
    2,136,712       2,001,427  
Derivative liabilities
    789,058       155,813  
Notes payable to related parties and others, net of discounts
    1,398,475       1,128,549  
Total current liabilities
    5,571,320       4,547,629  
                 
Commitments and contingencies
               
                 
Stockholders' Deficiency:
               
Preferred stock, no stated value authorized;
               
10,000,000 shares authorized; -0- shares issued
               
and outstanding as of March 31, 2012 and December 31, 2011
    -       -  
Common stock, $.0001 par value, 100,000,000 shares
               
authorized, 11,032,593 shares issued and outstanding
               
as of March 31, 2012 and December 31, 2011
    1,103       1,103  
  Additional paid-in capital
    9,161,849       9,064,265  
  Accumulated deficit
    (14,385,564 )     (13,454,732 )
Total stockholders' deficiency
    (5,222,612 )     (4,389,364 )
                 
Total Liabilities and Stockholders' Deficiency
  $ 348,708     $ 158,265  
                 
The common stock shares authorized, issued and outstanding have been
               
adjusted to reflect a 20 to 1 reverse split, which was effective in February 2011.
               
                 
The accompanying notes are an integral part of these financial statements
               
 
 
F-1

 
Organic Alliance Inc.
           
Condensed Consolidated Statements of Operations (unaudited)
 
             
             
   
For the Three Months Ended
 
   
March 31, 2012
   
March 31, 2011
 
             
             
Revenue
  $ 336,007     $ 255,755  
Cost of sales
    302,863       248,405  
                 
Gross margin
    33,144       7,350  
                 
General and administrative expenses
  $ 456,842     $ 1,075,467  
                 
Operating loss
    (423,698 )     (1,068,117 )
                 
Other (income) expense:
               
Interest expense
    228,870       64,301  
Change in fair value of derivative liability
    278,265       40,572  
Total net other expenses
    507,135       104,873  
                 
Net loss
  $ (930,833 )   $ (1,172,990 )
                 
Basic and diluted loss per share
  $ (0.05 )   $ (0.19 )
                 
Weighted average number of
               
common shares outstanding - basic and diluted
    17,358,027       6,046,778  
                 
The common stock shares authorized, issued and outstanding have been
 
adjusted to reflect a 20 to 1 reverse split, which was effective in February 2011.
               
                 
The accompanying notes are an integral part of these financial statements
 
 
 
F-2

 
Organic Alliance Inc.
           
Condensed Consolidated Statements of Cash Flows (unaudited)
           
             
             
   
For the Three Months Ended
 
   
March 31, 2012
   
March 31, 2011
 
             
Cash flows from operating activities:
           
Net loss
  $ (930,833 )   $ (1,172,990 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Common stock issued for services
    -       201,796  
Share-based compensation
    89,587       388,945  
Non-cash interest
    22,892       11,762  
Change in fair value of derivative liability
    278,265       40,572  
Amortization on discount of note payable
    110,012       24,694  
Changes in operating assets and liabilities:
               
Accounts receivable
    (66,436 )     (187,727 )
Inventory
    (19,073 )     (8,978 )
Prepaid expenses and other current assets
    (8,967 )     2,263  
Accounts payable
    16,393       (397,229 )
Accrued expenses and other current liabilities
    135,285       365,508  
Net cash used in operating activities
    (372,875 )     (731,384 )
                 
Cash flows from financing activities
               
Proceeds from notes and loans payable
    500,000       566,926  
Principal payments on note payable
    -       (38,262 )
Due to factor - net of repayment
    (31,158 )     201,267  
Net cash provided by financing activities
    468,842       729,931  
                 
Net increase (decrease) in cash
    95,967       (1,453 )
Cash - beginning of the period
    5,852       1,461  
Cash - end of the period
  $ 101,819     $ 8  
                 
Supplemental disclosures:
               
Interest paid
  $ 95,967     $ 20,607  
                 
Supplemental disclosure for non-cash financing activities:
               
Discount on notes payable
  $ 362,977     $ 137,703  
                 
Reclassification of derivative liabilities upon conversion of note
  $ -     $ 44,852  
                 
Issuance of common stock to settle notes payable
  $ -     $ 274,507  
                 
Issuance of common stock to convert notes payable
  $ -     $ 5,000  
                 
                 
The accompanying notes are an integral part of these financial statements
               
 
 
F-3

 
Organic Alliance, Inc. and Subsidiary
Notes to Condensed Consolidated Financial Statements (unaudited)
 
1.
NATURE OF BUSINESS
 
Organic Alliance, Inc. ("OAI" or the "Company") is a sales and marketing distribution company that supplies conventional, organic, natural, and Fair Trade food products to the global market.  OAI works directly with growers while also contracting farming production domestically and abroad to vertically integrate supply chains, reduce costs and provide a high degree of control over quality, food safety and production sustainability.

History - NB Design & Licensing, Inc., (“NB Design”) was organized in September 2001.  The former parent, New Bridge Products, Inc., was originally incorporated in August 1995 as a manufacturer of minivans and filed a petition in bankruptcy under Chapter 11 of the U.S. Bankruptcy Code. Its Plan of Reorganization was approved by the U.S. Bankruptcy Court for the District of Arizona in September 2002 and NB Design was discharged from bankruptcy in October 2002.   NB Design was inactive from October 2002 to April 29, 2008.

Organic Alliance Inc., a Texas corporation, (“Organic Texas”) was organized on February 19, 2008 to sell organically grown fruits and vegetables.  During the second quarter of 2009, it ceased being a development stage company when it commenced its operations.

On April 29, 2008, NB Design, a Nevada corporation, acquired all 10,916,917 issued and outstanding shares of common stock of Organic Texas for 464,999 shares of the NB Design’s common stock. Organic Texas thereupon became a wholly owned subsidiary of NB Design. The business of Organic Texas is the only business of NB Design.  The Company operates in California.

The acquisition of Organic Texas by NB Design on April 29, 2008 was accounted for as a reverse capitalization in accordance with the Securities and Exchange Commission’s (“SEC”) Division of Corporate Financial Reporting manual Topic 12 “Reverse Acquisition and Reverse Capitalization”. The reverse capitalization was the acquisition of a private operating company (Organic Texas) into a non-operating public shell corporation with nominal net assets and as such is treated as a capital transaction, rather than a business combination. As a result no goodwill is recorded.  In this situation, NB Design is the legal acquirer because it issued its equity interests, and Organic Texas is the legal acquiree because its equity interests were acquired.  However, NB Design is the acquiree and Organic Texas is the acquirer for accounting purposes.  Organic Texas is treated as the continuing reporting entity that acquired the registrant, NB Design.  The pre-acquisition financial statements of Organic Texas are treated as the historical financial statements of the consolidated companies. 

On June 2, 2008, the name NB Design was changed to Organic Alliance, Inc.  On August 29, 2008, the name of Organic Texas was changed to Organic Texas, Inc.  All references throughout the annual report to “Organic Alliance, Inc.” or the “Company” refers to the combined operations for Organic Alliance, Inc., a Nevada Corporation, and its wholly owned subsidiary, Organic Texas.

During November 2010, the Company increased the number of authorized shares of common stock from 60 million shares to 2 billion shares.

On February 14, 2011, the Company executed a 20:1 reverse split and decreased the number of authorized shares of common stock from 2 billion shares to 100 million shares.
 
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The Company's unaudited condensed consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business and in accordance with the instructions for Form 10-Q and article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.

In the opinion of management, the condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

The results for the three months ended March 31, 2012 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission on June 18, 2012.

Use of Estimates - The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include but are not limited to, realization of deferred tax assets, allowance for doubtful accounts and assumptions used in share based payment transactions.  Actual results could differ from those estimates.

Principles of Consolidation - The condensed consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly owned subsidiary, Organic Texas. Inc. (collectively, the "Company”). All significant inter-company transactions and balances have been eliminated in consolidation.

Allowance for Doubtful Accounts - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company’s produce is sold to the Company’s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $77,969 at March 31, 2012 and December 31, 2011, respectively.
 
In addition, the Company also factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition of such fees may differ from the estimates depending upon the timing of collections.

 
F-4

 
Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market, and includes produce the Company purchases from growers and packaging materials. The Company held $19,073 and $0 of inventory as of March 31, 2012 and December 31, 2011, respectively.

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet date presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet date presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of the Company’s financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.  The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date.  As a result of entering into the convertible notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date.  Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date.  The Company reassesses the classification at each balance sheet date.  If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method and conversion options at variable rates and any options and warrants  with ratchet provisions are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815.  Since, “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock” which is a requirement for the scope exception as outlined under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Intrinsic Value Method to be materially the same. Warrants that have been reclassified to derivative liability that did not contain “down-round protection” were valued using the black-scholes model.

For the Black-Scholes pricing model, which approximates the binomial lattice model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:

   
2012
 
2011
Risk-free interest rate
  0.31% - 0.38%   0.30%
Dividend yield
  N/A   N/A
Expected volatility
  46.5%-46.8%   36.0%-37.2%
Expected life in months and years
 
20 months
 
9 months- 2 years

For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:
 
   
2012
 
2011
 
Risk-free interest rate
  0.15% - 0.62%   N/A  
Dividend yield
  N/A   N/A  
Expected volatility
  43.4%-46.1%   N/A  
Expected life in months and years
 
6 months - 3 years
  N/A  

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product and title has been transferred and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.  

Share Based Compensation - The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718.  For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on interim financial reporting dates until the service period is complete.

Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate.  The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model.  The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding.  The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 
F-5

 
For the Black-Scholes pricing model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:

   
2012
 
2011
Risk-free interest rate
  0.43% - 0.86%   2.37%
Dividend yield
  N/A   N/A
Expected volatility
  44.7% - 55.2%   54.5%
Expected life in years
  3-5   5
 
Concentrations

 ·
Credit Risk - The Company maintains cash balances at various high quality federally insured financial institutions, with balances at times, in excess of federally insured limits.  Management believes that the financial institutions that hold the Company’s deposits are financially sound and therefore pose a minimum credit risk. The Company has not experienced any losses in such accounts.
·
Major customers - The Company has two and four major customers, which accounted for approximately 65% and 61% of the sales during three months ended March 31, 2012 and 2011, respectively. For the three months ended March 31, 2012, the total sales comprised of customer A 42% and customer B 23% compared to the three months ended March 31, 2011, comprised of customer E 26%, customer F 14%, customer G 12% and customer B 10%.  The loss of any of these customers could adversely affect the Company's operations.
·
Major receivables - The Company has five major receivables at March 31, 2012  comprised of customer E 27%, customer A 16%, customer C 17%, customer B 14% and customer D 11%  compared to five major receivables at March 31, 2011, comprised of customer E 28%, customer F 15%, G 13%, customer B 11% and customer H 11%.
·
Major suppliers - The Company has four and three major suppliers, which accounted for approximately 63% and 94% of purchases during three months ended March 31, 2012 and 2011, respectively. The loss of any of these suppliers could adversely affect the Company's operations.
 

 
 
F-6

 
Net Loss Per Share - Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.

In accordance with ASC 260 “Earnings per Share”, the Company has given effect to the issuance of 2,795,538 and 1,323,070 warrants as of March 31, 2012 and 2011, respectively, exercisable at $0.01. These warrants have been included in computing the basic net loss per share for the three months ended March 31, 2012 and 2011.  Additionally, included in the Company’s weighted average shares outstanding are 3,529,897 and 56,189 shares earned, but not issued as at March 31, 2012 and 2011, respectively.

Total shares issuable upon the exercise of warrants, options and the conversion of convertible notes for the three months ended March 31, 2012 and 2011 were as follows:

   
March 31,
 
   
2012
   
2011
 
Options
    4,483,750       33,750  
Warrants
    4,710,350       320,008  
Convertible notes
    5,304,352       581,575  
Total Common stock equivalents
    14,498,452       935,333  

 
 
 
 
 
F-7

 

Recently Issued Accounting Standards
 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs." This ASU addresses fair value measurement and disclosure requirements within Accounting Standards Codification ("ASC") Topic 820 for the purpose of providing consistency and common meaning between U.S. GAAP and IFRSs. Generally, this ASU is not intended to change the application of the requirements in Topic 820. Rather, this ASU primarily changes the wording to describe many of the requirements in U.S. GAAP for measuring fair value or for disclosing information about fair value measurements. This ASU is effective for periods beginning after December 15, 2011 and did not have a material impact on the Company’s consolidated financial statements or disclosures. 

In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. This guidance improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. The guidance provided by this update becomes effective for interim and annual periods beginning on or after December 15, 2011. The adoption of this standard did not have a material impact on the Company’s financial position or results of operations.
 
3.
 GOING CONCERN

The consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of March 31, 2012, the Company has limited cash, a working capital deficit of approximately $5,223,000, has accumulated losses of approximately $14,386,000 since its inception and has withheld $163,949 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities and are delinquent. The Company is currently delinquent with its payroll tax filings since December 31, 2008. Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due and increasing its revenue in order to achieve profitable operations. The Company estimates a $2,000,000 capital infusion will be required to continue operations through the end of 2012. The outcome of these matters cannot be predicted with any certainty at this time and raises substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

The Company intends to overcome the circumstances that impact its ability to remain a going concern through a combination of growing high margin revenues, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however the Company does not have commitments from third parties for a sufficient amount of additional capital. The Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary to raise additional funds, and may require that the Company relinquish valuable rights.
 
 
F-8

 
 
4.
DUE TO FACTOR

On November 1, 2010 the Company entered into a new one year accounts receivable factoring facility with a financial services company with maximum borrowings of $1,800,000.  The contract expired on October 31, 2011, and the Company is operating on a month to month basis, thereafter. The financial services company advances up to 80% of qualified customer invoices less applicable discount fee, and holds the remaining 20% as a reserve until the customer pays the financial services company.  The released reserves are used to fund other vendor purchases or returned to the Company.  The Company is charged 3% for the first 30 days outstanding plus 1/10 of 1% for funds outstanding over 30 days. Uncollectable customer invoices are charged back to the Company.  The new financial services company commenced funding during February 2011. At March 31, 2012 the advances from the factor inclusive of fees amounted to $64,789 which was offset against due from factor of approximately $13,860. Advances from the factor are collateralized by substantially all assets of the Company.
 
5.
PREFERRED STOCK

The Company’s articles of incorporation authorize the Company's Board of Directors to issue up to 10,000,000 shares of preferred stock, having no par value, in one or more series without stockholder approval. Each such series of preferred stock may have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as determined by the Company’s Board of Directors. At December 31, 2011 and 2010, no shares of preferred stock were issued or outstanding.

In August 2010, the Company signed a one year consulting agreement with a consultant to provide investor and public relation services. The consultant’s compensation includes convertible preferred stock which, at the final determination date, will be converted into shares of common stock of the Company equivalent to 25% of outstanding common shares, as defined in the agreement.  The consultant elected to receive the common stock equivalent directly as compensation.  The Company calculated the fair value of the award to be $868,724 or 4,169,638 shares of common stock. The Company accrued $506,680 of stock based compensation for these services during the year ended December 31, 2011, which has been included in accrued expenses and other current liabilities. During March 2011, 695,930 shares of common stock valued at $173,982 were issued to the consultant for the settlement of a portion of the accrued compensation, the remaining 3,473,708 shares of common stock valued at $694,742 have not been issued as of March 31, 2012 and is currently due and payable.

6.
 NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES

Notes payable to related parties and others, net of discounts consists of the following:

   
March 31,
   
December 31,
 
   
2012
   
2011
 
   
(Unaudited)
   
(Audited)
 
             
N Notes Payable (net of Debt Discount of $42,076 at March 31, 2012 and $63,114 at December 31, 2011) (A)
 
$
599,491
   
$
551,978
 
Notes Payable – Related Parties (net of Debt Discount of $30,053 at March 31, 2012 and $50,053 at December 31, 2011) (B)
   
486,455
     
348,130
 
Convertible Notes Payable (net of Debt Discount of $335,471 at March 31, 2012 and $41,469 at December 31, 2011) (C)
   
312,529
     
228,441
 
Total
 
$
1,398,475
   
$
1,128,549
 

Notes Payable

(A)  
Notes Payable

i.  
In May 2010, an individual advanced to the Company $20,000 bearing interest at 6% per annum.  As a financing incentive, the individual received warrants to purchase 20,000 shares of the Company’s common stock at $1.00 per share.  The warrants expired in November 2011.  The gross proceeds of the note were recorded net of a debt discount of $9,200. The debt discount consisted of the relative fair value of the warrants of $9,200 and is accreted to interest expense ratably over the term of the note. The promissory note matured on November 17, 2011.   The unpaid balance, including accrued interest, was $22,142 and $21,843 at March 31, 2012 and December 31, 2011, respectively. The Company is not compliant with the repayment terms of the note.

 
F-9

 
ii.  
On November 3, 2010, the Company signed a $38,262 demand note with an interest rate of 5% per annum. The unpaid balance, including accrued interest, was $38,565 at December 31, 2011. The note was repaid in January 2011.

iii.  
On February 3, 2011, the Company signed a $500,000 promissory note with a maturity date of August 2, 2012, and has a stated interest rate of 15% per annum. As a financing incentive, the lender received three year warrants vesting on January 31, 2011, to purchase 452,354 shares of common stock at an exercise price of $0.01 per share and also received five year warrants, vesting on June 30, 2011, to purchase 452,354 shares at an exercise price of $0.01 per share.

The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 “Derivatives and Hedging”.    Accordingly, the warrants are recorded as derivative liabilities at their fair value and are marked to market through earnings at the end of each reporting period.  The gross proceeds from the sale of the note $500,000 was recorded net of a discount of $137,703.  The debt discount consisted of $137,703 related to the fair value of the warrants and is accreted to interest expense ratably over the term of the note which amounted to $21,038 and $15,300 for the three months ended March 31, 2012 and 2011, respectively, and is included as a component of interest expense in the accompanying condensed consolidated statement of operations. The Company has not made any note payments and received a waiver from the lender on September 1, 2011 that defers payment until September 1, 2012 and increased the interest rate to 21% beginning April 4, 2011, the date of the first event of  default. The unpaid balance, including accrued interest, was $619,425 and $593,247 at March 31, 2012 and December 31, 2011, respectively.

(B)  
Notes Payable – Related Parties

i.  
In September 2008, Earnest Mathis, a former owner, advanced to the Company $15,000. The advance is evidenced by a promissory note bearing interest at 10% per annum.  The promissory note matured on September 13, 2009.  The unpaid balance, including accrued interest, was $20,316 and $19,942 at March 31, 2012 and December 31, 2011, respectively.  The note has not been repaid as of June 18, 2012. The Company is not compliant with the repayment provisions of this note.

ii.  
On February 18, 2011, the Company issued 3,858,574 shares of common stock to Parker Booth, Chief Executive Officer, for the settlement of $231,514 of principal and $5,996 of the accrued interest.  The fair value of the common stock issued exceeded the fair value of the promissory notes and accrued interest by $64,824 which the Company recorded a charge to stock based compensation expense during the three months ended March 31, 2011. The unpaid balance for accrued interest was $6,803 at March 31, 2012 and December 31, 2011.  The Company is not compliant with the repayment terms of this note.

iii.  
In October and December 2009, Michael Rosenthal, director, advanced the Company $100,000 and $30,000, respectively, totaling $130,000. The advances are evidenced by promissory notes bearing interest at 5% per annum.  The notes matured on March 31, 2010 and June 30, 2010, respectively. On February 18, 2011, at the option of the holder, the Company issued 964,643 shares of common stock for the settlement of $57,879 of the remaining principal and accrued interest of $7,091.  The fair value of the common stock issued exceeded the remaining portion of promissory notes plus accrued interest by $31,092 and is included as a component of stock based compensation expense in the accompanying condensed consolidated statement of operations.

iv.  
In November 2009 and February 2010, Morrison Partners, LLC (Thomas Morrison, former CEO and Chairman of the Board is the President), advanced to the Company $10,000 and $15,000, respectively, totaling $25,000. The advances are evidenced by promissory notes bearing interest at 5% per annum.  The November advance provides for the issuance of 2,770 shares of the Company’s common stock as a financing incentive.  The Company recorded a debt discount of $2,935 for the relative fair value of the common stock. The discount was accreted over the life of the note.

 
F-10

 
The November 2009 and February 2010 notes were due on June 30, 2010 and September 30, 2010, respectively. The unpaid balance, including accrued interest, was $27,784 and $27,472 at March 31, 2012 and December 31, 2011, respectively. The shares have not been issued to Morrison Partners, LLC. The Company is not compliant with the repayment terms of this note.

v.  
During March, 2010 through October 2011, an employee of the Company loaned to the Company $65,958 of which an aggregate amount of $16,000 and $49,958 was advanced during 2011 and 2010, respectively. The loans are evidenced by promissory notes payable with interest at 5% and are due on demand. The Company repaid $9,000 during 2010. In addition, the employee will be issued 47,690 shares of the Company’s common stock upon repayment of the promissory notes as additional consideration. The Company will record a fair value for these shares on the measurement date as a charge to interest expense. The unpaid balance including accrued interest was $60,684 and $59,974 at March 31, 2012 and December 31, 2011, respectively.

vi.  
On October 17, 2011, the Company entered into a $400,000 convertible multi-draw term loan facility (“loan”) with an entity owned by a related party who is a 100% shareholder.  The loan bears interest at 21% and has a maturity date of the earlier of an event of default or April 17, 2012.  The Company has not made a note payment and is currently negotiating an extension of such loan. At the time of any new debt or equity financing of the Company, the note balance of principal and interest may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing.  In addition, the related party received a warrant to purchase 2.5 shares of the Company’s common stock for each $1.00 of principal extended to the Company up to 1,000,000 shares.  The warrants have an exercise price of $.10 per share and vest with each cash advance from the loan and collectively expire on October 17, 2014. The Company received $75,000 and $275,000 in gross proceeds during the three months ended March 31, 2012, and year ended December 31, 2012, respectively. The Company issued three-year warrants to purchase an aggregate of 187,500 and 687,500 shares of the Company’s common stock during the three months ended March 31, 2012 and the year ended December 31, 2011, respectively. The unpaid balance, including accrued interest, was $350,000 and $283,993 at March 31, 2012 and December 31, 2011, respectively. As of June 18, 2012, the Company has been advanced $400,000 on the loan.

The conversion price of the notes was not fixed and  determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion option of the notes on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the three-year warrants issued in connection with the note on the date of issuance aggregated $70,074, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $40,062 for the three months ended March 31, 2012.

vii.  
On February 28, 2012, Michael Rosenthal, director, advanced the Company $50,000. The advance is evidenced by promissory notes bearing interest at 21% and has a maturity date of the earlier of an event of default or August 28, 2012.  In addition, Mr. Rosenthal received three year warrants vesting February 28, 2012, to purchase 125,000 shares of Company’s common stock at an exercise price of $0.10 per share. The Company recorded a debt discount of $7,997 to the face value of the note based upon the relative fair values of the note and the common stock. The discount is being accreted over the life of the note which amounted to $1,406 for three months ended March 31, 2012, and is included as a component of interest expense in the accompanying condensed consolidated statement of operations. The unpaid balance including accrued interest was $50,921 at March 31, 2012.
 
 
F-11

 
 
(C)  
Convertible Notes Payable

i.  
On July 14, 2010, the Company issued a $52,380 convertible promissory note with a maturity date of September 13, 2012, and with an interest rate of 20% per annum. The note can be converted into the Company's common stock by the holder based on a variable conversion price. The variable conversion price is defined in the note as 45% multiplied by the average of the five lowest intraday prices for the Company’s stock during the previous 20 trading days prior to the date of conversion.  The total conversion may not exceed 4.99% of the Company’s common stock issued and outstanding. In addition, the Company placed 250,000 shares of the Company’s common stock in escrow to secure our conversion obligations under the note. During September 2010, the lender converted $7,500 of the debt into 75,758 shares of the Company’s common stock for $.099 per share.  During December 2010, the lender converted $7,500 of the debt into 53,419 shares of the Company’s common stock for $.14 per share.  During March 2011, the lender converted $5,000 of the debt to 198,413 shares of the Company’s common stock for $.0252 per share. During September 2011, the lender converted $20,000 of the debt to 444,444 shares of the Company’s common stock for $.045 per share. The unpaid balance, including accrued interest, was $22,318 and $21,567 at March 31, 2012 and December 31, 2011, respectively.  As of June 18, 2012, approximately $23,000 of the note and accrued interest remains unpaid.

The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance were valued using the Black-Scholes pricing model, which approximates the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option in connection with the note on the date of issuance aggregated $52,380, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $6,548 for the three months ended March 31, 2012 and 2011.

ii.  
On July 30, 2010, an individual advanced the Company $8,000. The advance is evidenced by a promissory note bearing interest at 6% per annum and maturing on March 2, 2011.  The holder, at any time, may convert the promissory note into shares of Company’s common stock at $0.05 per share.  The Company calculated the fair value of the beneficial conversion feature using the Black-Scholes pricing model on the date of issuance.  The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,000, and was recorded as debt discount. The debt discount was amortized through the term of the note and amounted to $1,333 for the three months ended March 31, 2011.  The unpaid balance, including accrued interest, was $8,802 and $8,683 at March 31, 2012 and December 31, 2011, respectively. The Company is not compliant with the repayment terms of this note.

iii.  
On April 28, 2011, the Company issued a $70,588 convertible promissory note with an original issue discount of 15%.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) May 31, 2011.  The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company has not made a note payment and received a waiver from the lender on September 1, 2011 that defers payment until May 31, 2012 and waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. The Company is currently negotiating an extension of such loan. As a financing incentive, the lender received five-year warrants vesting April 28, 2011, to purchase 705,882 shares of Company’s common stock at an exercise price of $0.25 per share.  The unpaid balance, including accrued interest, was $70,588 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $60,000, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $60,000 for the year ended December 31, 2011.

 
F-12

 
iv.  
On June 15, 2011, the Company issued a $57,500 convertible promissory note with an original issue discount of 15%.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) June 14, 2012. The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company received a waiver from the lender on September 1, 2011 that waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. As a financing incentive, the lender received five-year warrants vesting June 15, 2011, to purchase 575,000 shares of Company’s common stock at an exercise price of $0.25 per share. The unpaid balance, including accrued interest, was $57,500 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $50,000, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $12,500 for the three months ended March 31, 2012.

v.  
On July 15, 2011, the Company issued a $109,822 convertible promissory note with an original issue discount of 15% that consolidated various demand notes from September 2010 through July 2011.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) August 31, 2011. The Company has not made a note payment and is currently negotiating an extension of such loan. The note may be converted into the Company's common stock by the holder at $0.05 per share.  As a financing incentive, the lender received five-year warrants vesting July 15, 2011, to purchase 1,098,220 shares of Company’s common stock at an exercise price of $0.25 per share.  The unpaid balance, including accrued interest, was $111,572 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $95,497, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $95,497 for the year ended December 31, 2011.
 
 
F-13

 
vi.  
On March 2, 2012, the Company entered into an agreement to sell secured promissory notes for an aggregate principal amount of $1,000,000, with warrants to purchase 2.5 shares the Company’s common stock for each $1 of the principal amount of the notes purchased.  In addition, the Company will issue to the investment banker, warrants for the purchase of the number of shares of the Company’s common stock equal to 10% of the common stock issuable in conjunction with the promissory notes sold in this offering. The three year warrants vesting immediately was 1,031,250 shares of the Company’s common stock at an exercise price of $.10 per share. The notes bear interest at 18% and have a maturity date of September 2, 2012. At the time of any new debt or equity financing of the Company, the note balance of principal and interest may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing.  The Company received $375,000 in gross proceeds during the three months ended March 31, 2012. The unpaid balance, including accrued interest, was $377,219 at March 31, 2012.  As of June 18, a total of $850,000 has been raised by the offering.

The conversion price of the note and three-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $341,509, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $25,542 for the three months ended March 31, 2012.

7. FAIR VALUE MEASURES
 
ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements.  As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.

ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:

 
Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 
Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.

 
Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair measurements requires judgment and considers factors specific to each asset or liability.
 
 
F-14

 
The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of March 31, 2012 and December 31, 2011, respectively:
 
   
Fair Value Measurements
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
                         
Derivative liabilities:
                       
March 31, 2012
  $     $     $ 789,058     $ 789,058  
December 31, 2011
  $     $     $ 155,813     $ 155,813  
 
The 2010 derivative liabilities are measured at fair value using the Black-Scholes options pricing model, which approximates the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy.  The 2012 and 2011 derivative liabilities are measured at fair value using the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:
 
   
Three Month Ended
March 31, 2012
   
Year Ended
December 31, 2011
 
             
Fair value, beginning of period
 
$
155,813
   
$
84,819
 
Derivative liabilities recorded during the period
   
354,980
     
357,040
 
Reclassification to equity upon conversion of note
   
-
     
(66,836)
 
Net unrealized (gain) loss on derivative financial instruments
   
278,265
     
(219,210)
 
Fair value, end of period
 
$
789,058
   
$
155,813
 
                 
8.  STOCK OPTIONS AND WARRANTS

Stock Options – Employment Letter Agreement: 

On January 6, 2012, in conjunction with Mark Zeller’s employment as the Company’s North American Director of Sales the Company provided an option to purchase 1,500,000 shares of common stock at $0.20 per share. The option has a life of five years and 250,000 options vested immediately and 416,667 shares vest on each anniversary after such date. The fair value option was approximately $44,000.

The Company recognized stock based compensation expense included in general and administrative expenses on the consolidated statement of operations for the three months ended March 31, 2012 and 2011, for $30,134 and $8,719, respectively for these awards.
 
 
F-15

 
 

Options Summary:

A summary of option activity during the three months ended March 31, 2012 and year ended December 31, 2011 is presented below:

               
Weighted
       
         
Weighted
   
Average
       
         
Average
   
Remaining
       
         
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term
   
Value
 
Balance at December 31, 2010
    33,750     $ 10.20       3.88     $ -  
Granted
    2,950,000     $ 0.20       7.00       -  
Exercised
    -       -       -       -  
Forfeited
    -       -       -       -  
Balance at December 31, 2011
    2,983,750     $ 0.31       4.00     $ -  
Granted
    1,500,000     $ 0.20       5.00       -  
Exercised
    -       -       -       -  
Forfeited
    -       -       -       -  
Balance at March 31, 2012
    4,483,750     $ 0.28       4.21     $ -  
                                 
Exercisable at March 31, 2012
    1,758,750     $ 0.28       4.21     $ -  

Common Stock Warrants Summary:

Warrant transactions during the three months ended March 31, 2012 and the year ended December 31, 2011 are as follows:

         
Weighted
   
Average
       
         
Average
   
Remaining
       
   
Number of
   
Exercise
   
Life
   
Intrinsic
 
   
Warrants
   
Price
   
In Years
   
Value
 
Balance, December 31, 2010
   
394,858
   
$
15.2
                 
Granted
   
5,787,290
     
0.12
                 
Exercised
   
     
                 
Forfeited
   
(320,008
)
   
18.81
                 
Balance, December 31, 2011
   
5,862,140
   
$
0.12
                 
Granted
   
1,643,750
     
0.13
                 
Exercised
   
     
                 
Forfeited
   
     
                 
Balance, March 31, 2012
   
7,505,890
   
$
0.12
     
3.16
   
$
744,132
 
                                 
Exercisable, March 31, 2012
   
7,505,890
   
$
0.12
     
3.16
   
$
744,132
 
                                 

 
F-16

 
The intrinsic value is calculated on the difference between the fair market value of the Company’s restricted stock, which was $0.20 per share as of March 31, 2012, and the exercise price of the warrants.

The following table presents information related to warrants at March 31, 2012:

Warrants Outstanding
   
Warrants Exercisable
 
           
Weighted
       
           
Average
   
Exercisable
 
Exercise
   
Number of
   
Remaining Life
   
Number of
 
Price
   
Warrants
   
In Years
   
Warrants
 
                     
$ 0.001       74,850       1.50       74,850  
  0.01       452,354       1.83       452,354  
  0.01       795,866       3.88       795,866  
  0.25       705,882       4.08       705,882  
  0.25       575,000       4.21       575,000  
  0.01       452,355       4.25       452,355  
  0.25       1,098,220       4.29       1,098,220  
  0.001       1,020,113       2.50       1,020,113  
  0.10       875,000       2.63       875,000  
  0.10       125,000       2.92       125,000  
  0.25       300,000       2.92       300,000  
  0.10       1,031,250       2.96       1,031,250  
          7,505,890       3.16       7,505,890  
           
 
 
F-17

 
 
9. 
RELATED PARTY TRANSACTIONS
 
Consulting Agreement

On July 1, 2008, the Company signed a 16 month consulting agreement with a related party. The consulting services include financial advisory, investment relations and certain administrative and other services for $6,250 monthly fees. At March 31, 2012 and December 31, 2011, the Company owed $100,000 related to above consulting services, which is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.  

Employee Warrants

On February 29, 2012, an employee was granted three year warrants to purchase 300,000 shares of the Company’s common stock for services to the Company.  The warrants vest immediately with an exercise price of $0.25 per share. The Company recorded a charge for $6,149 to stock based compensation for the three months ended March 31, 2012.

10. 
COMMITMENTS AND CONTINGENCIES

Agreements

On September 27, 2010 the Company signed a twelve month agreement for investment banking services which was renewed for another 12 months. The banking services include equity financing, business combinations and other financing transactions. The compensation to the banker includes a flat fee plus other compensation as defined in the agreement.  The agreement includes three year warrants “Initial Warrants”, which were fully vested on the date of the grant to purchase 74,850 shares of Company’s common stock at an exercise price of $0.001 per share. The fair value of the award was $19,443 and is amortized over the term of the agreement; accordingly, the Company recorded a stock based compensation charge of $4,861 for the three months ended March 31, 2011.

In addition, the agreement provides for an additional warrant to be issued by the Company upon the 1 year anniversary provided that the banker did not exercise any of their other compensation elements as defined in the agreement. This warrant carries a cashless exercise provision and is limited to up to 4.99% of the Company’s outstanding common stock on a fully diluted basis. In September 2011, the Company issued warrants to purchase 1,020,113 shares of the Company’s common stock.  The warrants are exercisable at $0.001 per share, have a life of 3 years and were fully vested on the date of the grant.  The fair value of the award was $213,215 and is amortized over the term of the agreement; accordingly, the Company recorded a stock based compensation charge of $53,304 for the three months ended March 31, 2012.

On November 2, 2010, the Company entered into an agreement with an attorney for general corporate and transactional matters that provide a 3.50% equity interest in the Company upon meeting certain milestones.  These milestones were met in February 2011, and the attorney was granted 5 year warrants vesting on February 14, 2011 to purchase 795,866 shares of Company’s common stock at an exercise price of $0.01 per share. The warrant was fully vested on the date of the grant and accordingly the Company recorded a stock based compensation charge of $279,453 for the three months ended March 31, 2011 which represents the fair value of the award.

Legal matters

In the normal course of business, the Company is, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceedings would not have a material adverse effect on the business or financial condition of the Company.  Additionally, from time to time, the Company may pursue litigation against third parties to enforce or protect the Company’s rights under the Company’s trademarks, trade secrets and the Company’s intellectual property rights generally.
 
 
F-18

 
During 2010, the Company was served with three lawsuits for past due liabilities of the Company.  The first lawsuit was Peri & Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and OAI has been making payments to the plaintiff. OAI was dismissed from the action and signed a confession of judgment.  Over half of the past due amount has been paid with a balance of approximately $21,000 remaining.  The second lawsuit filed in the US. District Court, Northern California District by a group of plaintiffs: Full Circle Sales, Inc., Growers Express LLC, Steinbeck County Produce Inc., Steve Almquist Sales and Brokerage, Dan Andrews Farms, Fresh Networks, LLC and Quebec Distributing Co., Inc., vs. Organic Alliance, Inc., defendant, for approximately $97,000 plus attorney fees and interest.  These plaintiffs are produce suppliers of the Company.  An agreement was reached and three of the plaintiffs were paid in full for $31,000. The balance of $66,000 remains unpaid. The third lawsuit was filed in Monterey County Superior Court by RE Transportation, plaintiff, vs. Organic Alliance, Inc., defendant, seeking approximately $34,000 principal plus interest at 18% per annum and attorney’s fees.  The plaintiff provided transportation services for the Company.  An agreement was reach with the plaintiff receiving $10,000 a month for three months starting May 2012. The Company has accrued for all amounts claimed.
 
11.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
 
Accrued expenses and other current liabilities consist of the following:
 
   
March 31, 2012
   
December 31, 2011
 
Due to consultant (Note 9)
  $ 100,000     $ 100,000  
Accrued consulting fees (Note 5)
    694,742       694,742  
Payroll and payroll taxes payable (A)
    1,277,360       1,131,572  
Other accrued liabilities
    64,610       75,113  
    $ 2,136,712     $ 2,001,427  
 
(A) As of March 31 2011 and December 31, 2011, the Company has withheld $163,949 and $153,009 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities.
 
12. 
SUBSEQUENT EVENTS

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required further adjustment to or disclosure in the consolidated financial statements. 

 
F-19

 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the consolidated financial statements and related notes to the consolidated financial statements included elsewhere in this report. This discussion contains forward-looking statements that relate to future events or our future financial performance. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements are based largely on our current expectations and are subject to a number of uncertainties and risks including the Risk Factors identified in our Annual Report on Form 10-K for the year ended December 31, 2011. Actual results could differ materially from these forward-looking statements. Organic Alliance, Inc. is sometimes referred to herein as “we”, “us”, “our” and the “Company”. 

OVERVIEW
 
Overview

Organic Alliance, Inc. ("OAI" or the "Company") is a sales and marketing distribution company that supplies conventional, organic, natural, and Fair Trade food products to the global market.  Unlike most food marketers, OAI works directly with growers while also contracting farming production domestically and abroad to vertically integrate supply chains, reduce costs and provide a high degree of control over quality, food safety and production sustainability.  Direct involvement in growing operations and an unparalleled international agriculture network allows the Company to develop new Organic and Fair Trade production and offer consistent supply with highly competitive pricing – the primary obstacles facing buyers in those fast growing segments.  The Company also sources and distributes conventional produce (non-Organic and/or Fair Trade) using its high revenue potential to fuel development of Organic and Fair Trade production.

Beyond fresh produce, OAI applies its direct access to raw materials to create value-added consumer packaged goods and bulk products such as juices, oils, purees and dried fruit allowing a substantial cost and control edge over other large consumer packaged goods firms that rely on third parties for sourcing.  Currently, the Company is focusing its sourcing and development strategy in Mexico, the U.S.’s largest food supplier with sales to the U.S. growing 25% in 2010 to $6 Billion.  The focus there is the growing greenhouse agriculture industry (35% in 2010), which drastically reduces the risks of contract farming – particularly in organics. 1  This strategy will be rolled out in stages to key Latin American food exporting countries where OAI currently has strong grower and professional networks in Argentina, Chile, Peru, Dominican Republic and Costa Rica.

The primary segments for marketing the Company’s products are the mainstream supermarket channel, natural grocery chains, mass merchandisers, food service distributors, fresh produce processors, consumer package goods companies, and overseas markets focusing on grocery chains and their importer partners.   The Company has strong food industry relationships and currently supply product to most of these market segments.

Organic Market

Globally, sales of organic products have grown rapidly since 2000, with food products driving the market.  In particular, the United States has seen sales of organic foods grow from $6.1 billion in 2000 to $29.2 billion in 2011, up 9.4% from 2010. Registering a third straight year of double-digit gains, sales of organic fruits and vegetables rose 11.7% in 2011 to $11.8 billion.  The principal barriers to organic product growth are short supply and inconsistent quality /pricing, which OAI directly addresses. 2

Organic certified foods are generally viewed as having a positive impact on one’s health and long-term viability, even though studies are mixed.  As Helpguide.org describes, some studies suggest that, on average, organically grown fruits and vegetables may contain slightly higher levels of vitamin C, trace minerals, and antioxidant phytonutrients than conventionally grown produce.   Other studies, however, have found no nutritional differences between organic and non-organic foods.

Aside from the nutritional aspect, there is a more important part of the growing process related to chemicals.  In crops that are grown using chemicals (fungicides, herbicides, insecticides) to ensure growth, the chemicals often never leave the product after it leaves the farms and ends up on the store shelves.  Studies have linked certain chemicals used in farming to cancer, obesity, Alzheimer’s and certain birth defects.3
 
1 Source:  http://www.ota.com/organic/mt/business.html. 
2 Source:  http://www.thepacker.com/fruit-vegetable-enewsletter/organics-insider/Survey-organic-produce-grows-by-double-digits-in-2011-149132005.html. 
3 Source:  http://www.organicfoodinfo.net. 
 
-3-

 
Another advantage of organic foods is that they are often fresher, because they lack the preservatives that other foods often contain.  In addition, organic farming practices reduce pollution in the air, water and soil, and use less energy than traditional non-organic farms.4  While these do not implicate or eliminate all non-organic foods, all things being equal, most would seek to consume organic foods for the benefits to the individual and to the earth.

Fair Trade

In addition to providing fresh, healthy foods, the Company is dedicated to the practice of Fair Trade.  Global Fair Trade sales have followed the rise of organic at an 18% annual growth rate reaching a total of $4.8 billion in 2009.  Mainstream retailers such as Wal-Mart and Whole Foods have demonstrated strong interest in the segment with each offering a growing number of Fair Trade products including retail-brand private label options.  In 2007, Whole Foods launched its ‘Whole Trade’ initiative requiring 50% of its imported food to be certified as Fair Trade within 10 years.  Fair Trade sales in U.S. mainstream grocery outlets grew 24% in 2010.  Like organic, the principal barrier to growth is lack of supply and inconsistent quality and/or pricing, which OAI directly addresses.

Fair Trade certification offers producers the ability to trade directly with improved payment terms while paying workers dignified wages and providing a premium for community development.  This allows marginalized agricultural communities the opportunity to improve their lives with technical training, better business infrastructure, improved schooling, health care and nutritious food.  Fair Trade investment provides a platform from which communities can rise out of poverty, be economically sustainable and take control of their future while providing the market with better, more sustainable products.  Fair Trade certified products offer consumers a powerful way to reduce poverty through their everyday shopping.5

The key objectives of the Fair Trade standards are to:

·  
Ensure that producers receive prices that cover their average costs of sustainable production;
·  
Provide an additional Fair Trade premium which can be invested in projects that enhance social, economic and environmental development;
·  
Ensure safe working conditions and dignified wages for agriculture workers
·  
Facilitate long-term trading partnerships and enable greater producer control over the trading process; and
·  
Set clear minimum and progressive criteria to ensure that the conditions of production and trade of all Fair Trade certified products are socially, economically fair and environmentally responsible.

Sales and Marketing

           Due to the continued increase in demand for certified organic and Fair Trade products, procurement departments are actively seeking additional sources.  The challenge continues to be to attain a reliable, year round supply at sensible pricing for their buying programs, in part due to short supply and the fractionalized nature of the organic farm base.  By taking control and developing organic and Fair Trade production at the seed level, OAI addresses these issues directly and attracts buyer favor by creating supply and price conditions that more closely resemble the conventional food alternative. While executing this strategy, OAI will continue using its operational infrastructure to sell high volumes of conventional produce to generate substantial resources for the execution of large-scale development in the organic and Fair Trade agriculture sectors.

OAI brand marketing leverages its direct relationships with growing communities to take advantage of the "know where your food comes from" consumer trend.  This is supported by creating entertaining media that highlights the producer story; tracking sustainability metrics such as agrochemicals eliminated, wage increases and carbon emissions; and making these available to consumers online and at the point of purchase via the increasingly popular quick response ("QR") scan technology available on smart phones.  The Company’s conversations with grocery executives indicate that the industry is hungry for point-of-purchase methods of communicating product information and promotional media.  Additionally, Wal-Mart has developed and is implementing in phases its ‘Sustainability Index’ that will grade the level of sustainability of each of its supplier’s products with a label.  OAI believes it is far ahead of these trends and well poised to address the emerging production and communication needs of the 21st century food industry.
 
The primary segments for marketing the Company’s products are the mainstream supermarket channel, natural grocery chains, mass merchandisers, food service distributors, fresh produce processors, consumer packaged goods companies, and overseas markets focusing on grocery chains and their importer partners.   The Company has strong food industry relationships and currently supply product to most of these market segments with overseas markets in Asia being served.
 
4 Source:  http://www.helpguide.org/life/organic_foods_pesticides_gmo.htm. 
5 Source:  http://www.fairtrade.net/what_is_fairtrade.html.
 
-4-

 
History

NB Design & Licensing, Inc., (“NB Design”) was organized in September 2001.  The former parent, New Bridge Products, Inc., was originally incorporated in August 1995 as a manufacturer of minivans and filed a petition in bankruptcy under Chapter 11 of the U.S. Bankruptcy Code. Its Plan of Reorganization was approved by the U.S. Bankruptcy Court for the District of Arizona in September 2002 and NB Design was discharged from bankruptcy in October 2002.   NB Design was inactive from October 2002 to April 29, 2008.

Organic Alliance Inc., a Texas corporation, (“Organic Texas”) was organized on February 19, 2008 to sell organically grown fruits and vegetables.  During the second quarter of 2009, it ceased being a development stage company when it commenced its operations.

On April 29, 2008, NB Design, a Nevada corporation, acquired all 10,916,917 issued and outstanding shares of common stock of Organic Texas for 464,999 shares of the NB Design’s shares of common stock. Organic Texas thereupon became a wholly owned subsidiary of NB Design. The business of Organic Texas is the only business of NB Design. The Company operates in California.
 
The acquisition of Organic Texas by NB Design on April 29, 2008 was accounted for as a reverse capitalization in accordance with the Security and Exchange Commission’s (“SEC”) Division of Corporate Financial Reporting manual Topic 12 “Reverse Acquisition and Reverse Capitalization”. The reverse capitalization was the acquisition of a private operating company (Organic Texas) into a non-operating public shell corporation with nominal net assets and as such is treated as a capital transaction, rather than a business combination. As a result no goodwill is recorded.  In this situation, NB Design is the legal acquirer because it issued its equity interests, and Organic Texas is the legal acquiree because its equity interests were acquired.  However, NB Design is the acquiree and Organic Texas as the acquirer for accounting purposes.  Organic Texas is treated as the continuing reporting entity that acquired the registrant, NB Design.  The pre-acquisition financial statements of Organic Texas are treated as the historical financial statements of the consolidated companies.  Pursuant to the Securities Exchange, NB Design issued 464,999 shares of the Company’s Common Stock for all of the issued and outstanding Common Stock of Organic Texas and assumed all assets and liabilities.

On June 2, 2008, the name NB Design was changed to Organic Alliance, Inc.  On August 29, 2008, the name of Organic Texas was changed to Organic Texas, Inc.

              
 
-5-

 
 
Critical Accounting Estimates and Policies

Use of Estimates - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include but are not limited to, realization of deferred tax assets, allowance for doubtful accounts, derivative liabilities and assumptions used in share based payment transactions.  Actual results could differ from those estimates.

Principles of Consolidation - The consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly owned subsidiary, Organic Texas. Inc. (collectively, the "Company”). All significant inter-company transactions and balances have been eliminated in consolidation.

Allowance for Doubtful Accounts - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company’s produce is sold to the Company’s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $77,969 at March 31, 2012 and December 31, 2011, respectively.
In addition, the Company also factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition of such fees may differ from the estimates depending upon the timing of collections.

Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market, and includes produce the Company purchases from growers and packaging materials. The Company held $19,073 and $0 of inventory as of March 31, 2012 and December 31, 2011, respectively.

Income Taxes - The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes”.  Under this method, income tax expense is recognized for the amount of (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date.  A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, and accounts payable and accrued expenses approximated fair value as of the balance sheet date presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet date presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of the Company’s financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.  The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product and title has been transferred and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.  Sales are presented net of discounts and allowances. 

Share Based Compensation - The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718.  Share-based compensation expense for all share-based payment awards is based on the estimated grant-date fair value. The Company recognizes these compensation costs over the requisite service period of the award, which is generally the option vesting term.  Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate.  The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model.  The Company accounts for the expected life of options in accordance with the “simplified” method provisions of SEC Staff Accounting Bulletin (“SAB”) No. 110, which enables the use of the simplified method for “plain vanilla” share options as defined in SAB No. 107. 

 
-6-

 
Results of Operations
 
Results of operations for the three months ended March 31, 2012 compared to the three months ended March 31, 2011

For the three months ended March 31, 2012, the Company had net sales of $336,007 compared to $255,755, for the three months ended March 31, 2011.  The $80,252, or 31% increase is attributable to additional funding available from the new financial services company advancing 80% of qualified customer invoices to the Company. The new financial services company commenced funding during February 2011.
 
For the three months ended March 31, 2012, our cost of goods sold was $302,863 compared to $248,405 for the three months ended March 31, 2011. 
 
For the three months ended March 31, 2012 and 2011, respectively, our gross margin was $33,144 and $7,350. The increased gross margin is attributable to the higher net sales and more efficient purchasing practices.
 
For the three months ended March 31, 2012, the Company had general and administrative (“G&A”) expenses of $456,842 compared to $1,075,467 for the three months ended March 31, 2011.  The decrease in G&A expenses of $618,625, or 58%, is primarily attributable to decreased share based compensation costs of approximately $716,000 as no new shares were issued during the three months ended March 31, 2012, offset by increased payroll of approximately $84,000 for the hiring of Barry Brookstein, CFO and Mark Zeller, North American Director of Sales.

For the three months ended March 31, 2012, our operating loss was $423,698 compared to $1,068,117 for the three months ended March 31, 2011.  The $644,419, or 60%, decrease is related to lower G&A expenses discussed above.
 
 
 
-7-

 
 
 
For the three months ended March 31, 2012, other expense was $507,135 compared to $104,873 for three months ended March 31, 2011.  Interest expense was $52,848 and $32,313 on notes and loans payable for the three months ended March 31, 2012 and 2011, respectively, which also included $34,625 and $16,813, amortization of finance discount on notes payable, $75,387 and $7,881, amortization of derivative discount on notes payable and $13,510 and $7,294, related to factor advances, and a $278,265 and 40,572 loss on derivative liability for convertible notes payable. Also included in the three months ended March 31, 2012 are finance fees of approximately $53,000 for the $375,000 sold under our agreement to sell secured promissory notes.

For the three months ended March 31, 2012, net loss was $930,833, or $0.05, basic and basic and diluted loss per share compared to $1,172,990, or $0.19, basic and diluted loss per share for the three months ended March 31, 2011. The $242,157 or 21% decrease in net loss was primarily attributable to the factors described above.
 
Liquidity and Capital Resources
 
The Company’s operations to date have generated substantial losses that have been funded through the issuance of common stock and loans from related parties and others. The Company will require additional sources of outside capital to continue the Company’s operations. The Company expects that the Company’s primary source of cash in the future will be from the issuance of common stock, loans, accounts receivable factoring and a line of credit.   On November 1, 2010, the Company signed a one year agreement with a financial services company for the purchase and sale of accounts receivables which expired on October 31, 2011.  The agreement is continuing on a month to month basis. The financial services company advances up to 80% of qualified customer invoices less applicable discount fee, and holds the remaining 20% as a reserve until the customer pays the financial services company.  The released reserves are used to fund other vendor purchases or returned to the Company.  The Company is charged 3% for the first 30 days outstanding plus 1/10 of 1% for funds outstanding over 30 days. Uncollectable customer invoices are charged back to the Company.  The new financial services company commenced funding during February 2011. As of March 31, 2012, the Company has withheld $163,949 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities.

The consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of March 31, 2012, the Company has limited cash, a working capital deficit of approximately $5,223,000 and has accumulated losses of approximately $14,386,000 since its inception. 

Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due and increasing its revenue in order to achieve profitable operations. The Company estimates a $2,000,000 capital infusion will be required to continue operations through the end of 2012. The outcome of these matters cannot be predicted with any certainty at this time and raises substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

Generally, the Company primarily has financed operations to date through the proceeds of the private placement of equity securities and the issuance of promissory notes.

For the period from inception (February 19, 2008) to March 31, 2012, the Company received approximately $212,000 from the sale of our common stock and received proceeds from the notes payable of $2,668,543, of which $194,410 has been paid back and $822,134 has been converted to shares of the Company’s common stock as of March 31, 2012.

The Company has limited funding available for marketing and will rely solely on our ability to raise debt or equity funds in the immediate future.

Our contractual obligations consist of notes and loans payable in the amount of $1,806,075, including accrued interest of $154,076, for the notes at March 31, 2012.  
 
On February 3, 2011, the Company signed a $500,000 promissory note with a maturity date of August 2, 2012, and with an interest rate of 15% per annum.

On April 28, 2011, the Company issued a $70,588 convertible promissory note with an original issue discount of 15%.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) May 31, 2011.  The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company received a waiver from the lender on September 1, 2011 that defers payment until May 31, 2012 and waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. The Company is currently negotiating an extension of such loan.

On June 15, 2011, the Company issued a $57,500 convertible promissory note with an original issue discount of 15%.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) June 14, 2012. The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company received a waiver from the lender on September 1, 2011 that waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more.

 
-8-

 
During June 2011, the Company entered into an agreement with a financial services company to provide deposits to suppliers not covered by the financial services company contracted with on November 1, 2010.  The financial services company advances deposits to suppliers in return for 1/3 of the gross margin paid by the customer. 

During July 2011, the Company entered into an agreement with a second financial services company to provide deposits to suppliers not covered by the financial services company contracted with on November 1, 2010.  The financial services company advances deposits to suppliers in return for 1/3 of the gross margin paid by the customer.

On July 15, 2011, the Company issued a $109,822 convertible promissory note with an original issue discount of 15% that consolidated various demand notes from September 2010 through July 2011.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) August 31, 2011. The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company is currently negotiating an extension of such loan.

On August 22, 2011, an employee advanced the Company $6,000 which was evidenced by promissory note bearing interest at 5% per annum and payable on demand.

On October 10, 2011, an employee advanced the Company $10,000, which was evidenced by promissory note bearing interest at 5% per annum and payable on demand.

On October 17, 2011, the Company issued a $400,000 convertible multi-draw term loan facility (“loan”) to an entity owned by a related party.  The loan bears interest at 21% and has a maturity date of the earlier of an event of default or April 17, 2012.  In addition, the related party received a warrant to purchase 2.5 shares of the Company’s common stock for each $1.00 of principal extended to the Company up to 1,000,000 shares. The Company is currently negotiating an extension of such loan. As of June 18, a total of $400,000 has been advanced on the loan.

On February 28, 2012, the Company issued a $50,000 convertible note to a related party.  The loan bears interest at 21% and has a maturity date of the earlier of an event of default or August 28, 2012.

On March 2, 2012, the Company entered into an agreement to sell secured promissory notes for an aggregate principal amount of $1,000,000, with warrants to purchase 2.5 shares the Company’s common stock for each $1 of the principal amount of the notes purchased.  In addition, the Company will issue to the investment banker, warrants for the purchase of the number of shares of the Company’s common stock equal to 10% of the common stock issuable in conjunction with the promissory notes sold in this offering. As of June 18, a total of $850,000 has been raised by the offering.

Net Cash Flows
 
For the three months ended March 31, 2012, net cash used in operating activities was $372,875 compared to $731,384 for three months ended March 31, 2011.  The decrease of $358,509, or 49%, was primarily attributable to the payments of accounts payable from the proceeds provided from notes payable during the three months ended March 31, 2011, and improvements in account receivable collections, offset by accrued expense.

For the three months ended March 31, 2012, net cash provided by financing activities was $468,842 compared to $729,931 for three months ended March 31, 2011.  The decrease of $261,089, or 36%, was related to proceeds from notes payable issued to third parties and advances from factor.
 
 
-9-

 
 
At March 31, 2012 and 2011, respectively, the Company had 4,483,750 and 33,750 stock options and 7,505,890 and 1,643,078 common stock purchase warrants outstanding. The outstanding stock options have a weighted average exercise price of $0.12 per share. The outstanding warrants have an exercise price from $0.001 to $0.25 per share. Accordingly, at March 31, 2012, the outstanding options and warrants represented a total of 11,989,640 shares issuable for a maximum of $2,125,251 if all of the options and warrants were exercised. The exercise of these options and warrants is at the discretion of the holder.  There is no assurance that any of these options or any additional warrants will be exercised.

Off Balance Sheet Arrangements
 
The Company does not have any off-balance sheet arrangements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures  
            
The Company’s management team, under the supervision and with the participation of the Company’s principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the last day of the fiscal period covered by this report, March 31, 2012. The term disclosure controls and procedures means the Company’s controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that the Company filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that the Company filed or submitted under the Exchange Act is accumulated and communicated to management, including the Company’s principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

The Company’s principal executive officer and principal financial officer are responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f). Management is required to base its assessment of the effectiveness of the Company’s internal control over financial reporting on a suitable, recognized control framework, such as the framework developed by the Committee of Sponsoring Organizations (COSO). The COSO framework, published in Internal Control-Integrated Framework, is known as the COSO Report. The Company’s principal executive officer and principal financial officer, has chosen the COSO framework on which to base its assessment. Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2012.

            The controls designed were adequate for financial disclosures required for the preparation of the 10-Q filing; however due to lack of resources in the Company’s accounting department the controls were not operating effectively. The remediation plan for improving the effectiveness over financial disclosure controls, which caused the material weakness over financial disclosures required in the 10-K, include the creation of a financial disclosures roll-forward model in accordance with the disclosures contained in the 10-Q report.  This model will be maintained and updated by Company staff and management as new business transactions require additional financial disclosures. As the Company obtains additional  resources these financial disclosures will be reviewed by an outside financial disclosure expert for completeness and accuracy earlier in the financial statement closing process cycle in order to help ensure completeness and accuracy for reporting financial disclosures.  During October 2011, the Company hired Barry Brookstein as Chief Financial Officer to augment the Company’s internal controls procedures and expand the Company’s accounting staff.

It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.
 
 
-10-

 
Management’s Annual Report on Internal Control over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a set of processes designed by, or under the supervision of, a company’s principal executive and principal financial officers, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes policies and procedures that:

 
·
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the Company’s transactions and dispositions of the Company’s assets;
 
·
provide reasonable assurance that The Company’s transactions are recorded as necessary to permit preparation of the Company’s financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of the Company’s management and directors; and
 
·
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statement.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. It should be noted that any system of internal control, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company conducted an assessment of the effectiveness of the Company’s internal control over financial reporting based on criteria established in “Internal Control-Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), as of December 31, 2011.

A material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of annual or interim financial statements will not be prevented or detected. In connection with the assessment described above, management identified the following control deficiency that represents a material weakness at December 31, 2011:

 
·
Due to the limited number of Company personnel, a lack of segregation of duties and responsibilities with respect to our cash and control over the disbursements related thereto. An essential part of internal control is for certain procedures to be properly segregated and the results of their performance are adequately reviewed. This is normally accomplished by assigning duties so that no one person handles a transaction from beginning to end and incompatible duties between functions are not handled by the same person.

As a result of this material weakness described above, management has concluded that, as of December 31, 2011, the Company’s internal control over financial reporting was not effective based on the criteria in “Internal Control-Integrated Framework” issued by COSO. The Company intends to augment the Company’s internal controls procedures and expand the Company’s accounting staff. The Company intends to initiate measures to remediate and refine the Company’s internal controls to address this identified material weakness as the Company grows and obtains a stronger cash position that would justify additional expenditures.

 
-11-

 
Changes in internal control over financial reporting

Based on the evaluation of the Company’s management as required by paragraph (d) of Rule 13a-15(f) or 15d-15(f) under the SEC Act of 1934 the Company believes that there were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II-OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS

In the normal course of business, the Company is, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceedings would not have a material adverse effect on the business or financial condition of the Company.  Additionally, from time to time, the Company may pursue litigation against third parties to enforce or protect our rights under our trademarks, trade secrets and our intellectual property rights generally.

During 2010, the Company was served with three lawsuits for past due liabilities of the Company.  The first lawsuit was Peri & Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and OAI has been making payments to the plaintiff. OAI was dismissed from the action and signed a confession of judgment.  Over half of the past due amount has been paid with a balance of approximately $21,000 remaining.  The second lawsuit filed in the US. District Court, Northern California District by a group of plaintiffs: Full Circle Sales, Inc., Growers Express LLC, Steinbeck County Produce Inc., Steve Almquist Sales and Brokerage, Dan Andrews Farms, Fresh Networks, LLC and Quebec Distributing Co., Inc., vs. Organic Alliance, Inc., defendant, for approximately $97,000 plus attorney fees and interest. These plaintiffs are produce suppliers of the Company.  An agreement was reached and three of the plaintiffs were paid in full for $31,000. The balance of $66,000 remains unpaid. The third lawsuit was filed in Monterey County Superior Court by RE Transportation, plaintiff, vs. Organic Alliance, Inc., defendant, seeking approximately $30,000 principal plus interest at 18% per annum and attorney’s fees.  The plaintiff provided transportation services for the Company. An agreement was reach with the plaintiff receiving $10,000 a month for three months starting May 2012.
 
 
-12-

 
 
ITEM 1A. RISK FACTORS
 
Not applicable.

ITEM 2. UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS
 
None.
     
 ITEM 3.  DEFULT UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable.

ITEM 5. OTHER INFORMATION

    None.

ITEM 6. EXHIBITS

See accompanying index to exhibits included after the signature page of this report for a list of exhibits filed or furnished with this report.
 
 
31.1
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
 
31.2
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
 
32.1
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
  
32.2
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
 
 
-13-

 
 
 
SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
ORGANIC ALLIANCE, INC.
   
 
By: /s/ Parker Booth                                         
 
Parker Booth
 
Chief Executive Officer, and Director
 
 
Date: June 18, 2012

 
 
By: /s/ Barry Brookstein                                   
 
Barry Brookstein
 
Chief Financial Officer
 
 
Date: June 18, 2012
   
   

 
 
 
-14-

 
INDEX TO EXHIBIT


Exhibit No.                 Description

 
31.1
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
 
31.2
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
 
32.1
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
  
32.2
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act



 
 
 
 
 
 
 
 
 
 
-15-

 
EX-31.1 2 ex31-1.htm ex31-1.htm
Exhibit 31.1


Certification of Principal Executive Officer
Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended,
As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002

I, Parker Booth, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Organic Alliance, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 18, 2012

   
/s/ Parker Booth
Name:
Parker Booth
Title:
Chief Executive Officer

 
 

 
 
EX-31.2 3 ex31-2.htm ex31-2.htm
Exhibit 31.2


Certification of Principal Financial Officer
Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended,
As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002

I, Barry Brookstein, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Organic Alliance, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 18, 2012

   
/s/ Barry Brookstein
Name:
Barry Brookstein
Title:
Chief Financial Officer

 
 

 

 
EX-32.1 4 ex32-1.htm ex32-1.htm
Exhibit 32.1


Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Organic Alliance, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Parker Booth, Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Parker Booth
Name:
Parker Booth
Title:
Chief Executive Officer
   
Date: June 18, 2012

A signed original of this written statement required by Section 906 has been provided to Organic Alliance, Inc. and will be retained by Organic Alliance, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 
 
 
 
 
 

 
EX-32.2 5 ex32-2.htm ex32-2.htm
Exhibit 32.2


Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Organic Alliance, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Barry Brookstein, Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Barry Brookstein
Name:
Barry Brookstein
Title:
Chief Financial Officer
 
Date: June 18, 2012

A signed original of this written statement required by Section 906 has been provided to Organic Alliance, Inc. and will be retained by Organic Alliance, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


 
 
 
 
 

 
EX-101.INS 6 orgc-20120331.xml 0001442634 2010-12-31 0001442634 2011-12-31 0001442634 2012-01-01 2012-03-31 0001442634 2011-01-01 2011-03-31 0001442634 2012-03-31 0001442634 2011-03-31 0001442634 2012-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares 0.0001 0.0001 100000000 100000000 10000000 10000000 11032593 11032593 11032593 11032593 158265 348708 -13454732 -14385564 9064265 9161849 1103 1103 4547629 5571320 1128549 1398475 155813 789058 2001427 2136712 82087 50929 1179753 1196146 158265 348708 158265 348708 23527 32494 128886 195322 5852 101819 1461 5852 101819 8 Organic Alliance, Inc. 0001442634 10-Q 2012-03-31 false --12-31 No No Yes Smaller Reporting Company Q1 2012 5000 274507 44852 362977 137703 95967 20607 95967 -1453 468842 729931 -31158 201267 38262 500000 566926 -372875 -731384 135285 365508 16393 -397229 -8967 2263 -19073 -8978 -66436 -187727 110012 24694 22892 11762 89587 388945 -4389364 -5222612 19073 77968 77968 17358027 6046778 -0.05 -0.19 -930833 -1172990 -507135 -104873 -278265 -40572 228870 64301 -423698 -1068117 456842 1075467 33144 7350 302863 248405 336007 255755 <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 2%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">1.</font></div> </td> <td style="text-align: left; vertical-align: top; width: 88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">NATURE OF BUSINESS</font></div> <div style="text-indent: 0pt; display: block">&#160;</div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: 10pt Times New Roman"><font style="font-style: italic; display: inline">Organic Alliance, Inc.</font> ("OAI" or the "Company") is a sales and marketing distribution company that supplies conventional, organic, natural, and Fair Trade food products to the global market.&#160;&#160;OAI works directly with growers while also contracting farming production domestically and abroad to vertically integrate supply chains, reduce costs and provide a high degree of control over quality, food safety and production sustainability.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">History </font><font style="font-style: italic; display: inline">- NB Design &#38; Licensing, Inc.,</font> (&#8220;NB Design&#8221;) was organized in September 2001.&#160;&#160;The former&#160;parent, New Bridge Products, Inc., was originally incorporated in August 1995 as a manufacturer of minivans and filed a petition in bankruptcy under Chapter 11 of the U.S. Bankruptcy Code. Its Plan of Reorganization was approved by the U.S. Bankruptcy Court for the District of Arizona in September 2002 and NB Design was discharged from bankruptcy in October 2002.&#160;&#160; NB Design was inactive from October 2002 to April 29, 2008.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="font-style: italic; display: inline">Organic Alliance Inc.,</font> a Texas corporation, (&#8220;Organic Texas&#8221;) was organized on February 19, 2008 to sell organically grown fruits and vegetables.&#160;&#160;During the second quarter of 2009, it ceased being a development stage company when it commenced its operations.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On April 29, 2008, NB Design, a Nevada corporation, acquired all 10,916,917 issued and outstanding shares of common stock of Organic Texas for 464,999 shares of the NB Design&#8217;s common stock. Organic Texas thereupon became a wholly owned subsidiary of NB Design. The business of Organic Texas is the only business of NB Design.&#160;&#160;The Company operates in California.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The acquisition of Organic Texas by NB Design on April 29, 2008 was accounted for as a reverse capitalization in accordance with the Securities and Exchange Commission&#8217;s (&#8220;SEC&#8221;) Division of Corporate Financial Reporting manual Topic 12 &#8220;Reverse Acquisition and Reverse Capitalization&#8221;. The reverse capitalization was the acquisition of a private operating company (Organic Texas) into a non-operating public shell corporation with nominal net assets and as such is treated as a capital transaction, rather than a business combination. As a result no goodwill is recorded.&#160;&#160;In this situation, NB Design is the legal acquirer because it issued its equity interests, and Organic Texas is the legal acquiree because its equity interests were acquired.&#160;&#160;However, NB Design is the acquiree and Organic Texas is the acquirer for accounting purposes.&#160;&#160;Organic Texas is treated as the continuing reporting entity that acquired the registrant, NB Design.&#160;&#160;The pre-acquisition financial statements of Organic Texas are treated as the historical financial statements of the consolidated companies.&#160;</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On June 2, 2008, the name NB Design was changed to Organic Alliance, Inc.&#160;&#160;On August 29, 2008, the name of Organic Texas was changed to Organic Texas, Inc.&#160;&#160;All references throughout the annual report to &#8220;Organic Alliance, Inc.&#8221; or the &#8220;Company&#8221; refers to the combined operations for Organic Alliance, Inc., a Nevada Corporation, and its wholly owned subsidiary, Organic Texas.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">During November 2010, the Company increased the number of authorized shares of common stock from 60 million shares to 2 billion shares.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On February 14, 2011, the Company executed a 20:1 reverse split and decreased the number of authorized shares of common stock from 2 billion shares to 100 million shares.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 3%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">2.</font></div> </td> <td style="text-align: left; vertical-align: top; width: 87%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Basis of Presentation</font> - The Company's unaudited condensed consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business and in accordance with the instructions for Form 10-Q and article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In the opinion of management, the&#160;condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The results for the three months ended March 31, 2012 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K for the&#160;year ended December 31, 2011 filed with the Securities and Exchange Commission on June 18, 2012.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Use of Estimates</font> - The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include but are not limited to, realization of deferred tax assets, allowance for doubtful accounts and assumptions used in share based payment transactions.&#160;&#160;Actual results could differ from those estimates.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Principles of Consolidation</font><font style="font-style: italic; display: inline"> - </font>The condensed consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly owned subsidiary, Organic Texas. Inc. (collectively, the "Company&#8221;). All significant inter-company transactions and balances have been eliminated in consolidation.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Allowance for Doubtful Accounts</font> - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company&#8217;s produce is sold to the Company&#8217;s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $77,969 at March 31, 2012 and December 31, 2011, respectively.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In addition, the Company also factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition of such fees may differ from the estimates depending upon the timing of collections.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Inventory -</font> Inventory is stated at the lower of cost (first-in, first-out) or market, and includes produce the Company purchases from growers and packaging materials. The Company held $19,073 and $0 of inventory as of March 31, 2012 and December 31, 2011, respectively.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Fair Value of Financial Instruments</font> - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet date presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet date presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Derivative Financial Instruments</font> - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of the Company&#8217;s financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.&#160;&#160;The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date.&#160;&#160;As a result of entering into the convertible notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date.&#160;&#160;Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date.&#160;&#160;The Company reassesses the classification at each balance sheet date.&#160;&#160;If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method and conversion options at variable rates and any options and warrants&#160;&#160;with ratchet provisions are deemed to be a &#8220;down-round protection&#8221; and therefore, do not meet the scope exception for treatment as a derivative under ASC 815.&#160;&#160;Since, &#8220;down-round protection&#8221; is not an input into the calculation of the fair value of the equity instruments and cannot be considered &#8220;indexed to the Company&#8217;s own stock&#8221; which is a requirement for the scope exception as outlined under ASC 815.&#160;The Company determined the fair value of the Binomial Lattice Model and the Intrinsic Value Method to be materially the same. Warrants that have been reclassified to derivative liability that did not contain &#8220;down-round protection&#8221; were valued using the&#160;black-scholes model.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: 10pt Times New Roman">For the Black-Scholes pricing model, which approximates the binomial lattice model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: center"> <table cellpadding="0" cellspacing="0" style="width: 50%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: bottom; width: 26%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">2012</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">2011</font></div> </td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Risk-free interest rate</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">0.31% - 0.38</font><font style="display: inline; font: 10pt times new roman">%</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">0.30</font><font style="display: inline; font: 10pt times new roman">%</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Dividend yield</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Expected volatility</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">46.5%-46.8</font><font style="display: inline; font: 10pt times new roman">%</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">36.0%-37.2</font><font style="display: inline; font: 10pt times new roman">%</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Expected life in months and years</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; text-align: center"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">20 months</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; text-align: center"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">9 months- 2 years</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left">&#160;</div> <div style="text-align: center"> <table cellpadding="0" cellspacing="0" style="width: 50%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: bottom; width: 26%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">2012</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">2011</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Risk-free interest rate</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">0.15% - 0.62</font><font style="display: inline; font: 10pt times new roman">%</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Dividend yield</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Expected volatility</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">43.4%-46.1</font><font style="display: inline; font: 10pt times new roman">%</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Expected life in months and years</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; text-align: center"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt"><font style="display: inline; font: 10pt times new roman">6 months - 3 years</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Revenue Recognition - </font>Revenue is recorded when (1) the customer accepts delivery of the product and title has been transferred and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.&#160;&#160;</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Share Based Compensation</font> - The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) No. 718.&#160; For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on interim financial reporting dates until the service period is complete.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate.&#160; The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model.&#160; The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding.&#160;&#160;The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">For the Black-Scholes pricing model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: center"> <table cellpadding="0" cellspacing="0" style="width: 50%; font: 10pt times new roman"> <tr> <td style="vertical-align: bottom; width: 26%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">2012</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">2011</font></div> </td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Risk-free interest rate</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">0.43% - 0.86</font><font style="display: inline; font: 10pt times new roman">%</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">2.37</font><font style="display: inline; font: 10pt times new roman">%</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Dividend yield</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">N/A</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Expected volatility</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">44.7% - 55.2</font><font style="display: inline; font: 10pt times new roman">%</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">54.5</font><font style="display: inline; font: 10pt times new roman">%</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Expected life in years</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">3-5</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: center"><font style="display: inline; font: 10pt times new roman">5</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: bold 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: bold 10pt Times New Roman">Concentrations</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="vertical-align: top; width: 8%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt Symbol, serif">&#160;&#183;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Credit Risk -<font style="display: inline; font-weight: bold">&#160;</font>The Company maintains cash balances at various high quality federally insured financial institutions, with balances at times, in excess of federally insured limits.&#160;&#160;Management believes that the financial institutions that hold the Company&#8217;s deposits are financially sound and therefore pose a minimum credit risk. The Company has not experienced any losses in such accounts.</font></div> </td> </tr><tr> <td style="vertical-align: top; width: 8%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt Symbol, serif">&#183;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Major customers - The Company has two and four major customers, which accounted for approximately 65% and 61% of the sales during three months ended March 31, 2012 and 2011, respectively. For the three months ended March 31, 2012, the total sales comprised of customer A 42% and customer B 23% compared to the three months ended March 31, 2011, comprised of customer E 26%, customer F 14%, customer G 12% and customer B 10%.&#160;&#160;The loss of any of these customers could adversely affect the Company's operations.</font></div> </td> </tr><tr> <td style="vertical-align: top; width: 8%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt Symbol, serif">&#183;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Major receivables - The Company has five major receivables at March 31, 2012&#160;&#160;comprised of customer E 27%, customer A 16%, customer C 17%, customer B 14% and customer D 11%&#160;&#160;compared to five major receivables at March 31, 2011, comprised of customer E 28%, customer F 15%, G 13%, customer B 11% and customer H 11%.</font></div> </td> </tr><tr> <td style="vertical-align: top; width: 8%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt Symbol, serif">&#183;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Major suppliers - The Company has four and three major suppliers, which accounted for approximately 63% and 94% of purchases during three months ended March 31, 2012 and 2011, respectively. The loss of any of these suppliers could adversely affect the Company's operations.</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block">&#160;</div> <div style="text-indent: 0pt; display: block"></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; font-weight: bold">Net Loss Per Share - </font>Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In accordance with ASC 260 &#8220;Earnings per Share&#8221;, the Company has given effect to the issuance of 2,795,538 and 1,323,070 warrants as of March 31, 2012 and 2011, respectively, exercisable at $0.01.&#160;These warrants have been included in computing the basic net loss per share for the three months ended March 31, 2012 and 2011.&#160;&#160;Additionally, included in the Company&#8217;s weighted average shares outstanding are 3,529,897 and 56,189 shares earned, but not issued as at March 31, 2012 and 2011, respectively.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Total shares issuable upon the exercise of warrants, options and the conversion of convertible notes for the three months ended March 31, 2012 and 2011 were as follows:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: center"> <table cellpadding="0" cellspacing="0" style="width: 50%; font: 10pt times new roman"> <tr> <td style="vertical-align: bottom; width: 26%; padding-bottom: 2px; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="6" style="vertical-align: bottom; width: 22%; border-bottom: black 2px solid; border-top-style: none; border-top-width: medium"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">March 31,</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 26%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">2012</font></font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; width: 10%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman"><font style="display: inline">2011</font></font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Options</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4,483,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">33,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Warrants</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4,710,350</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">320,008</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 26%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Convertible notes</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">5,304,352</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">581,575</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td rowspan="2" style="text-align: left; vertical-align: bottom; width: 26%; padding-bottom: 4px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Total Common stock equivalents</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">14,498,452</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">935,333</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: bold 10pt Times New Roman">Recently Issued Accounting Standards</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In May 2011, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2011-04, &#8220;Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs." This ASU addresses fair value measurement and disclosure requirements within Accounting Standards Codification ("ASC") Topic 820 for the purpose of providing consistency and common meaning between U.S. GAAP and IFRSs. Generally, this ASU is not intended to change the application of the requirements in Topic 820. Rather, this ASU primarily changes the wording to describe many of the requirements in U.S. GAAP for measuring fair value or for disclosing information about fair value measurements. This ASU is effective for periods beginning after December 15, 2011 and did not have a material impact on the Company&#8217;s consolidated financial statements or disclosures.<font style="display: inline; font-weight: bold">&#160;</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. This guidance improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. The guidance provided by this update becomes effective for interim and annual periods beginning on or after December 15, 2011. The adoption of this standard did not have a material impact on the Company&#8217;s financial position or results of operations.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">3.</font></div> </td> <td style="text-align: left; vertical-align: top; width: 89%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;GOING CONCERN</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of March 31, 2012, the Company has limited cash, a working capital deficit of approximately $5,223,000, has accumulated losses of approximately $14,386,000 since its inception and has withheld $163,949 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities and are delinquent. The Company is currently delinquent with its payroll tax filings since December 31, 2008. Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due and increasing its revenue in order to achieve profitable operations. The Company estimates a $2,000,000 capital infusion will be required to continue operations through the end of 2012. The outcome of these matters cannot be predicted with any certainty at this time and raises substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The Company intends to overcome the circumstances that impact its ability to remain a going concern through a combination of growing high margin revenues, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however the Company does not have commitments from third parties for a sufficient amount of additional capital. The Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue its operations. The Company&#8217;s ability to obtain additional funding will determine its ability to continue as a going concern. Furthermore, additional equity financing may be dilutive to the holders of the Company&#8217;s common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary to raise additional funds, and may require that the Company relinquish valuable rights.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">4.</font></div> </td> <td style="text-align: left; vertical-align: top; width: 89%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">DUE TO FACTOR</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On November 1, 2010 the Company entered into a new one year accounts receivable factoring facility with a financial services company with maximum borrowings of $1,800,000.&#160;&#160;The contract expired on October 31, 2011, and the Company is operating on a month to month basis, thereafter. The financial services company advances up to 80% of qualified customer invoices less applicable discount fee, and holds the remaining 20% as a reserve until the customer pays the financial services company.&#160;&#160;The released reserves are used to fund other vendor purchases or returned to the Company.&#160;&#160;The Company is charged 3% for the first 30 days outstanding plus 1/10 of 1% for funds outstanding over 30 days. Uncollectable customer invoices are charged back to the Company.&#160;&#160;The new financial services company commenced funding during February 2011. At March 31, 2012 the advances from the factor inclusive of fees amounted to $64,789 which was offset against due from factor of approximately $13,860. Advances from the factor are collateralized by substantially all assets of the Company.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">5.</font></div> </td> <td style="text-align: left; vertical-align: top; width: 89%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">PREFERRED STOCK</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify"><font style="display: inline; font: 10pt Times New Roman">The Company&#8217;s articles of incorporation authorize&#160;the Company's Board of Directors to issue up to 10,000,000 shares of preferred stock, having no par value, in one or more series without stockholder approval.&#160;Each such series of preferred stock&#160;may have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as determined by the&#160;Company&#8217;s Board of Directors. At December&#160;31, 2011 and 2010, no shares of preferred stock were issued or outstanding.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In August 2010, the Company signed a one year consulting agreement with a consultant to provide investor and public relation services. The consultant&#8217;s compensation includes convertible preferred stock which, at the final determination date, will be converted into shares of common stock of the Company equivalent to 25% of outstanding common shares, as defined in the agreement.&#160;&#160;The consultant elected to receive the common stock equivalent directly as compensation.&#160;&#160;The Company calculated the fair value of the award to be $868,724 or 4,169,638 shares of common stock. The Company accrued $506,680 of stock based compensation for these services during the year ended December 31, 2011, which has been included in accrued expenses and other current liabilities. During March 2011, 695,930 shares of common stock valued at $173,982 were issued to the consultant for the settlement of a portion of the accrued compensation, the remaining 3,473,708 shares of common stock valued at $694,742 have not been issued as of March 31, 2012 and is currently due and payable.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 2%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">9.&#160;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">RELATED PARTY TRANSACTIONS</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Consulting Agreement</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On July 1, 2008, the Company signed a 16 month consulting agreement with a related party. The consulting services include financial advisory, investment relations and certain administrative and other services for $6,250 monthly fees. At March 31, 2012 and December 31, 2011, the Company owed $100,000 related to above consulting services, which is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.&#160;&#160;</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Employee Warrants</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On February 29, 2012, an employee was granted three year warrants to purchase 300,000 shares of the Company&#8217;s common stock for services to the Company.&#160;&#160;The warrants vest immediately with an exercise price of $0.25 per share. The Company recorded a charge for $6,149 to stock based compensation for the three months ended March 31, 2012.</font></div> <div style="text-indent: 0pt; display: block"></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 2%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">10.&#160;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 87%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">COMMITMENTS AND CONTINGENCIES</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Agreements</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On September 27, 2010 the Company signed a twelve month agreement for investment banking services which was renewed for another 12 months. The banking services include equity financing, business combinations and other financing transactions. The compensation to the banker includes a flat fee plus other compensation as defined in the agreement.&#160;&#160;The agreement includes three year warrants &#8220;Initial Warrants&#8221;, which were fully vested on the date of the grant to purchase 74,850 shares of Company&#8217;s common stock at an exercise price of $0.001 per share. The fair value of the award was $19,443 and is amortized over the term of the agreement; accordingly, the Company recorded a stock based compensation charge of $4,861 for the three months ended March 31, 2011.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In addition, the agreement provides for an additional warrant to be issued by the Company upon the 1 year anniversary provided that the banker did not exercise any of their other compensation elements as defined in the agreement. This warrant carries a cashless exercise provision and is limited to up to 4.99% of the Company&#8217;s outstanding common stock on a fully diluted basis. In September 2011, the Company issued warrants to purchase 1,020,113 shares of the Company&#8217;s common stock.&#160;&#160;The warrants are exercisable at $0.001 per share, have a life of 3 years and were fully vested on the date of the grant.&#160;&#160;The fair value of the award was $213,215 and is amortized over the term of the agreement; accordingly, the Company recorded a stock based compensation charge of $53,304 for the three months ended March 31, 2012.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On November 2, 2010, the Company entered into an agreement with an attorney for general corporate and transactional matters that provide a 3.50% equity interest in the Company upon meeting certain milestones.&#160;&#160;These milestones were met in February 2011, and the attorney was granted 5 year warrants vesting on February 14, 2011 to purchase 795,866 shares of Company&#8217;s common stock at an exercise price of $0.01 per share. The warrant was fully vested on the date of the grant and accordingly the Company recorded a stock based compensation charge of $279,453 for the three months ended March 31, 2011 which represents the fair value of the award.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Legal matters</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">In the normal course of business, the Company is, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceedings would not have a material adverse effect on the business or financial condition of the Company.&#160; Additionally, from time to time, the Company may pursue litigation against third parties to enforce or protect the Company&#8217;s rights under the Company&#8217;s trademarks, trade secrets and the Company&#8217;s intellectual property rights generally.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: justify">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">During 2010, the Company was served with three lawsuits for past due liabilities of the Company.&#160;&#160;The first lawsuit was Peri &#38; Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and OAI has been making payments to the plaintiff. OAI was dismissed from the action and signed a confession of judgment.&#160;&#160;Over half of the past due amount has been paid with a balance of approximately $21,000 remaining.&#160;&#160;The second lawsuit filed in the US. District Court, Northern California District by a group of plaintiffs: Full Circle Sales, Inc., Growers Express LLC, Steinbeck County Produce Inc., Steve Almquist Sales and Brokerage, Dan Andrews Farms, Fresh Networks, LLC and Quebec Distributing Co., Inc., vs. Organic Alliance, Inc., defendant, for approximately $97,000 plus attorney fees and interest.&#160;&#160;These plaintiffs are produce suppliers of the Company.&#160;&#160;An agreement was reached and three of the plaintiffs were paid in full for $31,000. The balance of $66,000 remains unpaid. The third lawsuit was filed in Monterey County Superior Court by RE Transportation, plaintiff, vs. Organic Alliance, Inc., defendant, seeking approximately $34,000 principal plus interest at 18% per annum and attorney&#8217;s fees.&#160; The plaintiff provided transportation services for the Company.&#160;&#160;An agreement was reach with the plaintiff receiving $10,000 a month for three months starting May 2012.<font style="display: inline; font-family: Times New Roman">&#160;</font>The Company has accrued for all amounts claimed.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 3%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">11.</font></div> </td> <td style="text-align: left; vertical-align: top; width: 87%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Accrued expenses and other current liabilities consist of the following:</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">March 31, 2012</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">December 31, 2011</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Due to consultant (Note 9)</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">100,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">100,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Accrued consulting fees (Note 5)</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">694,742</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">694,742</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Payroll and payroll taxes payable (A)</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1,277,360</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1,131,572</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 76%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Other accrued liabilities</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">64,610</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">75,113</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 76%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">2,136,712</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">2,001,427</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">(A) As of March 31 2011 and December 31, 2011, the Company has withheld $163,949 and $153,009 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities.</font></div> <div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman"> <tr> <td style="text-align: left; vertical-align: top; width: 3%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">12.&#160;</font></div> </td> <td style="text-align: left; vertical-align: top; width: 87%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">SUBSEQUENT EVENTS</font></div> </td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required further adjustment to or disclosure in the consolidated financial statements.&#160;</font></div> <div style="text-indent: 0pt; display: block"></div> 201796 11032593 <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 2%; font: 10pt/115% Times New Roman, Times, Serif">6.</td> <td style="width: 98%; font: 10pt/115% Times New Roman, Times, Serif">&#160;NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Notes payable to related parties and others, net of discounts consists of the following:</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">March 31,</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">December 31,</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">2012</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">2011</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">(Unaudited)</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">(Audited)</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; line-height: 115%; text-indent: -9pt">N Notes Payable (net of Debt Discount of $42,076 at March 31, 2012 and $63,114 at December 31, 2011) (A)</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">599,491</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">551,978</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">Notes Payable &#150; Related Parties (net of Debt Discount of $30,053 at March 31, 2012 and $50,053 at December 31, 2011) (B)</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">486,455</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">348,130</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">Convertible Notes Payable (net of Debt Discount of $335,471 at March 31, 2012 and $41,469 at December 31, 2011) (C)</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">312,529</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">228,441</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,398,475</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,128,549</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><u>Notes Payable</u></p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 115%; text-align: right">(A)&#160;&#160;</td> <td style="line-height: 115%; text-decoration: underline">Notes Payable</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">i.&#160;&#160;</td> <td style="line-height: 115%">In May 2010, an individual advanced to the Company $20,000 bearing interest at 6% per annum.&#160;&#160;As a financing incentive, the individual received warrants to purchase&#160;20,000 shares of the Company&#146;s common stock at $1.00 per share.&#160;&#160;The warrants expired in November 2011.&#160;&#160;The gross proceeds of the note were recorded net of a debt discount of $9,200. The debt discount consisted of the relative fair value of the warrants of $9,200 and is accreted to interest expense ratably over the term of the note. The promissory note matured on November 17, 2011.&#160;&#160;&#160;The unpaid balance, including accrued interest, was $22,142 and $21,843 at March 31, 2012 and December 31, 2011, respectively. The Company is not compliant with the repayment terms of the note.</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">ii.&#160;&#160;</td> <td style="line-height: 115%">On November 3, 2010, the Company signed a $38,262 demand note with an interest rate of 5% per annum. The unpaid balance, including accrued interest, was $38,565 at December 31, 2011. The note was repaid in January 2011.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">iii.&#160;&#160;</td> <td style="line-height: 115%">On February 3, 2011, the Company signed a $500,000 promissory note with a maturity date of August 2, 2012, and has a stated interest rate of 15% per annum. As a financing incentive, the lender received three year warrants vesting on January 31, 2011, to purchase 452,354 shares of common stock at an exercise price of $0.01 per share and also received five year warrants, vesting on June 30, 2011, to purchase 452,354 shares at an exercise price of $0.01 per share.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 &#147;Derivatives and Hedging&#148;.&#160;&#160;&#160; Accordingly, the warrants are recorded as derivative liabilities at their fair value and are marked to market through earnings at the end of each reporting period.&#160;&#160;The gross proceeds from the sale of the note $500,000 was recorded net of a discount of $137,703.&#160;&#160;The debt discount consisted of $137,703 related to the fair value of the warrants and is accreted to interest expense ratably over the term of the note which amounted to $21,038 and $15,300 for the three months ended March 31, 2012 and 2011, respectively, and is included as a component of interest expense in the accompanying condensed consolidated statement of operations. The Company has not made any note payments and received a waiver from the lender on September 1, 2011 that defers payment until September 1, 2012 and increased the interest rate to 21% beginning April 4, 2011, the date of the first event of&#160;&#160;default. The unpaid balance, including accrued interest, was $619,425 and $593,247 at March 31, 2012 and December 31, 2011, respectively.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 115%; text-align: right">(B)&#160;&#160;</td> <td style="line-height: 115%; text-decoration: underline">Notes Payable &#150; Related Parties</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">i.&#160;&#160;</td> <td style="line-height: 115%">In September 2008, Earnest Mathis, a former owner, advanced to the Company $15,000. The advance is evidenced by a promissory note bearing interest at 10% per annum.&#160;&#160;The promissory note matured on September 13, 2009.&#160;&#160;The unpaid balance, including accrued interest, was $20,316 and $19,942 at March 31, 2012 and December 31, 2011, respectively.&#160;&#160;The note has not been repaid as of June 18, 2012. The Company is not compliant with the repayment provisions of this note.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">ii.&#160;&#160;</td> <td style="line-height: 115%">On February 18, 2011, the Company issued 3,858,574 shares of common stock to Parker Booth, Chief Executive Officer,&#160;for the settlement of $231,514 of principal and $5,996 of the accrued interest.&#160; The fair value of the common stock issued exceeded the fair value of the promissory notes and accrued interest by $64,824 which the Company recorded a charge to stock based compensation expense during the three months ended March 31, 2011. The unpaid balance for accrued interest was $6,803 at March 31, 2012 and December 31, 2011.&#160; The Company is not compliant with the repayment terms of this note.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">iii.&#160;&#160;</td> <td style="line-height: 115%">In October and December 2009, Michael Rosenthal, director, advanced the Company $100,000 and $30,000, respectively, totaling $130,000. The advances are evidenced by promissory notes bearing interest at 5% per annum.&#160;&#160;The notes matured on March 31, 2010 and June 30, 2010, respectively. On February 18, 2011, at the option of the holder, the Company issued 964,643 shares of common stock for the settlement of $57,879 of the remaining principal and accrued interest of $7,091.&#160;&#160;The fair value of the common stock issued exceeded the remaining portion of promissory notes plus accrued interest by $31,092 and is included as a component of stock based compensation expense in the accompanying condensed consolidated statement of operations.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">iv.&#160;&#160;</td> <td style="line-height: 115%">In November 2009 and February 2010, Morrison Partners, LLC (Thomas Morrison, former CEO and Chairman of the Board is the President), advanced to the Company $10,000 and $15,000, respectively, totaling $25,000. The advances are evidenced by promissory notes bearing interest at 5% per annum.&#160;&#160;The November advance provides for the issuance of 2,770 shares of the Company&#146;s common stock as a financing incentive.&#160;&#160;The Company recorded a debt discount of $2,935 for the relative fair value of the common stock. The discount was accreted over the life of the note.</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The November 2009 and February 2010 notes were due on June 30, 2010 and September 30, 2010, respectively. The unpaid balance, including accrued interest, was $27,784 and $27,472 at March 31, 2012 and December 31, 2011, respectively. The shares have not been issued to Morrison Partners, LLC. The Company is not compliant with the repayment terms of this note.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">v.&#160;&#160;</td> <td style="line-height: 115%">During March, 2010 through October 2011, an employee of the Company loaned to the Company $65,958 of which an aggregate amount of $16,000 and $49,958 was advanced during 2011 and 2010, respectively. The loans are evidenced by promissory notes payable with interest at 5% and are due on demand. The Company repaid $9,000 during 2010. In addition, the employee will be issued 47,690 shares of the Company&#146;s common stock upon repayment of the promissory notes as additional consideration. The Company will record a fair value for these shares on the measurement date as a charge to interest expense. The unpaid balance including accrued interest was $60,684 and $59,974 at March 31, 2012 and December 31, 2011, respectively.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">vi.&#160;&#160;</td> <td style="line-height: 115%">On October 17, 2011, the Company entered into a $400,000 convertible multi-draw term loan facility (&#147;loan&#148;) with an entity owned by a related party who is a 100% shareholder.&#160;&#160;The loan bears interest at 21% and has a maturity date of the earlier of an event of default or April 17, 2012.&#160;&#160;The Company has not made a note payment and is currently negotiating an extension of such loan. At the time of any new debt or equity financing of the Company, the note balance of principal and interest may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing.&#160;&#160;In addition, the related party received a warrant to purchase 2.5 shares of the Company&#146;s common stock for each $1.00 of principal extended to the Company up to 1,000,000 shares.&#160;&#160;The warrants have an exercise price of $.10 per share and vest with each cash advance from the loan and collectively expire on October 17, 2014. The Company received $75,000 and $275,000 in gross proceeds&#160;during the three months ended March 31, 2012, and year ended December 31, 2012, respectively.&#160;The Company issued three-year warrants to purchase an aggregate of 187,500 and 687,500 shares of the Company&#146;s common stock during the three months ended March 31, 2012 and the year ended December 31, 2011, respectively. The unpaid balance, including accrued interest, was $350,000 and $283,993 at March 31, 2012 and December 31, 2011, respectively. As of June 18, 2012, the Company has been advanced $400,000 on the loan.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The conversion price of the notes was not fixed and&#160;&#160;determinable on the date of issuance and as such in accordance with ASC Topic 815 &#147;<i>Derivatives and Hedging</i>&#148; (&#147;ASC 815&#148;), the embedded conversion option of the notes on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the three-year warrants issued in connection with the note on the date of issuance aggregated $70,074, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $40,062 for the three months ended March 31, 2012.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">vii.&#160;&#160;</td> <td style="line-height: 115%">On February 28, 2012, Michael Rosenthal, director, advanced the Company $50,000. The advance is evidenced by promissory notes bearing interest at 21% and has a maturity date of the earlier of an event of default or August 28, 2012.&#160;&#160;In addition, Mr. Rosenthal received three year warrants vesting February 28, 2012, to purchase 125,000 shares of Company&#146;s common stock at an exercise price of $0.10 per share. The Company recorded a debt discount of $7,997 to the face value of the note based upon the relative fair values of the note and the common stock. The discount is being accreted over the life of the note which amounted to $1,406 for three months ended March 31, 2012, and is included as a component of interest expense in the accompanying condensed consolidated statement of operations. The unpaid balance including accrued interest was $50,921 at March 31, 2012.</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; line-height: 115%; text-align: right">(C)&#160;&#160;</td> <td style="line-height: 115%; text-decoration: underline">Convertible Notes Payable</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">i.&#160;&#160;</td> <td style="line-height: 115%">On July 14, 2010, the Company issued a $52,380 convertible promissory note with a maturity date of September 13, 2012, and with an interest rate of 20% per annum. The note can be converted into the Company's common stock by the holder based on a variable conversion price. The variable conversion price is defined in the note as 45% multiplied by the average of the five lowest intraday prices for the Company&#146;s stock during the previous 20 trading days prior to the date of conversion.&#160;&#160;The total conversion may not exceed 4.99% of the Company&#146;s common stock issued and outstanding. In addition, the Company placed 250,000 shares of the Company&#146;s common stock in escrow to secure our conversion obligations under the note. During September 2010, the lender converted $7,500 of the debt into 75,758 shares of the Company&#146;s common stock for $.099 per share.&#160;&#160;During December 2010, the lender converted $7,500 of the debt into 53,419 shares of the Company&#146;s common stock for $.14 per share.&#160;&#160;During March 2011, the lender converted $5,000 of the debt to 198,413 shares of the Company&#146;s common stock for $.0252 per share. During September 2011, the lender converted $20,000 of the debt to 444,444 shares of the Company&#146;s common stock for $.045 per share. The unpaid balance, including accrued interest, was $22,318 and $21,567 at March 31, 2012 and December 31, 2011, respectively.&#160;&#160;As of June 18, 2012, approximately $23,000 of the note and accrued interest remains unpaid.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 &#147;<i>Derivatives and Hedging</i>&#148; (&#147;ASC 815&#148;), the embedded conversion options of the note on the date of issuance were valued using the Black-Scholes pricing model, which approximates the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option in connection with the note on the date of issuance aggregated $52,380, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $6,548 for the three months ended March 31, 2012 and 2011.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">ii.&#160;&#160;</td> <td style="line-height: 115%">On July 30, 2010, an individual advanced the Company $8,000. The advance is evidenced by a promissory note bearing interest at 6% per annum and maturing on March 2, 2011.&#160; The holder, at any time, may convert the promissory note into shares of Company&#146;s common stock at $0.05 per share.&#160;&#160;The Company calculated the fair value of the beneficial conversion feature using the Black-Scholes pricing model on the date of issuance.&#160;&#160;The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,000, and was recorded as debt discount. The debt discount was amortized through the term of the note and amounted to $1,333 for the three months ended March 31, 2011.&#160;&#160;The unpaid balance, including accrued interest, was $8,802 and $8,683 at March 31, 2012 and December 31, 2011, respectively. The Company is not compliant with the repayment terms of this note.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">iii.&#160;&#160;</td> <td style="line-height: 115%">On April 28, 2011, the Company issued a $70,588 convertible promissory note with an original issue discount of 15%.&#160;&#160;The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) May 31, 2011.&#160;&#160;The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company has not made a note payment and received a waiver from the lender on September 1, 2011 that defers payment until May 31, 2012 and waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. The Company is currently negotiating an extension of such loan. As a financing incentive, the lender received five-year warrants vesting April 28, 2011, to purchase 705,882 shares of Company&#146;s common stock at an exercise price of $0.25 per share.&#160;&#160;The unpaid balance, including accrued interest, was $70,588 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 &#147;<i>Derivatives and Hedging</i>&#148; (&#147;ASC 815&#148;), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $60,000, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $60,000 for the year ended December 31, 2011.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">iv.&#160;&#160;</td> <td style="line-height: 115%">On June 15, 2011, the Company issued a $57,500 convertible promissory note with an original issue discount of 15%.&#160;&#160;The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) June 14, 2012. The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company received a waiver from the lender on September 1, 2011 that waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. As a financing incentive, the lender received five-year warrants vesting June 15, 2011, to purchase 575,000 shares of Company&#146;s common stock at an exercise price of $0.25 per share. The unpaid balance, including accrued interest, was $57,500 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 &#147;<i>Derivatives and Hedging</i>&#148; (&#147;ASC 815&#148;), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $50,000, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $12,500 for the three months ended March 31, 2012.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">v.&#160;&#160;</td> <td style="line-height: 115%">On July 15, 2011, the Company issued a $109,822 convertible promissory note with an original issue discount of 15% that consolidated various demand notes from September 2010 through July 2011.&#160;&#160;The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) August 31, 2011. The Company has not made a note payment and is currently negotiating an extension of such loan. The note may be converted into the Company's common stock by the holder at $0.05 per share.&#160;&#160;As a financing incentive, the lender received five-year warrants vesting July 15, 2011, to purchase 1,098,220 shares of Company&#146;s common stock at an exercise price of $0.25 per share.&#160;&#160;The unpaid balance, including accrued interest, was $111,572 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 &#147;<i>Derivatives and Hedging</i>&#148; (&#147;ASC 815&#148;), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $95,497, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $95,497 for the year ended December 31, 2011.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px; line-height: 115%; text-align: right">vi.&#160;&#160;</td> <td style="line-height: 115%">On March 2, 2012, the Company entered into an agreement to sell secured promissory notes for an aggregate principal amount of $1,000,000, with warrants to purchase 2.5 shares the Company&#146;s common stock for each $1 of the principal amount of the notes purchased.&#160;&#160;In addition, the Company will issue to the investment banker, warrants for the purchase of the number of shares of the Company&#146;s common stock equal to 10% of the common stock issuable in conjunction with the promissory notes sold in this offering. The three year warrants vesting immediately was 1,031,250 shares of the Company&#146;s common stock at an exercise price of $.10 per share. The notes bear interest at 18% and have a maturity date of September 2, 2012. At the time of any new debt or equity financing of the Company, the note balance of principal and interest may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing.&#160;&#160;The Company received $375,000 in gross proceeds during the three months ended March 31, 2012. The unpaid balance, including accrued interest, was $377,219 at March 31, 2012.&#160;&#160;As of June 18, a total of $850,000 has been raised by the offering.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">The conversion price of the note and three-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 &#147;<i>Derivatives and Hedging</i>&#148; (&#147;ASC 815&#148;), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $341,509, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $25,542 for the three months ended March 31, 2012.</p> <p style="margin: 0pt"></p> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">8.&#160; STOCK OPTIONS AND WARRANTS</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Stock Options &#8211; Employment Letter Agreement:&#160;</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">On January 6, 2012, in conjunction with Mark Zeller&#8217;s employment as the Company&#8217;s North American Director of Sales the Company provided an option to purchase 1,500,000 shares of common stock at $0.20 per share. The option has&#160;a life of five years and 250,000 options vested immediately and 416,667 shares vest on each anniversary after such date. The fair value of the option was approximately $44,000.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The Company recognized stock based compensation expense included in general and administrative expenses on the consolidated statement of operations for the three months ended March 31, 2012 and 2011, for $30,134 and $8,719, respectively for these awards.</font></div> <div style="text-indent: 0pt; display: block"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Options Summary:</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">A summary of option activity during the three months ended March 31, 2012 and year ended December 31, 2011 is presented below:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-top-style: none; border-top-width: medium"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Weighted</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; border-top-style: none; border-top-width: medium"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Weighted</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Average</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Average</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Remaining</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Exercise</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Contractual</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Intrinsic</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Shares</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Price</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Term</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Value</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Balance at December 31, 2010</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">33,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">10.20</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">3.88</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Granted</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">2,950,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">0.20</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">7.00</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Exercised</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Forfeited</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Balance at December 31, 2011</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">2,983,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">0.31</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">4.00</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Granted</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">1,500,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">0.20</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">5.00</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Exercised</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Forfeited</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Balance at March 31, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">4,483,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">0.28</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">4.21</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 52%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 4px"> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Exercisable at March 31, 2012</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">1,758,750</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">0.28</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">4.21</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 4px double; text-align: right"><font style="display: inline; font: 10pt times new roman">-</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block"><font style="display: inline; font: 10pt Times New Roman"><font style="display: inline; text-decoration: underline">Common Stock Warrants Summary:</font></font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">Warrant transactions during the three months ended March 31, 2012 and the year ended December 31, 2011 are as follows:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Weighted</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Average</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Average</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Remaining</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Number of</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Exercise</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Life</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Intrinsic</font></div> </td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Warrants</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Price</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">In Years</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Value</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Balance, December 31, 2010</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">394,858</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: left; vertical-align: bottom; width: 1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">15.2</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Granted</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">5,787,290</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">0.12</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Exercised</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">&#8211;</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">&#8211;</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Forfeited</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">(320,008</font></div> </td> <td style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">)</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">18.81</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Balance, December 31, 2011</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">5,862,140</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: left; vertical-align: bottom; width: 1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">0.12</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Granted</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">1,643,750</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">0.13</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Exercised</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">&#8211;</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">&#8211;</font></div> </td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 2px"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Forfeited</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">&#8211;</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">&#8211;</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 4px"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Balance, March 31, 2012</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">7,505,890</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">0.12</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">3.16</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">744,132</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom; width: 52%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="text-align: left; vertical-align: bottom; width: 52%; padding-bottom: 4px"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">Exercisable, March 31, 2012</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">7,505,890</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">0.12</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 4px double"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">3.16</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></div> </td> <td style="text-align: right; vertical-align: bottom; width: 9%; border-bottom: black 4px double"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: right"><font style="display: inline; font: 10pt times new roman">744,132</font></div> </td> <td style="vertical-align: bottom; width: 1%; padding-bottom: 4px"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr><tr> <td style="vertical-align: bottom; width: 52%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 9%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> <td style="vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160; </font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The intrinsic value is calculated on the difference between the fair market value of the Company&#8217;s restricted stock, which was $0.20 per share as of March 31, 2012, and the exercise price of the warrants.</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: left"><font style="display: inline; font: 10pt Times New Roman">The following table presents information related to warrants at March 31, 2012:</font></div> <div style="text-indent: 0pt; display: block"><br /> </div> <div style="text-align: left"> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt times new roman; font-size: 10pt; font-family: times new roman"> <tr> <td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Warrants Outstanding</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="6" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Warrants Exercisable</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Weighted</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Average</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Exercisable</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Exercise</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Number of</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Remaining Life</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Number of</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Price</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Warrants</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">In Years</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 2px solid"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt times new roman">Warrants</font></div> </td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="2" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">$</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.001</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">74,850</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1.50</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">74,850</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.01</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">452,354</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1.83</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">452,354</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.01</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">795,866</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">3.88</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">795,866</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.25</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">705,882</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4.08</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">705,882</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.25</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">575,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4.21</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">575,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.01</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">452,355</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4.25</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">452,355</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.25</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1,098,220</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">4.29</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1,098,220</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.001</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1,020,113</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">2.50</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">1,020,113</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.10</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">875,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">2.63</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">875,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.10</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">125,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">2.92</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">125,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">0.25</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">300,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">2.92</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right"><font style="display: inline; font: 10pt times new roman">300,000</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">0.10</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">1,031,250</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">2.96</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">1,031,250</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; text-align: right; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">7,505,890</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">3.16</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 1%; border-bottom: black 2px solid; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; width: 9%; border-bottom: black 2px solid; text-align: right"><font style="display: inline; font: 10pt times new roman">7,505,890</font></td> <td nowrap="nowrap" style="vertical-align: bottom; width: 1%; text-align: left; padding-bottom: 2px"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr><tr> <td style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td colspan="10" style="vertical-align: bottom"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> <td nowrap="nowrap" style="vertical-align: bottom; text-align: left"><font style="display: inline; font: 10pt times new roman">&#160;</font></td> </tr></table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt; text-align: center"><font style="display: inline; font: 10pt Times New Roman">&#160;</font></div> <p style="margin: 0pt">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">7. FAIR VALUE MEASURES</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">ASC 820 &#147;Fair Value Measurements and Disclosures&#148; defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements.&#160;&#160;As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 3%; font: 10pt/115% Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; font: 10pt/115% Calibri, Helvetica, Sans-Serif">&#183;</td> <td style="width: 94%; font: 10pt/115% Times New Roman, Times, Serif">Level 1 &#150; Inputs use quoted prices in active markets for identical assets or liabilities&#160;that the Company has the ability to access.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"> <tr style="vertical-align: top"> <td style="width: 3%; line-height: 115%; font-family: Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; line-height: 115%; font-family: Calibri, Helvetica, Sans-Serif">&#183;</td> <td style="width: 94%; line-height: 115%; font-family: Times New Roman, Times, Serif">Level 2 &#150; Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"> <tr style="vertical-align: top"> <td style="width: 3%; line-height: 115%; font-family: Times New Roman, Times, Serif">&#160;</td> <td style="width: 3%; line-height: 115%; font-family: Calibri, Helvetica, Sans-Serif">&#183;</td> <td style="width: 94%; line-height: 115%; font-family: Times New Roman, Times, Serif">Level 3 &#150; Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company&#146;s assessment of the significance of particular inputs to these fair measurements requires judgment and considers factors specific to each asset or liability.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of March 31, 2012 and December 31, 2011, respectively:</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="14" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">Fair Value Measurements</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">Level 1</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">Level 2</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">Level 3</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: center">Total</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: justify">Derivative liabilities:</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 52%; line-height: 115%; text-align: justify">March 31, 2012</td> <td style="width: 1%; line-height: 115%; text-align: right">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">&#150;</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%; text-align: right">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">&#150;</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%; text-align: right">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">789,058</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%; text-align: right">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">789,058</td> <td nowrap="nowrap" style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: justify">December 31, 2011</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">$</td> <td style="line-height: 115%; text-align: right">&#150;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">$</td> <td style="line-height: 115%; text-align: right">&#150;</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">$</td> <td style="line-height: 115%; text-align: right">155,813</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">$</td> <td style="line-height: 115%; text-align: right">155,813</td> <td nowrap="nowrap" style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The 2010 derivative liabilities are measured at fair value using the Black-Scholes options pricing model, which approximates the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy.&#160;&#160;The 2012 and 2011 derivative liabilities are measured at fair value using the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy.&#160;The following table sets forth a summary of the changes in the fair value of the Company&#146;s Level 3 financial liabilities that are measured at fair value on a recurring basis:</p> <p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Three Month Ended</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">March 31, 2012</p></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Year Ended</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">December 31, 2011</p></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; line-height: 115%; text-align: justify">Fair value, beginning of period</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">155,813</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 9%; line-height: 115%; text-align: right">84,819</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: justify">Derivative liabilities recorded during the period</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">354,980</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">357,040</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: justify">Reclassification to equity upon conversion of note</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">-</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">(66,836)</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: justify">Net unrealized (gain) loss on derivative financial instruments</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">278,265</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">(219,210)</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: justify">Fair value, end of period</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">789,058</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">155,813</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt">&#160;</p> <p style="margin: 0pt"></p> The common stock shares authorized, issued and outstanding have been adjusted to reflect a 20 to 1 reverse split, which was effective in February 2011. EX-101.SCH 7 orgc-20120331.xsd 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Condensed Consolidated Balance Sheet (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0006 - Disclosure - NATURE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - DUE TO FACTOR link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - FAIR VALUE MEASURES link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - STOCK OPTIONS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 orgc-20120331_cal.xml EX-101.DEF 9 orgc-20120331_def.xml EX-101.LAB 10 orgc-20120331_lab.xml Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash Accounts receivable, net of allowance for doubtful accounts of $77,968 at March 31, 2012 and December 31, 2011 Inventory Prepaid expenses and other current assets Total current assets Total Assets Liabilities and Stockholders' Deficiency Current liabilities: Accounts payable Due to factor Accrued expenses and other current liabilities Derivative liabilities Notes payable to related parties and others, net of discounts Total current liabilities Commitments and contingencies Stockholders' Deficiency: Preferred stock, no stated value authorized; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2012 and December 31, 2011 Common stock, $.0001 par value, 100,000,000 shares authorized, 11,032,593 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively Additional paid-in capital Accumulated deficit Total stockholders' deficiency Total Liabilities and Stockholders' Deficiency Allowance for doubtful accounts Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of sales Gross margin General and administrative expenses Operating loss Other (income) expense: Interest expense Change in fair value of derivative liability Total net other expenses Net loss Basic and diluted loss per share Weighted average number of common shares outstanding - basic and diluted Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Common stock issued for services Share-based compensation Non-cash interest Amortization on discount of note payable Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable Accrued expenses and other current liabilities Net cash used in operating activities Cash flows from financing activities Proceeds from notes and loans payable Principal payments on note payable Due to factor - net of repayment Net cash provided by financing activities Net increase (decrease) in cash Cash - beginning of the period Cash - end of the period Supplemental disclosures: Interest paid Supplemental disclosure for non-cash financing activities: Discount on notes payable Reclassification of derivative liabilities upon conversion of note Issuance of common stock to settle notes payable Issuance of common stock to convert notes payable Nature Of Business NATURE OF BUSINESS Summary Of Significant Accounting Policies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Going Concern GOING CONCERN Due To Factor DUE TO FACTOR Preferred Stock PREFERRED STOCK Notes Payable Loans And Derivative Liabilites NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES Fair Value Measures FAIR VALUE MEASURES Stock Options And Warrants STOCK OPTIONS AND WARRANTS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments And Contingencies COMMITMENTS AND CONTINGENCIES Accrued Expenses And Other Current Liabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Assets, Current Assets [Default Label] Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Income (Loss) Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments Nonoperating Income (Expense) Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash [Default Label] The amount of discount on notes payable in a noncash financing transaction. The reclassification of derivative liabilities upon the conversion of a note in a noncash financing transaction. The fair value of stock issued in noncash financing activities. The fair value of stock issued in noncash financing activities. The disclosure for due to factor. The disclosure for stock options and warrants. EX-101.PRE 11 orgc-20120331_pre.xml XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
DUE TO FACTOR
3 Months Ended
Mar. 31, 2012
Due To Factor  
DUE TO FACTOR
4.
DUE TO FACTOR

On November 1, 2010 the Company entered into a new one year accounts receivable factoring facility with a financial services company with maximum borrowings of $1,800,000.  The contract expired on October 31, 2011, and the Company is operating on a month to month basis, thereafter. The financial services company advances up to 80% of qualified customer invoices less applicable discount fee, and holds the remaining 20% as a reserve until the customer pays the financial services company.  The released reserves are used to fund other vendor purchases or returned to the Company.  The Company is charged 3% for the first 30 days outstanding plus 1/10 of 1% for funds outstanding over 30 days. Uncollectable customer invoices are charged back to the Company.  The new financial services company commenced funding during February 2011. At March 31, 2012 the advances from the factor inclusive of fees amounted to $64,789 which was offset against due from factor of approximately $13,860. Advances from the factor are collateralized by substantially all assets of the Company.
EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T-#$W,SDW.5]C,V4P7S0T9&5?.3@S,%]D9#%F M83`Q8S=B.60B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E!2149%4E)%1%]35$]#2SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$537U!!64%"3$5?3$]!3E-?04Y$7T1%4DE603PO>#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E)%3$%4141?4$%25%E?5%)!3E-!0U1) M3TY3/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7 M;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z M4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H M96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E M;F5D('=I=&@@36EC'1087)T7S0T,3'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,30T M,C8S-#QS<&%N/CPO'0^,3`M43QS<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO'0^3F\\2=S(%)E M<&]R=&EN9R!3=&%T=7,@0W5R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'!E M;G-E6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-#$W M,SDW.5]C,V4P7S0T9&5?.3@S,%]D9#%F83`Q8S=B.60-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-#0Q-S,Y-SE?8S-E,%\T-&1E7SDX,S!?9&0Q M9F$P,6,W8CED+U=O'0O:'1M;#L@8VAA'0^ M)FYB'0^)FYB M'0^)FYB'0^)FYBF5D+"!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'!E;G-E.CPO'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'!E;G-E2`R,#$Q+CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\T-#$W,SDW.5]C,V4P7S0T9&5?.3@S,%]D9#%F83`Q8S=B.60-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#0Q-S,Y-SE?8S-E,%\T-&1E7SDX M,S!?9&0Q9F$P,6,W8CED+U=O'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2!F:6YA;F-I;F<@86-T:79I=&EE6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-#$W,SDW.5]C M,V4P7S0T9&5?.3@S,%]D9#%F83`Q8S=B.60-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-#0Q-S,Y-SE?8S-E,%\T-&1E7SDX,S!?9&0Q9F$P,6,W M8CED+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@ M8FQO8VLG/B8C,38P.SPO9&EV/@T*/"]T9#X-"CPO='(^/"]T86)L93X-"CPO M9&EV/@T*#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I2<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^/&9O;G0@ M2P@9F]O9"!S869E='D@86YD('!R;V1U8W1I;VX@6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I2`\+V9O;G0^ M/&9O;G0@2!I;F-O2!U;F1E3H@ M8FQO8VLG/CQB3H@8FQO8VL[(&UA6QE.B!I=&%L:6,[(&1I M&%S)B,X M,C(Q.RD@=V%S(&]R9V%N:7IE9"!O;B!&96)R=6%R>2`Q.2P@,C`P."!T;R!S M96QL(&]R9V%N:6-A;&QY(&=R;W=N(&9R=6ET6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;B<^3VX@07!R:6P@,CDL(#(P,#@L($Y"($1E&%S(&9O&%S('1H97)E M=7!O;B!B96-A;64@82!W:&]L;'D@;W=N960@2!O9B!.0B!$ M97-I9VXN(%1H92!B=7-I;F5S&%S(&ES('1H92!O M;FQY(&)U2!O<&5R871E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I&%S(&)Y($Y"($1E M&-H86YG92!#;VUM:7-S:6]N)B,X,C$W.W,@ M*"8C.#(R,#M314,F(S@R,C$[*2!$:79I2`H3W)G86YI M8R!497AA&%S M(&ES('1H92!A8W%U:7)E&%S(&ES('1R96%T960@87,@=&AE(&-O;G1I M;G5I;F<@2!T:&%T(&%C<75I&%S(&%R M92!T'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I28C.#(R,3L@2P@3W)G86YI8R!497AA3H@ M8FQO8VLG/CQB3H@8FQO8VL[(&UA3H@8FQO8VLG/CQB3H@8FQO M8VL[(&UA2`Q-"P@ M,C`Q,2P@=&AE($-O;7!A;GD@97AE8W5T960@82`R,#HQ(')E=F5R'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^/&1I=CX\=&%B M;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W M:61T:#H@,3`P)3L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`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`P<'0[(&1I2!E3H@8FQO M8VL[(&UA2!P=7)C:&%S97,@9G)O;2!G2!H96QD M("0Q.2PP-S,@86YD("0P(&]F(&EN=F5N=&]R>2!A2X\+V9O M;G0^/"]D:78^#0H-"CQD:78@3H@8FQO8VLG/CQB3H@8FQO8VL[(&UA2!S:&]R="!M871U2!D871E6%B;&4@:7-S M=65D(&%P<')O>&EM871E(&9A:7(@=F%L=64@87,@;V8@=&AE(&)A;&%N8V4@ M&EM M871E('1E2!A=F%I;&%B;&4@;VX@3H@8FQO8VLG/CQB3H@8FQO M8VL[(&UA2!D M;V5S(&YO="!U'!O2!R:7-K28C.#(Q-SMS(&9I;F%N8VEA;"!I;G-T2!R96-O2P@:7,@979A;'5A=&5D(&%T('1H92!E;F0@;V8@96%C:"!R97!O6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;B<^5&AE(&%C8V]U;G1I;F<@=')E871M96YT(&]F(&1E M'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I2!O<'1I;VYS(&%N9"!W87)R86YT28C M.#(Q-SMS(&]W;B!S=&]C:R8C.#(R,3L@=VAI8V@@:7,@82!R97%U:7)E;65N M="!F;W(@=&AE('-C;W!E(&5X8V5P=&EO;B!A2!T:&%T(&1I9"!N;W0@8V]N=&%I;B`F(S@R M,C`[9&]W;BUR;W5N9"!P'0M86QI9VXZ(&IU6QE/3-$)V1I3H@8FQO8VLG/CQB6QE/3-$)W=I9'1H.B`U,"4[(&9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N)SX-"CQT'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@'0M86QI9VXZ M(&-E;G1E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,C`Q,3PO9F]N=#X\+V1I=CX-"CPO M=&0^#0H\+W1R/CQT3H@8FQO8VL[(&UA M'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^,"XS,24@+2`P+C,X/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)3PO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@6QE/3-$)V1I M3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)3PO9F]N=#X\+W1D/@T* M/"]T6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^ M1F]R('1H92!B:6YO;6EA;"!L871T:6-E(&]P=&EO;G,@<')I8VEN9R!M;V1E M;"P@=&AE($-O;7!A;GD@=7-E9"!T:&4@9F]L;&]W:6YG(&%S'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO9&EV/@T*#0H\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@8FQO8VL[(&UA6QE/3-$)V1I6QE M/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@3H@8FQO8VL[ M(&UA6QE/3-$)V1I'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^4FES:RUF6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^3B]!/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\+W1R/CQT3H@8FQO8VL[(&UA M'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M3B]!/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^3B]!/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE M/3-$)W9E'!E8W1E9"!V;VQA=&EL:71Y/"]F;VYT M/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9"<^4F5V96YU92!2 M96-O9VYI=&EO;B`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`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)W9E"!S;VQI9"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)3PO M9F]N=#X\+W1D/@T*/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^1&EV:61E;F0@>6EE;&0\ M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M17AP96-T960@=F]L871I;&ET>3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@ M'0M86QI M9VXZ(&-E;G1E3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^-#0N-R4@+2`U-2XR/"]F;VYT M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I65A6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F;VYT.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H-"CQD:78@3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M86QI9VXZ(&-E M;G1E3H@:6YL:6YE.R!F;VYT.B`Q M,'!T(%-Y;6)O;"P@6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;B<^0W)E9&ET(%)I6QE/3-$)V1I&-E6QE/3-$)W9E6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I2!H87,@='=O(&%N9"!F;W5R(&UA:F]R(&-U M3H@ M8FQO8VL[(&UA6QE/3-$)V1I6UB;VPL('-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6UB M;VPL('-E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M2`V,R4@86YD(#DT)2!O9B!P=7)C:&%S97,@9'5R:6YG('1H2!A9F9E8W0@=&AE($-O;7!A;GDG3H@8FQO8VLG/CPO9&EV/@T*#0H-"@T*/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I2!H87,@9VEV96X@969F M96-T('1O('1H92!I&5R8VES86)L92!A="`D,"XP,2XF(S$V,#M4:&5S92!W M87)R86YT28C.#(Q-SMS('=E M:6=H=&5D(&%V97)A9V4@'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E#L@8F]R M9&5R+71O<"US='EL93H@;F]N93L@8F]R9&5R+71O<"UW:61T:#H@;65D:75M M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!C;VQS M<&%N/3-$-B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T M:#H@,C(E.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M86QI M9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^/&9O;G0@3H@:6YL:6YE)SXR M,#$R/"]F;VYT/CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^/&9O;G0@ M3H@:6YL:6YE)SXR,#$Q/"]F;VYT/CPO9F]N=#X\ M+V1I=CX-"CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E M"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^3W!T:6]N3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXT+#0X,RPW-3`\ M+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N)SXU+#,P-"PS-3(\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N M;W=R87`@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXU M.#$L-36QE M/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT3H@8FQO M8VL[(&UA3H@:6YL:6YE M.R!F;VYT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I2`R,#$Q+"!T:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A2P@=&AI2!O9B!T:&4@28C.#(Q-SMS(&-O;G-O;&ED871E9"!F:6YA;F-I86P@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;B<^26X@2G5N92`R,#$Q+"!T:&4@1D%30B!I2!A;F0@=')A;G-P87)E;F-Y(&]F(&9I;F%N8VEA;"!R97!O28C.#(Q-SMS(&9I;F%N8VEA;"!P;W-I=&EO;B!O7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^#0H\='(^ M#0H\=&0@3H@8FQO8VL[(&UA'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I2!C;W5R2!H87,@;&EM:71E9"!C87-H+"!A('=O&EM871E;'D@)#4L,C(S+#`P M,"P@:&%S(&%C8W5M=6QA=&5D(&QO"!L:6%B:6QI=&EE&EN9R!A=71H;W)I=&EE2!D96QI;G%U96YT('=I=&@@:71S('!A>7)O M;&P@=&%X(&9I;&EN9W,@2!O9B!T:&4@0V]M<&%N>2!T;R!O8G1A M:6X@=&AE(&YE8V5S2!F:6YA;F-I;F<@=&\@;65E="!I=',@;V)L:6=A M=&EO;G,@86YD('!A>2!I=',@;&EA8FEL:71I97,@87)I2!C;VUE(&1U92!A M;F0@:6YC2!A="!T:&ES('1I;64@86YD M(')A:7-E2!B92!U;F%B;&4@ M=&\@8V]N=&EN=64@87,@82!G;VEN9R!C;VYC97)N+CPO9F]N=#X\+V1I=CX- M"@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:R<^/&)R("\^#0H\+V1I=CX-"@T*/&1I=B!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I2!D;V5S(&YO="!H879E(&-O;6UI=&UE;G1S(&9R M;VT@=&AI'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/&1I=CX\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T M:#H@,3`P)3L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;B<^-"X\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO M8VLG/CQB3H@8FQO8VL[(&UA65A2!W:71H(&$@9FEN86YC:6%L('-E2!A9'9A;F-E7,@=&AE(&9I;F%N8VEA;"!S97)V:6-E M7,@;W5T7,N(%5N8V]L;&5C=&%B;&4@8W5S=&]M97(@:6YV;VEC97,@87)E M(&-H87)G960@8F%C:R!T;R!T:&4@0V]M<&%N>2XF(S$V,#LF(S$V,#M4:&4@ M;F5W(&9I;F%N8VEA;"!S97)V:6-E2`R,#$Q+B!!="!-87)C:"`S,2P@,C`Q,B!T M:&4@861V86YC97,@9G)O;2!T:&4@9F%C=&]R(&EN8VQU2!A;&P@87-S971S(&]F('1H92!#;VUP86YY+CPO9F]N M=#X\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=CX\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N M=#H@,3!P="!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^-2X\+V9O;G0^ M/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(&IU6QE/3-$)V1I MF4F(S$V,#MT:&4@0V]M<&%N>2=S($)O87)D(&]F($1I2!T:&4F(S$V,#M#;VUP86YY)B,X,C$W.W,@0F]A'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I2!S:6=N960@82!O;F4@>65A2!C86QC=6QA=&5D('1H92!F86ER('9A;'5E(&]F('1H92!A=V%R9"!T;R!B M92`D.#8X+#65A'!E;G-E'1087)T7S0T,3'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@3&]A;G,@06YD($1E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$)W=I M9'1H.B`R)3L@9F]N=#H@,3!P="\Q,34E(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)W=I9'1H.B`Y M."4[(&9O;G0Z(#$P<'0O,3$U)2!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6%B;&4@=&\@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS M<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG M;CH@8V5N=&5R)SY-87)C:"`S,2P\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L M:6=N.B!C96YT97(G/D1E8V5M8F5R(#,Q+#PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@8V]L6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@8V5N=&5R)SXH56YA M=61I=&5D*3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`W-B4[(&QI;F4M:&5I9VAT M.B`Q,34E.R!T97AT+6EN9&5N=#H@+3EP="<^3B!.;W1E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SY.;W1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXT.#8L-#4U/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M M86QI9VXZ(')I9VAT)SXS-#@L,3,P/"]T9#X-"B`@("`\=&0@6%B M;&4@*&YE="!O9B!$96)T($1I'0M86QI9VXZ(')I M9VAT)SXS,3(L-3(Y/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@6QE/3-$)W=I9'1H.B`R-'!X.R!L:6YE+6AE:6=H=#H@ M,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+61E M8V]R871I;VXZ('5N9&5R;&EN92<^3F]T97,@4&%Y86)L93PO=&0^/"]T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE28C,30V.W,@8V]M;6]N M('-T;V-K(&%T("0Q+C`P('!E2X@5&AE($-O;7!A;GD@:7,@;F]T(&-O;7!L:6%N M="!W:71H('1H92!R97!A>6UE;G0@=&5R;7,@;V8@=&AE(&YO=&4N/"]T9#X\ M+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SYI:2XF(S$V,#LF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^3VX@3F]V96UB97(@,RP@,C`Q M,"P@=&AE($-O;7!A;GD@6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SYI:6DN)B,Q-C`[)B,Q-C`[/"]T9#X- M"B`@("`\=&0@2`S,2P@,C`Q,2P@=&\@<'5R8VAA6QE/3-$)V9O;G0Z(#$P M<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!N;W1E(&EN(&%C8V]R M9&%N8V4@=VET:"!!4T,@.#$U("8C,30W.T1E2P@=&AE M('=A2P@86YD(&ES(&EN8VQU M9&5D(&%S(&$@8V]M<&]N96YT#0IO9B!I;G1E'!E;G-E(&EN('1H M92!A8V-O;7!A;GEI;F<@8V]N9&5N6UE;G0@=6YT:6P@4V5P=&5M8F5R(#$L(#(P,3(@86YD(&EN8W)E87-E9"!T M:&4@:6YT97)E2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E#L@ M;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SXH0BDF(S$V M,#LF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)3L@=&5X="UD96-O6%B M;&4@)B,Q-3`[(%)E;&%T960@4&%R=&EE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!N;W1E(&)E87)I;F<@:6YT M97)E2!N;W1E(&UA='5R960@;VX@4V5P=&5M8F5R(#$S+"`R,#`Y+B8C,38P M.R8C,38P.U1H92!U;G!A:60@8F%L86YC92P@:6YC;'5D:6YG(&%C8W)U960@ M:6YT97)E6QE/3-$)V9O;G0Z(#$R<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SYI M:2XF(S$V,#LF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^3VX@1F5B2!R M96-O2!I6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E#L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SYI:6DN M)B,Q-C`[)B,Q-C`[/"]T9#X-"B`@("`\=&0@2P@=&]T86QI;F<@ M)#$S,"PP,#`N(%1H92!A9'9A;F-E2X@3VX@1F5B'!E;G-E(&EN('1H92!A8V-O;7!A;GEI;F<@ M8V]N9&5N6QE/3-$)W=I M9'1H.B`W,G!X.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SY);B!.;W9E;6)E2`R,#$P+"!-;W)R:7-O;B!087)T;F5R2!P2X@ M5&AE('-H87)E2!I6UE;G0@=&5R;7,@;V8@=&AI6QE/3-$)W=I9'1H.B`W,G!X.R!L:6YE+6AE:6=H=#H@ M,3$U)3L@=&5X="UA;&EG;CH@2!P6%B;&4@=VET:"!I;G1E28C,30V.W,@8V]M M;6]N('-T;V-K('5P;VX@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2!O=VYE9"!B>2!A(')E;&%T960@<&%R='D@=VAO(&ES(&$@ M,3`P)2!S:&%R96AO;&1E2!H87,@;F]T(&UA9&4@82!N M;W1E('!A>6UE;G0@86YD(&ES(&-U2!N96=O=&EA=&EN9R!A;B!E M>'1E;G-I;VX@;V8@2P@=&AE M(&YO=&4@8F%L86YC92!O9B!P2!B M92!C;VYV97)T960@:6YT;R!T:&4@;G5M8F5R(&]F(&9U;&QY('!A:60@86YD M(&YO;BUA&5R8VES M92!P2!E M>'!I2XF(S$V,#M4:&4@0V]M<&%N>2!I65A2X@5&AE('5N<&%I9"!B86QA;F-E+"!I;F-L=61I;F<@86-C M2X@07,@;V8@2G5N92`Q."P@,C`Q,BP@=&AE($-O;7!A;GD@:&%S(&)E M96X@861V86YC960@)#0P,"PP,#`@;VX@=&AE(&QO86XN/"]T9#X\+W1R/@T* M/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E65A6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SY/;B!&96)R=6%R>2`R."P@ M,C`Q,BP@36EC:&%E;"!2;W-E;G1H86PL(&1I2`D-3`L,#`P+B!4:&4@861V86YC92!I2!N;W1E&5R8VES92!P6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SXH0RDF(S$V,#LF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UD96-O6%B;&4\+W1D/CPO='(^ M#0H\+W1A8FQE/@T*/'`@6QE/3-$)W=I9'1H.B`W,G!X.R!L M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@2!N;W1E('=I=&@@82!M871U M2!D871E(&]F(%-E<'1E;6)E&-E M960@-"XY.24@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&-O;6UO;B!S=&]C:R!I M28C,30V.W,@8V]M;6]N('-T;V-K(&9O&EM871E;'D@)#(S+#`P,"!O9B!T:&4@;F]T92!A;F0@86-C&5D(&%N9"!D971E&EM871E6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E#L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SYI:2XF M(S$V,#LF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^3VX@2G5L>2`S,"P@,C`Q,"P@86X@:6YD:79I9'5A;"!A9'9A M;F-E9"!T:&4@0V]M<&%N>2`D."PP,#`N(%1H92!A9'9A;F-E(&ES(&5V:61E M;F-E9"!B>2!A('!R;VUI2!C;VYV97)T('1H M92!P28C,30V M.W,@8V]M;6]N('-T;V-K(&%T("0P+C`U('!E2!C86QC=6QA=&5D('1H92!F86ER('9A;'5E(&]F('1H M92!B96YE9FEC:6%L(&-O;G9E2!I6QE/3-$)V9O;G0Z(#$R<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SYI M:6DN)B,Q-C`[)B,Q-C`[/"]T9#X-"B`@("`\=&0@2!I M2!N;W1E(&AA2!B92!C;VYV97)T960@:6YT;R!T:&4@0V]M<&%N>2=S(&-O M;6UO;B!S=&]C:R!B>2!T:&4@:&]L9&5R(&%T("0P+C`U('!E2!I65A6QE/3-$)V9O;G0Z(#$P<'0O M;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`W,G!X.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X M="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SY/;B!*=6YE(#$U+"`R,#$Q M+"!T:&4@0V]M<&%N>2!I2!N;W1E(&AA2!R96-E:79E9"!A('=A:79E65A&5R8VES92!P6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SYV+B8C,38P.R8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SY/;B!*=6QY M(#$U+"`R,#$Q+"!T:&4@0V]M<&%N>2!I2!N M;W1E(&AA2!H87,@;F]T(&UA9&4@82!N;W1E('!A>6UE;G0@86YD M(&ES(&-U2!N96=O=&EA=&EN9R!A;B!E>'1E;G-I;VX@;V8@65A28C,30V.W,@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C M:7-E('!R:6-E(&]F("0P+C(U('!E2!I6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E65A65A<@T*=V%R MF5D('1H65A6QE/3-$)V9O;G0Z M(#$R<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE28C,30V.W,@8V]M;6]N('-T;V-K(&9O M2!N;W1E&5R8VES92!P2!F:6YA;F-I M;F<@;V8@=&AE($-O;7!A;GDL('1H92!N;W1E(&)A;&%N8V4@;V8@<')I;F-I M<&%L(&%N9"!I;G1E2!P86ED(&%N9"!N;VXM87-S97-S86)L92!D96)T(&EN M2!T:&4@;V9F M97)I;F6QE/3-$)V9O;G0Z M(#$R<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@2!I;B!A;B!OF5S#0IT:&%T(&9A M:7(@=F%L=64@:7,@82!M87)K970M8F%S960@;65A6QE M/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V9O;G0Z(#$R<'0O;F]R;6%L(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E2X@5&AE6QE/3-$ M)V9O;G0Z(#$R<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W=I9'1H.B`S)3L@;&EN92UH M96EG:'0Z(#$Q-24[(&9O;G0M9F%M:6QY.B!4:6UE2X\+W1D M/CPO='(^#0H\+W1A8FQE/@T*/'`@2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@8V]L6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M+C5P="!S;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)V)O6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)3L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS M<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG M;CH@6QE/3-$)W9E6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA M;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)W=I9'1H.B`U,B4[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L M:6=N.B!J=7-T:69Y)SY-87)C:"`S,2P@,C`Q,CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Y)3L@;&EN92UH96EG M:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W=I9'1H.B`Q)3L@ M;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@.24[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H M="<^-S@Y+#`U.#PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q M,34E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W=I9'1H.B`Y)3L@;&EN92UH96EG:'0Z(#$Q M-24[('1E>'0M86QI9VXZ(')I9VAT)SXW.#DL,#4X/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG M:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T'0M86QI9VXZ(&IU'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-3`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXD/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2XF(S$V,#LF(S$V,#M4:&4@,C`Q,B!A;F0@,C`Q,2!D97)I=F%T:79E M(&QI86)I;&ET:65S(&%R92!M96%S=7)E9"!A="!F86ER('9A;'5E('5S:6YG M#0IT:&4@8FEN;VUI86P@;&%T=&EC92!O<'1I;VYS('!R:6-I;F<@;6]D96PL M(&%N9"!A2XF(S$V,#M4:&4@9F]L;&]W:6YG('1A8FQE#0IS M971S(&9O2!O9B!T:&4@8VAA;F=E28C,30V.W,@3&5V96P@,R!F:6YA;F-I M86P@;&EA8FEL:71I97,@=&AA="!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q+C5P="!S;VQI9"<^#0H@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z M(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q+C5P="!S;VQI9"<^#0H@("`@("`@(#QP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/CPO='(^#0H\='(@6QE/3-$)W=I9'1H.B`W-B4[(&QI;F4M:&5I9VAT.B`Q M,34E.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY&86ER('9A;'5E+"!B96=I;FYI M;F<@;V8@<&5R:6]D/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Y)3L@;&EN92UH96EG:'0Z(#$Q-24[ M('1E>'0M86QI9VXZ(')I9VAT)SXQ-34L.#$S/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W=I9'1H.B`Y)3L@;&EN92UH96EG:'0Z(#$Q-24[('1E>'0M86QI9VXZ(')I M9VAT)SXX-"PX,3D\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[ M(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY$ M97)I=F%T:79E(&QI86)I;&ET:65S(')E8V]R9&5D(&1U6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@ M=&5X="UA;&EG;CH@6QE/3-$)W9E6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^+3PO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T M97AT+6%L:6=N.B!R:6=H="<^*#8V+#@S-BD\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXR-S@L,C8U/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S M;VQI9#L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY&86ER('9A;'5E+"!E;F0@;V8@<&5R M:6]D/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT)SXW.#DL,#4X/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!L:6YE+6AE:6=H M=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$Q<'0O,3$U)2!#86QI8G)I+"!(96QV971I8V$L(%-A;G,M4V5R M:68[(&UA6QE/3-$)VUA3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\T-#$W,SDW.5]C,V4P7S0T9&5?.3@S,%]D M9#%F83`Q8S=B.60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#0Q M-S,Y-SE?8S-E,%\T-&1E7SDX,S!?9&0Q9F$P,6,W8CED+U=O'0O:'1M;#L@8VAA3H@8FQO8VL[(&UA'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I2`D-#0L,#`P M+CPO9F]N=#X\+V1I=CX-"@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:R<^/&)R("\^#0H\+V1I=CX-"@T*/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)V1I3H\+V9O;G0^/"]F;VYT/CPO9&EV/@T*#0H\ M9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;B<^02!S=6UM87)Y(&]F(&]P=&EO;B!A8W1I=FET>2!D=7)I;F<@=&AE('1H M65A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/@T*/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QLF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@8V]L6QE/3-$)V1I6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)O3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^5V5I9VAT960\+V9O;G0^/"]D:78^#0H\+W1D/@T* M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!T97AT+6%L:6=N.B!L969T.R!B;W)D97(M=&]P+7-T>6QE.B!N M;VYE.R!B;W)D97(M=&]P+7=I9'1H.B!M961I=6TG/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W9E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@8V]L6QE/3-$)W9E6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W9E6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^079E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^17AE6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^4VAA"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^5F%L=64\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&YO M=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^/'1R/@T*/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXS,RPW M-3`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,3`N,C`\+V9O;G0^/"]T9#X-"CQT M9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N)SXS+C@X/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXR M+#DU,"PP,#`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`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`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^17AE'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W M:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^+3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^+3PO9F]N=#X\+W1D/@T*/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^+3PO9F]N M=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^-"XP,#PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A M<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W M:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXM M/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E M"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^1W)A;G1E9#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@ M"<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^,2PU,#`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V1I'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N)SXU+C`P/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@"<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^+3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M)SXM/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$ M)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N)SXM/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXM/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXM/"]F;VYT M/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT3H@:6YL:6YE.R!F;VYT.B`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`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R M87`@6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,"XR.#PO9F]N M=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0[ M('!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^+3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V1I M6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R M87`],T1N;W=R87`@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[('9E&5R8VES86)L92!A="!-87)C:"`S,2P@,C`Q,CPO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXQ+#'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N)SXP+C(X/"]F;VYT/CPO=&0^#0H\=&0@;F]W M6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M"<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N)SXT+C(Q/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E"<^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^+3PO9F]N=#X\ M+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)V1I3H@8FQO8VLG/CQB3H@8FQO8VLG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I M3H@8FQO8VLG/CQB6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/@T*/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QLF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W9E M6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E'0M86QI9VXZ M(&-E;G1E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^079E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)W9E6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M4F5M86EN:6YG/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)W9E6QE/3-$)V1I6QE M/3-$)W9E6QE/3-$)V1I M6QE/3-$)W9E M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I&5R8VES93PO9F]N=#X\+V1I=CX-"CPO M=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W9E6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I M3H@8FQO8VL[(&UA6QE/3-$ M)V1I"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"<^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I"<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I'0M M86QI9VXZ(&-E;G1E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^26X@665A6QE/3-$)W9E6QE/3-$)V1I M3H@8FQO8VL[(&UA6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('9E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^1W)A;G1E9#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^17AE6QE/3-$)V1I M6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,X,C$Q.SPO9F]N=#X\+V1I=CX-"CPO M=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/@T*/"]T"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^1F]R9F5I=&5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('!A M9&1I;F6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:61T:#H@.24[(&)O"!S;VQI9"<^ M#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E"<^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^,3@N.#$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T M>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^,"XQ,CPO9F]N=#X\+V1I=CX-"CPO=&0^ M#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,2PV-#,L-S4P M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^,"XQ,SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@&5R8VES960\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@.24G/@T* M/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXF(S@R,3$[/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,X,C$Q.SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,X,C$Q M.SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)V1I'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXF(S@R,3$[/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!W:61T:#H@,24[('!A9&1I;F6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E"<^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO M9F]N=#X\+W1D/@T*/"]T"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^0F%L86YC92P@36%R8V@@,S$L(#(P,3(\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D('-T>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:61T:#H@.24[(&)O"!D;W5B;&4G/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXW M+#4P-2PX.3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W9E M"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@.24[(&)O M"!D;W5B;&4G/@T*/&1I=B!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^,"XQ,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@ M6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W9E M"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('9E6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T3H@8FQO8VLG/CQB6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;B<^5&AE(&EN=')I;G-I8R!V86QU92!I&5R8VES92!P6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N)SX-"CQT'0M86QI9VXZ M(&-E;G1E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^5V%R'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^5V%R6QE/3-$)W9E6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I&5R8VES86)L93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\ M=&0@;F]W6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I&5R8VES93PO9F]N=#X\+V1I=CX-"CPO=&0^ M#0H\=&0@;F]W6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^3G5M8F5R(&]F M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^3G5M8F5R(&]F M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@'0M86QI M9VXZ(&-E;G1E3H@:6YL:6YE.R!F M;VYT.B`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`R<'@@'0M86QI M9VXZ(&-E;G1E3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^5V%R'0M M86QI9VXZ(&-E;G1E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^26X@665A'0M86QI9VXZ(&-E;G1E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^5V%R6QE/3-$ M)W9E6QE/3-$)V1I6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXW-"PX-3`\+V9O;G0^ M/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE M/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXP+C`Q/"]F;VYT M/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N)SXT-3(L,S4T/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N)SXQ+C@S/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXT-3(L,S4T M/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I M'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,"XR-3PO9F]N=#X\+W1D M/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T M:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M-S`U+#@X,CPO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W9E M3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^-S`U+#@X,CPO9F]N M=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N)SXP+C(U/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N)SXU-S4L,#`P/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXT+C(Q/"]F M;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N)SXU-S4L,#`P/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\+W1R/CQT'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W9E6QE/3-$)V1I'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E3H@:6YL M:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M,"XR-3PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXT+C(Y/"]F;VYT M/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N)SXQ+#`Y."PR,C`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R M87`@6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,"XP,#$\+V9O;G0^/"]T9#X-"CQT M9"!N;W=R87`],T1N;W=R87`@'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,2PP,C`L,3$S/"]F;VYT M/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE M/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,"XQ,#PO9F]N=#X\+W1D/@T*/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G M/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,3(U+#`P M,#PO9F]N=#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,3(U+#`P,#PO9F]N=#X\+W1D M/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0G/CQF;VYT M('-T>6QE/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXP M+C(U/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$ M)W9E3H@ M:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N)SXS,#`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXR+CDR/"]F;VYT/CPO M=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M)SXS,#`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\+W1R/CQT'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M)SXQ+#`S,2PR-3`\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@ M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXR+CDV/"]F M;VYT/CPO=&0^#0H\=&0@;F]W6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F M;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@'0M86QI M9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^,2PP,S$L,C4P/"]F;VYT/CPO=&0^ M#0H\=&0@;F]W6QE/3-$)W9E"<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO M=&0^#0H\+W1R/CQT'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W9E6QE M/3-$)V1I'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T M:#H@,24[('!A9&1I;F6QE/3-$)V1I M6QE/3-$)W9E6QE/3-$)V1I'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXW+#4P-2PX.3`\+V9O;G0^/"]T M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@8V]L6QE/3-$)W9E M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\T-#$W,SDW.5]C,V4P7S0T9&5?.3@S,%]D9#%F83`Q8S=B.60- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#0Q-S,Y-SE?8S-E,%\T M-&1E7SDX,S!?9&0Q9F$P,6,W8CED+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/&1I=CX\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@ M9F]N=#H@,3!P="!T:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^.2XF(S$V M,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('9E'0M M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^)B,Q-C`[ M/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^ M/&9O;G0@3H@:6YL:6YE.R!T97AT+61E8V]R871I M;VXZ('5N9&5R;&EN92<^0V]N6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I2!S:6=N960@82`Q-B!M;VYT:"!C;VYS=6QT:6YG(&%G2X@5&AE(&-O;G-U;'1I;F<@2!O=V5D("0Q,#`L M,#`P(')E;&%T960@=&\@86)O=F4@8V]N'!E;G-E3H@ M8FQO8VLG/CQB3H@8FQO8VL[(&UA'0M M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SY%;7!L;WEE92!787)R86YT3H@8FQO8VLG/CQB3H@8FQO8VL[(&UA M2`R.2P@,C`Q,BP@ M86X@96UP;&]Y964@=V%S(&=R86YT960@=&AR964@>65A28C.#(Q M-SMS(&-O;6UO;B!S=&]C:R!F;W(@&5R8VES92!P3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-#$W,SDW M.5]C,V4P7S0T9&5?.3@S,%]D9#%F83`Q8S=B.60-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-#0Q-S,Y-SE?8S-E,%\T-&1E7SDX,S!?9&0Q9F$P M,6,W8CED+U=O'0O:'1M;#L@8VAA'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;B<^0T]-34E4345.5%,@04Y$($-/3E1)3D=%3D-)15,\+V9O M;G0^/"]D:78^#0H\+W1D/@T*/"]T3H@8FQO8VL[ M(&UA6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;B<^/&9O;G0@3H@:6YL:6YE.R!T M97AT+61E8V]R871I;VXZ('5N9&5R;&EN92<^06=R965M96YT3H@8FQO8VLG/CQB3H@8FQO8VL[(&UA28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!A="!A;B!E>&5R8VES92!P2P@=&AE($-O;7!A M;GD@6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^26X-"F%D9&ET:6]N+"!T M:&4@86=R965M96YT('!R;W9I9&5S(&9O65A M2!P28C M.#(Q-SMS(&]U='-T86YD:6YG(&-O;6UO;B!S=&]C:R!O;B!A(&9U;&QY(&1I M;'5T960-"F)A2!V97-T960@;VX@=&AE(&1A=&4-"F]F('1H92!G3H@8FQO8VLG/CQB2!E M;G1E65A'0M86QI9VXZ(&QE M9G0G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^26X@=&AE(&YO2!S=6-H(&MN;W=N('!R;V-E961I;F=S('=O=6QD(&YO="!H M879E(&$@;6%T97)I86P@861V97)S92!E9F9E8W0@;VX@=&AE(&)U2P@9G)O;2!T:6UE('1O('1I;64L('1H92!#;VUP86YY M(&UA>2!P=7)S=64@;&ET:6=A=&EO;B!A9V%I;G-T('1H:7)D('!A2X\+V9O;G0^/"]D:78^#0H- M"CQD:78@3H@8FQO M8VL[(&UA3H@8FQO8VL[(&UA2XF(S$V,#LF(S$V,#M4:&4@9FER M2`D,C$L,#`P(')E;6%I;FEN9RXF(S$V,#LF(S$V,#M4:&4@ M2!A(&=R;W5P(&]F M('!L86EN=&EF9G,Z($9U;&P@0VER8VQE(%-A;&5S+"!);F,N+"!'2`D.32!3=7!E2!212!4&EM871E;'D@)#,T+#`P,"!P2!H87,@86-C3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\T-#$W,SDW.5]C,V4P7S0T9&5?.3@S,%]D9#%F83`Q8S=B M.60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#0Q-S,Y-SE?8S-E M,%\T-&1E7SDX,S!?9&0Q9F$P,6,W8CED+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^04-#4E5%1"!%6%!%3E-% M4R!!3D0@3U1(15(@0U524D5.5"!,24%"24Q)5$E%4SPO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\+W1R/CPO=&%B;&4^#0H\+V1I=CX-"@T*/&1I=B!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0G M/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ M(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^#0H\='(^#0H\=&0@"<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E"!S;VQI9"<^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('!A M9&1I;F6QE/3-$)V1I6QE/3-$)W9E6QE/3-$)V1I6QE/3-$)W9E"!S;VQI M9"<^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^1'5E('1O M(&-O;G-U;'1A;G0@*$YO=&4@.2D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M)#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF M;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N)SXQ,#`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N)SXV.30L-S0R/"]F;VYT/CPO=&0^#0H\=&0@ M;F]W6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`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`Q,'!T('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)W9E3H@:6YL:6YE.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/CQT'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXV-"PV,3`\+V9O;G0^/"]T M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N)SXW-2PQ,3,\+V9O;G0^/"]T9#X-"CQT9"!N;W=R M87`],T1N;W=R87`@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E6QE/3-$)V1I'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T M>6QE/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M)SXR+#$S-BPW,3(\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@ M'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)V1I'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N)SXR+#`P,2PT,C<\ M+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE M.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;B<^*$$I($%S(&]F($UA2!H M87,@=VET:&AE;&0@)#$V,RPY-#D@86YD("0Q-3,L,#`Y(&]F('!A>7)O;&P@ M=&%X(&QI86)I;&ET:65S(&9R;VT@=V%G97,@<&%I9"!W:&EC:"!H879E('EE M="!T;R!B92!R96UI='1E9"!T;R!T:&4@=&%X:6YG(&%U=&AO'1087)T7S0T,3'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;B<^ M#0H\='(^#0H\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('9E'0M86QI9VXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I2!D:60@;F]T(&ED96YT:69Y(&%N>2!R96-O9VYI>F5D(&]R(&YO M;BUR96-O9VYI>F5D('-U8G-E<75E;G0@979E;G1S('1H870@=V]U;&0@:&%V M92!R97%U:7)E9"!F=7)T:&5R(&%D:G5S=&UE;G0@=&\@;W(@9&ES8VQO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-#$W,SDW.5]C,V4P7S0T9&5? M.3@S,%]D9#%F83`Q8S=B.60-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-#0Q-S,Y-SE?8S-E,%\T-&1E7SDX,S!?9&0Q9F$P,6,W8CED+U=O'0O:'1M;#L@ M8VAA&UL;G,Z;STS1")U XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
GOING CONCERN
3 Months Ended
Mar. 31, 2012
Going Concern  
GOING CONCERN
3.
 GOING CONCERN

The consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of business. As of March 31, 2012, the Company has limited cash, a working capital deficit of approximately $5,223,000, has accumulated losses of approximately $14,386,000 since its inception and has withheld $163,949 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities and are delinquent. The Company is currently delinquent with its payroll tax filings since December 31, 2008. Its ability to continue as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet its obligations and pay its liabilities arising from normal business operations when they come due and increasing its revenue in order to achieve profitable operations. The Company estimates a $2,000,000 capital infusion will be required to continue operations through the end of 2012. The outcome of these matters cannot be predicted with any certainty at this time and raises substantial doubt that the Company will be able to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

The Company intends to overcome the circumstances that impact its ability to remain a going concern through a combination of growing high margin revenues, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however the Company does not have commitments from third parties for a sufficient amount of additional capital. The Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary to raise additional funds, and may require that the Company relinquish valuable rights.
XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheet (Unaudited) (USD $)
Mar. 31, 2012
Dec. 31, 2011
Statement of Financial Position [Abstract]    
Cash $ 101,819 $ 5,852
Accounts receivable, net of allowance for doubtful accounts of $77,968 at March 31, 2012 and December 31, 2011 195,322 128,886
Inventory 19,073   
Prepaid expenses and other current assets 32,494 23,527
Total current assets 348,708 158,265
Total Assets 348,708 158,265
Accounts payable 1,196,146 1,179,753
Due to factor 50,929 82,087
Accrued expenses and other current liabilities 2,136,712 2,001,427
Derivative liabilities 789,058 155,813
Notes payable to related parties and others, net of discounts 1,398,475 1,128,549
Total current liabilities 5,571,320 4,547,629
Preferred stock, no stated value authorized; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2012 and December 31, 2011      
Common stock, $.0001 par value, 100,000,000 shares authorized, 11,032,593 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively 1,103 [1] 1,103 [1]
Additional paid-in capital 9,161,849 9,064,265
Accumulated deficit (14,385,564) (13,454,732)
Total stockholders' deficiency (5,222,612) (4,389,364)
Total Liabilities and Stockholders' Deficiency $ 348,708 $ 158,265
[1] The common stock shares authorized, issued and outstanding have been adjusted to reflect a 20 to 1 reverse split, which was effective in February 2011.
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
NATURE OF BUSINESS
3 Months Ended
Mar. 31, 2012
Nature Of Business  
NATURE OF BUSINESS
1.
NATURE OF BUSINESS
 
Organic Alliance, Inc. ("OAI" or the "Company") is a sales and marketing distribution company that supplies conventional, organic, natural, and Fair Trade food products to the global market.  OAI works directly with growers while also contracting farming production domestically and abroad to vertically integrate supply chains, reduce costs and provide a high degree of control over quality, food safety and production sustainability.

History - NB Design & Licensing, Inc., (“NB Design”) was organized in September 2001.  The former parent, New Bridge Products, Inc., was originally incorporated in August 1995 as a manufacturer of minivans and filed a petition in bankruptcy under Chapter 11 of the U.S. Bankruptcy Code. Its Plan of Reorganization was approved by the U.S. Bankruptcy Court for the District of Arizona in September 2002 and NB Design was discharged from bankruptcy in October 2002.   NB Design was inactive from October 2002 to April 29, 2008.

Organic Alliance Inc., a Texas corporation, (“Organic Texas”) was organized on February 19, 2008 to sell organically grown fruits and vegetables.  During the second quarter of 2009, it ceased being a development stage company when it commenced its operations.

On April 29, 2008, NB Design, a Nevada corporation, acquired all 10,916,917 issued and outstanding shares of common stock of Organic Texas for 464,999 shares of the NB Design’s common stock. Organic Texas thereupon became a wholly owned subsidiary of NB Design. The business of Organic Texas is the only business of NB Design.  The Company operates in California.

The acquisition of Organic Texas by NB Design on April 29, 2008 was accounted for as a reverse capitalization in accordance with the Securities and Exchange Commission’s (“SEC”) Division of Corporate Financial Reporting manual Topic 12 “Reverse Acquisition and Reverse Capitalization”. The reverse capitalization was the acquisition of a private operating company (Organic Texas) into a non-operating public shell corporation with nominal net assets and as such is treated as a capital transaction, rather than a business combination. As a result no goodwill is recorded.  In this situation, NB Design is the legal acquirer because it issued its equity interests, and Organic Texas is the legal acquiree because its equity interests were acquired.  However, NB Design is the acquiree and Organic Texas is the acquirer for accounting purposes.  Organic Texas is treated as the continuing reporting entity that acquired the registrant, NB Design.  The pre-acquisition financial statements of Organic Texas are treated as the historical financial statements of the consolidated companies. 

On June 2, 2008, the name NB Design was changed to Organic Alliance, Inc.  On August 29, 2008, the name of Organic Texas was changed to Organic Texas, Inc.  All references throughout the annual report to “Organic Alliance, Inc.” or the “Company” refers to the combined operations for Organic Alliance, Inc., a Nevada Corporation, and its wholly owned subsidiary, Organic Texas.

During November 2010, the Company increased the number of authorized shares of common stock from 60 million shares to 2 billion shares.

On February 14, 2011, the Company executed a 20:1 reverse split and decreased the number of authorized shares of common stock from 2 billion shares to 100 million shares.
XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 19 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2012
Summary Of Significant Accounting Policies  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The Company's unaudited condensed consolidated financial statements have been prepared on an accrual basis of accounting, in conformity with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information applicable for a going concern which assumes that the Company will realize its assets and discharge its liabilities in the ordinary course of the business and in accordance with the instructions for Form 10-Q and article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Certain information and disclosures included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.

In the opinion of management, the condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

The results for the three months ended March 31, 2012 are not necessarily indicative of the results of operations for the full year. These financial statements and related footnotes should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission on June 18, 2012.

Use of Estimates - The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates that are particularly sensitive to change in the near term include but are not limited to, realization of deferred tax assets, allowance for doubtful accounts and assumptions used in share based payment transactions.  Actual results could differ from those estimates.

Principles of Consolidation - The condensed consolidated financial statements include the accounts of Organic Alliance, Inc. and its wholly owned subsidiary, Organic Texas. Inc. (collectively, the "Company”). All significant inter-company transactions and balances have been eliminated in consolidation.

Allowance for Doubtful Accounts - An allowance for uncollectible accounts receivable is recorded based on a combination of aging analysis, past practices and any specific troubled accounts. The Company’s produce is sold to the Company’s customers for cash or on credit terms which are established in accordance with local and industry practices and typically require payment within 10 to 30 days of delivery. Accounts are written off when uncollectibility is confirmed. Subsequent recoveries, if any, are credited to the allowance account. The allowance for doubtful accounts amounted to $77,969 at March 31, 2012 and December 31, 2011, respectively.
 
In addition, the Company also factors its receivables with full recourse and, as a result, accounts for the factoring akin to a secured borrowing, maintaining the gross receivable asset and due to factor liability on its books and records. In connection with the factoring of its receivables, the Company estimates an allowance for factoring fees associated with the collections. These fees range from 3% to 5% depending on the actual timing of the collection. The actual recognition of such fees may differ from the estimates depending upon the timing of collections.

Inventory - Inventory is stated at the lower of cost (first-in, first-out) or market, and includes produce the Company purchases from growers and packaging materials. The Company held $19,073 and $0 of inventory as of March 31, 2012 and December 31, 2011, respectively.

Fair Value of Financial Instruments - The carrying amounts of financial instruments, including cash, receivables, accounts payable and accrued expenses approximated fair value as of the balance sheet date presented, because of the relatively short maturity dates on these instruments. The carrying amounts of the notes payable issued approximate fair value as of the balance sheet date presented, because interest rates and other terms on these instruments approximate terms currently available on similar instruments.

Derivative Financial Instruments - The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates all of the Company’s financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.  The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the instrument could be required within 12 months of the balance sheet date.

The accounting treatment of derivative financial instruments requires that the Company record the conversion option and related warrants at their fair values as of the inception date of the agreements and at fair value as of each subsequent balance sheet date.  As a result of entering into the convertible notes, the Company is required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date.  Any change in fair value was recorded as a change in the fair value of derivative liabilities for each reporting period at each balance sheet date.  The Company reassesses the classification at each balance sheet date.  If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

The fair value of conversion options at a fixed number of shares are recorded using the intrinsic value method and conversion options at variable rates and any options and warrants  with ratchet provisions are deemed to be a “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative under ASC 815.  Since, “down-round protection” is not an input into the calculation of the fair value of the equity instruments and cannot be considered “indexed to the Company’s own stock” which is a requirement for the scope exception as outlined under ASC 815. The Company determined the fair value of the Binomial Lattice Model and the Intrinsic Value Method to be materially the same. Warrants that have been reclassified to derivative liability that did not contain “down-round protection” were valued using the black-scholes model.

For the Black-Scholes pricing model, which approximates the binomial lattice model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:

   
2012
 
2011
Risk-free interest rate
  0.31% - 0.38%   0.30%
Dividend yield
  N/A   N/A
Expected volatility
  46.5%-46.8%   36.0%-37.2%
Expected life in months and years
 
20 months
 
9 months- 2 years

For the binomial lattice options pricing model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:
 
   
2012
 
2011
 
Risk-free interest rate
  0.15% - 0.62%   N/A  
Dividend yield
  N/A   N/A  
Expected volatility
  43.4%-46.1%   N/A  
Expected life in months and years
 
6 months - 3 years
  N/A  

Revenue Recognition - Revenue is recorded when (1) the customer accepts delivery of the product and title has been transferred and the Company has no significant obligations remaining to be performed; (2) a final understanding as to specific nature and terms of the agreed upon transaction has occurred; (3) price is fixed and (4) collection is reasonably assured.  

Share Based Compensation - The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 718.  For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on interim financial reporting dates until the service period is complete.

Option valuation models require the input of highly subjective assumptions, including the expected life of the option, and such assumptions can materially affect the fair value estimate.  The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model.  The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding.  The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

For the Black-Scholes pricing model, the Company used the following assumptions and weighted average fair value ranges for the three months ended March 31:

   
2012
 
2011
Risk-free interest rate
  0.43% - 0.86%   2.37%
Dividend yield
  N/A   N/A
Expected volatility
  44.7% - 55.2%   54.5%
Expected life in years
  3-5   5
 
Concentrations

 ·
Credit Risk - The Company maintains cash balances at various high quality federally insured financial institutions, with balances at times, in excess of federally insured limits.  Management believes that the financial institutions that hold the Company’s deposits are financially sound and therefore pose a minimum credit risk. The Company has not experienced any losses in such accounts.
·
Major customers - The Company has two and four major customers, which accounted for approximately 65% and 61% of the sales during three months ended March 31, 2012 and 2011, respectively. For the three months ended March 31, 2012, the total sales comprised of customer A 42% and customer B 23% compared to the three months ended March 31, 2011, comprised of customer E 26%, customer F 14%, customer G 12% and customer B 10%.  The loss of any of these customers could adversely affect the Company's operations.
·
Major receivables - The Company has five major receivables at March 31, 2012  comprised of customer E 27%, customer A 16%, customer C 17%, customer B 14% and customer D 11%  compared to five major receivables at March 31, 2011, comprised of customer E 28%, customer F 15%, G 13%, customer B 11% and customer H 11%.
·
Major suppliers - The Company has four and three major suppliers, which accounted for approximately 63% and 94% of purchases during three months ended March 31, 2012 and 2011, respectively. The loss of any of these suppliers could adversely affect the Company's operations.
 
Net Loss Per Share - Basic loss per share was computed using the weighted average number of outstanding common shares. Diluted loss per share includes the effect of dilutive common stock equivalents from the assumed exercise of options, warrants and convertible notes. Common stock equivalents were excluded in the computation of diluted loss per share since their inclusion would be anti-dilutive.

In accordance with ASC 260 “Earnings per Share”, the Company has given effect to the issuance of 2,795,538 and 1,323,070 warrants as of March 31, 2012 and 2011, respectively, exercisable at $0.01. These warrants have been included in computing the basic net loss per share for the three months ended March 31, 2012 and 2011.  Additionally, included in the Company’s weighted average shares outstanding are 3,529,897 and 56,189 shares earned, but not issued as at March 31, 2012 and 2011, respectively.

Total shares issuable upon the exercise of warrants, options and the conversion of convertible notes for the three months ended March 31, 2012 and 2011 were as follows:

   
March 31,
 
   
2012
   
2011
 
Options
    4,483,750       33,750  
Warrants
    4,710,350       320,008  
Convertible notes
    5,304,352       581,575  
Total Common stock equivalents
    14,498,452       935,333  

 
Recently Issued Accounting Standards
 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Fair Value Measurement (Topic 820) - Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs." This ASU addresses fair value measurement and disclosure requirements within Accounting Standards Codification ("ASC") Topic 820 for the purpose of providing consistency and common meaning between U.S. GAAP and IFRSs. Generally, this ASU is not intended to change the application of the requirements in Topic 820. Rather, this ASU primarily changes the wording to describe many of the requirements in U.S. GAAP for measuring fair value or for disclosing information about fair value measurements. This ASU is effective for periods beginning after December 15, 2011 and did not have a material impact on the Company’s consolidated financial statements or disclosures. 

In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. This guidance improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. The guidance provided by this update becomes effective for interim and annual periods beginning on or after December 15, 2011. The adoption of this standard did not have a material impact on the Company’s financial position or results of operations.
XML 20 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheet (Parenthetical) (USD $)
Mar. 31, 2012
Dec. 31, 2011
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 77,968 $ 77,968
Preferred stock, par value      
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued      
Preferred stock, shares outstanding      
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 11,032,593 [1] 11,032,593 [1]
Common stock, shares outstanding 11,032,593 [1] 11,032,593 [1]
[1] The common stock shares authorized, issued and outstanding have been adjusted to reflect a 20 to 1 reverse split, which was effective in February 2011.
XML 21 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2012
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
12. 
SUBSEQUENT EVENTS

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required further adjustment to or disclosure in the consolidated financial statements. 
XML 22 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Mar. 31, 2012
Jun. 18, 2012
Document And Entity Information    
Entity Registrant Name Organic Alliance, Inc.  
Entity Central Index Key 0001442634  
Document Type 10-Q  
Document Period End Date Mar. 31, 2012  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   11,032,593
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2012  
XML 23 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Income Statement [Abstract]    
Revenue $ 336,007 $ 255,755
Cost of sales 302,863 248,405
Gross margin 33,144 7,350
General and administrative expenses 456,842 1,075,467
Operating loss (423,698) (1,068,117)
Other (income) expense:    
Interest expense 228,870 64,301
Change in fair value of derivative liability 278,265 40,572
Total net other expenses 507,135 104,873
Net loss $ (930,833) $ (1,172,990)
Basic and diluted loss per share $ (0.05) $ (0.19)
Weighted average number of common shares outstanding - basic and diluted 17,358,027 [1] 6,046,778 [1]
[1] The common stock shares authorized, issued and outstanding have been adjusted to reflect a 20 to 1 reverse split, which was effective in February 2011.
XML 24 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
FAIR VALUE MEASURES
3 Months Ended
Mar. 31, 2012
Fair Value Measures  
FAIR VALUE MEASURES

 

7. FAIR VALUE MEASURES

 

ASC 820 “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements.  As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Standard clarifies that the exchange price is the price in an orderly transaction between market participants to sell an asset or transfer a liability at the measurement date and emphasizes that fair value is a market-based measurement and not an entity-specific measurement.

 

ASC 820 establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:

 

  · Level 1 – Inputs use quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

  · Level 2 – Inputs use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.

 

  · Level 3 – Inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability.

 

In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company’s assessment of the significance of particular inputs to these fair measurements requires judgment and considers factors specific to each asset or liability.

 

The following table provides the assets and liabilities carried at fair value measured on a recurring basis as of March 31, 2012 and December 31, 2011, respectively:

 

    Fair Value Measurements  
    Level 1     Level 2     Level 3     Total  
                         
Derivative liabilities:                        
March 31, 2012   $     $     $ 789,058     $ 789,058  
December 31, 2011   $     $     $ 155,813     $ 155,813  

 

The 2010 derivative liabilities are measured at fair value using the Black-Scholes options pricing model, which approximates the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy.  The 2012 and 2011 derivative liabilities are measured at fair value using the binomial lattice options pricing model, and are classified within Level 3 of the valuation hierarchy. The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:

 

   

Three Month Ended

March 31, 2012

   

Year Ended

December 31, 2011

 
             
Fair value, beginning of period   $ 155,813     $ 84,819  
Derivative liabilities recorded during the period     354,980       357,040  
Reclassification to equity upon conversion of note     -       (66,836)  
Net unrealized (gain) loss on derivative financial instruments     278,265       (219,210)  
Fair value, end of period   $ 789,058     $ 155,813  
                 

 

XML 25 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES
3 Months Ended
Mar. 31, 2012
Notes Payable Loans And Derivative Liabilites  
NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES

6.  NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES

 

Notes payable to related parties and others, net of discounts consists of the following:

 

    March 31,     December 31,  
    2012     2011  
    (Unaudited)     (Audited)  
             
N Notes Payable (net of Debt Discount of $42,076 at March 31, 2012 and $63,114 at December 31, 2011) (A)   $ 599,491     $ 551,978  
Notes Payable – Related Parties (net of Debt Discount of $30,053 at March 31, 2012 and $50,053 at December 31, 2011) (B)     486,455       348,130  
Convertible Notes Payable (net of Debt Discount of $335,471 at March 31, 2012 and $41,469 at December 31, 2011) (C)     312,529       228,441  
Total   $ 1,398,475     $ 1,128,549  

 

Notes Payable

 

(A)   Notes Payable

 

i.   In May 2010, an individual advanced to the Company $20,000 bearing interest at 6% per annum.  As a financing incentive, the individual received warrants to purchase 20,000 shares of the Company’s common stock at $1.00 per share.  The warrants expired in November 2011.  The gross proceeds of the note were recorded net of a debt discount of $9,200. The debt discount consisted of the relative fair value of the warrants of $9,200 and is accreted to interest expense ratably over the term of the note. The promissory note matured on November 17, 2011.   The unpaid balance, including accrued interest, was $22,142 and $21,843 at March 31, 2012 and December 31, 2011, respectively. The Company is not compliant with the repayment terms of the note.

 

ii.   On November 3, 2010, the Company signed a $38,262 demand note with an interest rate of 5% per annum. The unpaid balance, including accrued interest, was $38,565 at December 31, 2011. The note was repaid in January 2011.

 

iii.   On February 3, 2011, the Company signed a $500,000 promissory note with a maturity date of August 2, 2012, and has a stated interest rate of 15% per annum. As a financing incentive, the lender received three year warrants vesting on January 31, 2011, to purchase 452,354 shares of common stock at an exercise price of $0.01 per share and also received five year warrants, vesting on June 30, 2011, to purchase 452,354 shares at an exercise price of $0.01 per share.

 

The Company accounted for the issuance of the convertible promissory note in accordance with ASC 815 “Derivatives and Hedging”.    Accordingly, the warrants are recorded as derivative liabilities at their fair value and are marked to market through earnings at the end of each reporting period.  The gross proceeds from the sale of the note $500,000 was recorded net of a discount of $137,703.  The debt discount consisted of $137,703 related to the fair value of the warrants and is accreted to interest expense ratably over the term of the note which amounted to $21,038 and $15,300 for the three months ended March 31, 2012 and 2011, respectively, and is included as a component of interest expense in the accompanying condensed consolidated statement of operations. The Company has not made any note payments and received a waiver from the lender on September 1, 2011 that defers payment until September 1, 2012 and increased the interest rate to 21% beginning April 4, 2011, the date of the first event of  default. The unpaid balance, including accrued interest, was $619,425 and $593,247 at March 31, 2012 and December 31, 2011, respectively.

 

(B)   Notes Payable – Related Parties

 

i.   In September 2008, Earnest Mathis, a former owner, advanced to the Company $15,000. The advance is evidenced by a promissory note bearing interest at 10% per annum.  The promissory note matured on September 13, 2009.  The unpaid balance, including accrued interest, was $20,316 and $19,942 at March 31, 2012 and December 31, 2011, respectively.  The note has not been repaid as of June 18, 2012. The Company is not compliant with the repayment provisions of this note.

 

ii.   On February 18, 2011, the Company issued 3,858,574 shares of common stock to Parker Booth, Chief Executive Officer, for the settlement of $231,514 of principal and $5,996 of the accrued interest.  The fair value of the common stock issued exceeded the fair value of the promissory notes and accrued interest by $64,824 which the Company recorded a charge to stock based compensation expense during the three months ended March 31, 2011. The unpaid balance for accrued interest was $6,803 at March 31, 2012 and December 31, 2011.  The Company is not compliant with the repayment terms of this note.

 

iii.   In October and December 2009, Michael Rosenthal, director, advanced the Company $100,000 and $30,000, respectively, totaling $130,000. The advances are evidenced by promissory notes bearing interest at 5% per annum.  The notes matured on March 31, 2010 and June 30, 2010, respectively. On February 18, 2011, at the option of the holder, the Company issued 964,643 shares of common stock for the settlement of $57,879 of the remaining principal and accrued interest of $7,091.  The fair value of the common stock issued exceeded the remaining portion of promissory notes plus accrued interest by $31,092 and is included as a component of stock based compensation expense in the accompanying condensed consolidated statement of operations.

 

iv.   In November 2009 and February 2010, Morrison Partners, LLC (Thomas Morrison, former CEO and Chairman of the Board is the President), advanced to the Company $10,000 and $15,000, respectively, totaling $25,000. The advances are evidenced by promissory notes bearing interest at 5% per annum.  The November advance provides for the issuance of 2,770 shares of the Company’s common stock as a financing incentive.  The Company recorded a debt discount of $2,935 for the relative fair value of the common stock. The discount was accreted over the life of the note.

 

The November 2009 and February 2010 notes were due on June 30, 2010 and September 30, 2010, respectively. The unpaid balance, including accrued interest, was $27,784 and $27,472 at March 31, 2012 and December 31, 2011, respectively. The shares have not been issued to Morrison Partners, LLC. The Company is not compliant with the repayment terms of this note.

 

v.   During March, 2010 through October 2011, an employee of the Company loaned to the Company $65,958 of which an aggregate amount of $16,000 and $49,958 was advanced during 2011 and 2010, respectively. The loans are evidenced by promissory notes payable with interest at 5% and are due on demand. The Company repaid $9,000 during 2010. In addition, the employee will be issued 47,690 shares of the Company’s common stock upon repayment of the promissory notes as additional consideration. The Company will record a fair value for these shares on the measurement date as a charge to interest expense. The unpaid balance including accrued interest was $60,684 and $59,974 at March 31, 2012 and December 31, 2011, respectively.

 

vi.   On October 17, 2011, the Company entered into a $400,000 convertible multi-draw term loan facility (“loan”) with an entity owned by a related party who is a 100% shareholder.  The loan bears interest at 21% and has a maturity date of the earlier of an event of default or April 17, 2012.  The Company has not made a note payment and is currently negotiating an extension of such loan. At the time of any new debt or equity financing of the Company, the note balance of principal and interest may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing.  In addition, the related party received a warrant to purchase 2.5 shares of the Company’s common stock for each $1.00 of principal extended to the Company up to 1,000,000 shares.  The warrants have an exercise price of $.10 per share and vest with each cash advance from the loan and collectively expire on October 17, 2014. The Company received $75,000 and $275,000 in gross proceeds during the three months ended March 31, 2012, and year ended December 31, 2012, respectively. The Company issued three-year warrants to purchase an aggregate of 187,500 and 687,500 shares of the Company’s common stock during the three months ended March 31, 2012 and the year ended December 31, 2011, respectively. The unpaid balance, including accrued interest, was $350,000 and $283,993 at March 31, 2012 and December 31, 2011, respectively. As of June 18, 2012, the Company has been advanced $400,000 on the loan.

 

The conversion price of the notes was not fixed and  determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion option of the notes on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the three-year warrants issued in connection with the note on the date of issuance aggregated $70,074, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $40,062 for the three months ended March 31, 2012.

 

vii.   On February 28, 2012, Michael Rosenthal, director, advanced the Company $50,000. The advance is evidenced by promissory notes bearing interest at 21% and has a maturity date of the earlier of an event of default or August 28, 2012.  In addition, Mr. Rosenthal received three year warrants vesting February 28, 2012, to purchase 125,000 shares of Company’s common stock at an exercise price of $0.10 per share. The Company recorded a debt discount of $7,997 to the face value of the note based upon the relative fair values of the note and the common stock. The discount is being accreted over the life of the note which amounted to $1,406 for three months ended March 31, 2012, and is included as a component of interest expense in the accompanying condensed consolidated statement of operations. The unpaid balance including accrued interest was $50,921 at March 31, 2012.

 

 

(C)   Convertible Notes Payable

 

i.   On July 14, 2010, the Company issued a $52,380 convertible promissory note with a maturity date of September 13, 2012, and with an interest rate of 20% per annum. The note can be converted into the Company's common stock by the holder based on a variable conversion price. The variable conversion price is defined in the note as 45% multiplied by the average of the five lowest intraday prices for the Company’s stock during the previous 20 trading days prior to the date of conversion.  The total conversion may not exceed 4.99% of the Company’s common stock issued and outstanding. In addition, the Company placed 250,000 shares of the Company’s common stock in escrow to secure our conversion obligations under the note. During September 2010, the lender converted $7,500 of the debt into 75,758 shares of the Company’s common stock for $.099 per share.  During December 2010, the lender converted $7,500 of the debt into 53,419 shares of the Company’s common stock for $.14 per share.  During March 2011, the lender converted $5,000 of the debt to 198,413 shares of the Company’s common stock for $.0252 per share. During September 2011, the lender converted $20,000 of the debt to 444,444 shares of the Company’s common stock for $.045 per share. The unpaid balance, including accrued interest, was $22,318 and $21,567 at March 31, 2012 and December 31, 2011, respectively.  As of June 18, 2012, approximately $23,000 of the note and accrued interest remains unpaid.

 

The conversion price of the note was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note on the date of issuance were valued using the Black-Scholes pricing model, which approximates the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option in connection with the note on the date of issuance aggregated $52,380, and was recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $6,548 for the three months ended March 31, 2012 and 2011.

 

ii.   On July 30, 2010, an individual advanced the Company $8,000. The advance is evidenced by a promissory note bearing interest at 6% per annum and maturing on March 2, 2011.  The holder, at any time, may convert the promissory note into shares of Company’s common stock at $0.05 per share.  The Company calculated the fair value of the beneficial conversion feature using the Black-Scholes pricing model on the date of issuance.  The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,000, and was recorded as debt discount. The debt discount was amortized through the term of the note and amounted to $1,333 for the three months ended March 31, 2011.  The unpaid balance, including accrued interest, was $8,802 and $8,683 at March 31, 2012 and December 31, 2011, respectively. The Company is not compliant with the repayment terms of this note.

 

iii.   On April 28, 2011, the Company issued a $70,588 convertible promissory note with an original issue discount of 15%.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) May 31, 2011.  The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company has not made a note payment and received a waiver from the lender on September 1, 2011 that defers payment until May 31, 2012 and waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. The Company is currently negotiating an extension of such loan. As a financing incentive, the lender received five-year warrants vesting April 28, 2011, to purchase 705,882 shares of Company’s common stock at an exercise price of $0.25 per share.  The unpaid balance, including accrued interest, was $70,588 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.

 

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $60,000, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $60,000 for the year ended December 31, 2011.

 

 

iv.   On June 15, 2011, the Company issued a $57,500 convertible promissory note with an original issue discount of 15%.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) June 14, 2012. The note may be converted into the Company's common stock by the holder at $0.05 per share. The Company received a waiver from the lender on September 1, 2011 that waives the provision for payment upon the Company closing a debt or equity financing of $600,000 or more. As a financing incentive, the lender received five-year warrants vesting June 15, 2011, to purchase 575,000 shares of Company’s common stock at an exercise price of $0.25 per share. The unpaid balance, including accrued interest, was $57,500 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.

 

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $50,000, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $12,500 for the three months ended March 31, 2012.

 

v.   On July 15, 2011, the Company issued a $109,822 convertible promissory note with an original issue discount of 15% that consolidated various demand notes from September 2010 through July 2011.  The convertible promissory note has a maturity date of the earlier of (i) the Company raising debt or equity financing of $600,000 or more, or (ii) August 31, 2011. The Company has not made a note payment and is currently negotiating an extension of such loan. The note may be converted into the Company's common stock by the holder at $0.05 per share.  As a financing incentive, the lender received five-year warrants vesting July 15, 2011, to purchase 1,098,220 shares of Company’s common stock at an exercise price of $0.25 per share.  The unpaid balance, including accrued interest, was $111,572 at March 31, 2012 and December 31, 2011. The Company is not compliant with the repayment terms of this note.

 

The conversion price of the note and five-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and five-year warrants issued in connection with the note on the date of issuance aggregated $95,497, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $95,497 for the year ended December 31, 2011.

 

 

vi.   On March 2, 2012, the Company entered into an agreement to sell secured promissory notes for an aggregate principal amount of $1,000,000, with warrants to purchase 2.5 shares the Company’s common stock for each $1 of the principal amount of the notes purchased.  In addition, the Company will issue to the investment banker, warrants for the purchase of the number of shares of the Company’s common stock equal to 10% of the common stock issuable in conjunction with the promissory notes sold in this offering. The three year warrants vesting immediately was 1,031,250 shares of the Company’s common stock at an exercise price of $.10 per share. The notes bear interest at 18% and have a maturity date of September 2, 2012. At the time of any new debt or equity financing of the Company, the note balance of principal and interest may be converted into the number of fully paid and non-assessable debt instruments, shares/or units to be issued in the financing.  The Company received $375,000 in gross proceeds during the three months ended March 31, 2012. The unpaid balance, including accrued interest, was $377,219 at March 31, 2012.  As of June 18, a total of $850,000 has been raised by the offering.

 

The conversion price of the note and three-year warrants was not fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “Derivatives and Hedging” (“ASC 815”), the embedded conversion options of the note and warrants on the date of issuance were valued using the binomial lattice options pricing model and recorded as derivative liabilities. The fair value of the conversion option and three-year warrants issued in connection with the note on the date of issuance aggregated $341,509, and were recorded as debt discount. The debt discount was amortized through the term of the notes and amounted to $25,542 for the three months ended March 31, 2012.

XML 26 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2012
Commitments And Contingencies  
COMMITMENTS AND CONTINGENCIES
10. 
COMMITMENTS AND CONTINGENCIES

Agreements

On September 27, 2010 the Company signed a twelve month agreement for investment banking services which was renewed for another 12 months. The banking services include equity financing, business combinations and other financing transactions. The compensation to the banker includes a flat fee plus other compensation as defined in the agreement.  The agreement includes three year warrants “Initial Warrants”, which were fully vested on the date of the grant to purchase 74,850 shares of Company’s common stock at an exercise price of $0.001 per share. The fair value of the award was $19,443 and is amortized over the term of the agreement; accordingly, the Company recorded a stock based compensation charge of $4,861 for the three months ended March 31, 2011.

In addition, the agreement provides for an additional warrant to be issued by the Company upon the 1 year anniversary provided that the banker did not exercise any of their other compensation elements as defined in the agreement. This warrant carries a cashless exercise provision and is limited to up to 4.99% of the Company’s outstanding common stock on a fully diluted basis. In September 2011, the Company issued warrants to purchase 1,020,113 shares of the Company’s common stock.  The warrants are exercisable at $0.001 per share, have a life of 3 years and were fully vested on the date of the grant.  The fair value of the award was $213,215 and is amortized over the term of the agreement; accordingly, the Company recorded a stock based compensation charge of $53,304 for the three months ended March 31, 2012.

On November 2, 2010, the Company entered into an agreement with an attorney for general corporate and transactional matters that provide a 3.50% equity interest in the Company upon meeting certain milestones.  These milestones were met in February 2011, and the attorney was granted 5 year warrants vesting on February 14, 2011 to purchase 795,866 shares of Company’s common stock at an exercise price of $0.01 per share. The warrant was fully vested on the date of the grant and accordingly the Company recorded a stock based compensation charge of $279,453 for the three months ended March 31, 2011 which represents the fair value of the award.

Legal matters

In the normal course of business, the Company is, and in the future may be, subject to various disputes, claims, lawsuits, and administrative proceedings arising in the ordinary course of business with respect to commercial, product liability, employment, and other matters, which could involve substantial amounts of damages. In the opinion of management, any liability related to any such known proceedings would not have a material adverse effect on the business or financial condition of the Company.  Additionally, from time to time, the Company may pursue litigation against third parties to enforce or protect the Company’s rights under the Company’s trademarks, trade secrets and the Company’s intellectual property rights generally.
 
During 2010, the Company was served with three lawsuits for past due liabilities of the Company.  The first lawsuit was Peri & Sons, plaintiff, vs. Organic Alliance, Inc. and Parker Booth, defendants, for past due produce liabilities. An agreement was reached and OAI has been making payments to the plaintiff. OAI was dismissed from the action and signed a confession of judgment.  Over half of the past due amount has been paid with a balance of approximately $21,000 remaining.  The second lawsuit filed in the US. District Court, Northern California District by a group of plaintiffs: Full Circle Sales, Inc., Growers Express LLC, Steinbeck County Produce Inc., Steve Almquist Sales and Brokerage, Dan Andrews Farms, Fresh Networks, LLC and Quebec Distributing Co., Inc., vs. Organic Alliance, Inc., defendant, for approximately $97,000 plus attorney fees and interest.  These plaintiffs are produce suppliers of the Company.  An agreement was reached and three of the plaintiffs were paid in full for $31,000. The balance of $66,000 remains unpaid. The third lawsuit was filed in Monterey County Superior Court by RE Transportation, plaintiff, vs. Organic Alliance, Inc., defendant, seeking approximately $34,000 principal plus interest at 18% per annum and attorney’s fees.  The plaintiff provided transportation services for the Company.  An agreement was reach with the plaintiff receiving $10,000 a month for three months starting May 2012. The Company has accrued for all amounts claimed.
XML 27 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK OPTIONS AND WARRANTS
3 Months Ended
Mar. 31, 2012
Stock Options And Warrants  
STOCK OPTIONS AND WARRANTS
8.  STOCK OPTIONS AND WARRANTS

Stock Options – Employment Letter Agreement: 

On January 6, 2012, in conjunction with Mark Zeller’s employment as the Company’s North American Director of Sales the Company provided an option to purchase 1,500,000 shares of common stock at $0.20 per share. The option has a life of five years and 250,000 options vested immediately and 416,667 shares vest on each anniversary after such date. The fair value of the option was approximately $44,000.

The Company recognized stock based compensation expense included in general and administrative expenses on the consolidated statement of operations for the three months ended March 31, 2012 and 2011, for $30,134 and $8,719, respectively for these awards.
 
 

Options Summary:

A summary of option activity during the three months ended March 31, 2012 and year ended December 31, 2011 is presented below:

               
Weighted
       
         
Weighted
   
Average
       
         
Average
   
Remaining
       
         
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term
   
Value
 
Balance at December 31, 2010
    33,750     $ 10.20       3.88     $ -  
Granted
    2,950,000     $ 0.20       7.00       -  
Exercised
    -       -       -       -  
Forfeited
    -       -       -       -  
Balance at December 31, 2011
    2,983,750     $ 0.31       4.00     $ -  
Granted
    1,500,000     $ 0.20       5.00       -  
Exercised
    -       -       -       -  
Forfeited
    -       -       -       -  
Balance at March 31, 2012
    4,483,750     $ 0.28       4.21     $ -  
                                 
Exercisable at March 31, 2012
    1,758,750     $ 0.28       4.21     $ -  

Common Stock Warrants Summary:

Warrant transactions during the three months ended March 31, 2012 and the year ended December 31, 2011 are as follows:

         
Weighted
   
Average
       
         
Average
   
Remaining
       
   
Number of
   
Exercise
   
Life
   
Intrinsic
 
   
Warrants
   
Price
   
In Years
   
Value
 
Balance, December 31, 2010
   
394,858
   
$
15.2
                 
Granted
   
5,787,290
     
0.12
                 
Exercised
   
     
                 
Forfeited
   
(320,008
)
   
18.81
                 
Balance, December 31, 2011
   
5,862,140
   
$
0.12
                 
Granted
   
1,643,750
     
0.13
                 
Exercised
   
     
                 
Forfeited
   
     
                 
Balance, March 31, 2012
   
7,505,890
   
$
0.12
     
3.16
   
$
744,132
 
                                 
Exercisable, March 31, 2012
   
7,505,890
   
$
0.12
     
3.16
   
$
744,132
 
                                 

The intrinsic value is calculated on the difference between the fair market value of the Company’s restricted stock, which was $0.20 per share as of March 31, 2012, and the exercise price of the warrants.

The following table presents information related to warrants at March 31, 2012:

Warrants Outstanding
   
Warrants Exercisable
 
           
Weighted
       
           
Average
   
Exercisable
 
Exercise
   
Number of
   
Remaining Life
   
Number of
 
Price
   
Warrants
   
In Years
   
Warrants
 
                     
$ 0.001       74,850       1.50       74,850  
  0.01       452,354       1.83       452,354  
  0.01       795,866       3.88       795,866  
  0.25       705,882       4.08       705,882  
  0.25       575,000       4.21       575,000  
  0.01       452,355       4.25       452,355  
  0.25       1,098,220       4.29       1,098,220  
  0.001       1,020,113       2.50       1,020,113  
  0.10       875,000       2.63       875,000  
  0.10       125,000       2.92       125,000  
  0.25       300,000       2.92       300,000  
  0.10       1,031,250       2.96       1,031,250  
          7,505,890       3.16       7,505,890  
           
 
XML 28 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2012
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
9. 
RELATED PARTY TRANSACTIONS
 
Consulting Agreement

On July 1, 2008, the Company signed a 16 month consulting agreement with a related party. The consulting services include financial advisory, investment relations and certain administrative and other services for $6,250 monthly fees. At March 31, 2012 and December 31, 2011, the Company owed $100,000 related to above consulting services, which is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.  

Employee Warrants

On February 29, 2012, an employee was granted three year warrants to purchase 300,000 shares of the Company’s common stock for services to the Company.  The warrants vest immediately with an exercise price of $0.25 per share. The Company recorded a charge for $6,149 to stock based compensation for the three months ended March 31, 2012.
XML 29 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
3 Months Ended
Mar. 31, 2012
Accrued Expenses And Other Current Liabilities  
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
11.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
 
Accrued expenses and other current liabilities consist of the following:
 
   
March 31, 2012
   
December 31, 2011
 
Due to consultant (Note 9)
  $ 100,000     $ 100,000  
Accrued consulting fees (Note 5)
    694,742       694,742  
Payroll and payroll taxes payable (A)
    1,277,360       1,131,572  
Other accrued liabilities
    64,610       75,113  
    $ 2,136,712     $ 2,001,427  
 
(A) As of March 31 2011 and December 31, 2011, the Company has withheld $163,949 and $153,009 of payroll tax liabilities from wages paid which have yet to be remitted to the taxing authorities.
ZIP 30 0001432093-12-000494-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001432093-12-000494-xbrl.zip M4$L#!!0````(`$PPTT`9ZU"1E&@``#8@!0`1`!P`;W)G8RTR,#$R,#,S,2YX M;6Q55`D``R].X$\O3N!/=7@+``$$)0X```0Y`0``[%WK<^,VDO]^5?<_X+RU M>TF59?.AIYW)ED8>9W5);*\?VS M-:G:'9LDNG]H]!L@_=U?7Q68RXJ'X<&*?62>$"2_TN9A].'EZ:`T?1N/Q M"?GK]__Y'P3^^^Z_6BURS5G@7Y"KT&N-Q32\)#=TP2[(#TPP2>-07I)?:)#@ ME?":!TR24;A8!BQF<$-SNB#NF>.35JL"V5^8\$/Y=#_.R<[C>'EQ?O[R\G(F MPF?Z$LK/T9D75B/W$";28SFM4,Z\_[5V_U' MQ[EH]R_<3D4&,8V3*&=@O5KI?WKX=Z\3&?`+_'\"LA?1Q6O$/YP8.PD&Q5P\;ELG#T8#,[5W>S1K2>1><;#/[^E&>/>JSC>12V';OWUOST$]F`)&K-*%WF`Z8TFJB'TQLE M8.".#`,6E8Y1=TH&B5"(9%&.RX_E>;Q:LG-XJ`5/,9B'F\RJ_FU[F/=Z8E M_%)N2Q!\Z)>@4#84?[^>0,XBO;-)OT`INYC*8Z^0["]=2/9["NE:AHM,XRT[ M#O7/[I3D9I?6]K&`188Y!KR#F[TZB<;4/.]I?4Z+],'3:,?D,9W\DS?N%"LO\`(<%"=%MV_\L54CJ!YH24"*XE]/1PM266 M!:-1(MGW:2)Y`<]DQ+);119(;0?]ASF5+-K)(O4YZJ&#>0"^NQU\?/X,Z[$M M6QQ[@VDEUGO&[?HRV,181M5@>L5$N.!B']O]TQ^-[(R@J34C705")2$%X(''TYBF9A9\&%\ MLD#0#)_;)$;KP0[!^T]J#[/#9S8*%XM0*$YW5-Y*K-J9KVKV.R85E6JS,XR' M^,SC"QI`936^N0;?=H;>[;OS&CP;@KDMES\,IF8R3.)Y*/GO=15_`YJ=]4Y* MT6VR.A+5;F5J%%51S9M3OGKFU9PV'6+6#:O'>AW>9G8\M-HZ*,AIZ7+)(`?>P5FW(/TNT#)=:RW7:GW7.= M-;C]S)J!5T5P+;OM]CN=;OL8>$/?!U&'@@9WE/MC,:)+'M/@4)$-K&Z[H&4[ MZ!\!HXIH!G;7[K<'M6$8=JKB=0:ES2DD?QKR*$G#8,MXH0;7?0;_'@9GS;Z1EN M?!>'HZ!4D8MCN]V>[1P`Y3:>8Y47ROB1R<7'4,KP!6/SH4+I.U;?$,DN\L?` MJ.2=K('I&*O"`+&%B8@S"SS:&?4&O8Y;6)42\H>#J.1B[$'7;G=K@X@B%A^L M!9O9O*96G<5-R1ZY:^>1V<(1\90EYXZ?7)1,1@[)$J7LC M,W?&??G>\BO,UX!%HA:3`6/GO]D:TJ7D;U3F]N?]$F3RO3-8Q@[J9GLAG#7 MQR>N`SJKS&8*>L`TAP(!DW+JUZ]YY-'@5T9EW;FTLD-D;U';5H!_L"#X480O MXH'1*!3,5YUG69GM36@JP`YJVVQ_"0/PYU2NU!GJZ$!V&U1*U%O+X9XM(6,& MKZ>/+U?F]BONK^^CMLU5H1F!N&>AK&Y2#^`N\#QY3EZ=+*=B94(HD"XS!+WD M6H&OX5KUR?Y]PPBV*.UFAQI6CQG^7,8NIY0QPZ.Y%ZI]I;=$W*HL*C:S*M$O M.]3W=M&&>V-;I'?Q=-YY3J7TZ\[)Z;4[5F][5DZ!*R1H:7O'H]@(OIV6=C:> MEJ$8A2)]->-VBMVB]Q!"PW#JRJS=5FG+L5`*4[H".\%<^%:8+;8#A5>L0KK. MH)>M<#F;`Y'4E9OM]GK81:^`),NKQL!4LBC&?8&Q$]"S&573/_[#C+8S>PX6'7ET[+;9B^J.BRH&=7#,L03;_[' MU5,$&8JXY@*29PBX0P^,45EA$])K=_O]ME&T5.?>+.ZZXNTY@X%K-X$;AGB, M^1$"*38NK]@D;D+&<-\VV^AO7WU3MIUN[U!\D`G2%>9&D8X#1SK[??MY M==C5%83;=[J%_?UR5F^M4-/AKK-UA*F.W>[`Z=;'M,-&;Y=XVKAQ MS]9R>TZ_L-E7F7VSP&M'CIYKN_UV$\`W8\U8;.]4-2%KV^TX_8Z9#>SGVQ36 MVD;>[73,7G]C6,UMGD:$VG7-8V-[>38"LK:RNH.>8^[]-0`SW5FX2H^%E.XP M-.(A^AO9\R%`WF\ZM<.XTWU379J9S1BJ/A&'LBDO;0^LWINP#89'HZNMW?U! M[TU740O<]OY0(Q+L=MMNMXH!KODVA;5^4=3O]9PW;6X_V.$".X^_Y_V)29P5 MWZ#A"YXL&G&^MF453GCL8]H(RMHFW^Z:6[*U0>KSCS]RX6?U>Q.R?_)[N;.F+@85]Q>P^LM5.(6P$ MT#7)+9\4!.$+;L%>A_(J3";Q-`FV_>V19UAZO4'7/$I3AV?C@"N=Y!Y7?$@B=D!K>"R=T^ZV^^>]-Q. MWS+C[6'XWF^6;WNNLEGVMF;9M=K=GIFF-3/)[+6)[+6\H]?LC?<_6]:99?CC M/:P;0+HW8KR!U#R#4A,I^"3(^,(%^RF,FBD?!J[5=]U"KV3-H3;[^OFLC8UH MJRK_4(19TT8_E19AC8BB8_5LMW"X?0>WHV#5%Y'5[IL!JC*L[=K@FG*ICH3= M3I_$G/DS?),IVYX=6.T%:5N=GO,^\])Y=8-* M#:5$OV>98`LL#D!05UQ07)MOYN\!<%O4[,;<7-MQNP,CQ)7P.1#*`?;<[8/; MJX5%?YNTS89C78@2)'LG MPREOI$IW7;MM5&`&]9J,:V_=NAVK$M]1&,7XVF\JCT8LR;6=E3&*^@/D+]D*`,14GBOB?;%=SD,5?_8P:PFW1@,_$!0G8 M-+[$3_O&^*7.[&H<+B])RM3Y.BA5S2)](K$NN?]-(FGI-,1CC3C%=.F8N`"U80PZ,2PPV(X3X7@WV& M%,[QJ8S<>2;^;"KGL=^(B/K]+U-&-\/'I_M/Y/::?'QZ&-]\>GC8([,#YJ>! MTL7R\D]VUZJV#N>IZJH?T4Z*=X^%=(#(_Y5$,9^N&I'ZYGC\N:5^!A(Q,/0, MP)JF&E?^DD)AQ<@W)[?#\0D))8GGC)RD!Y]/OB4\(I1$-``T5/@XW<],G8WV M,:;S29(V;M7S,)@"O&2Y#-)=*FS8J<\1G)+TL[ZG1*`OQ"M($!-R\BBISV#Z MH4^6,O03#\J!.%109D$XH4'*]\S0A_PG`$[41[H!DF1>'*S`O.(YF'6JYQ_1*8M7V?`,601J!$STIOUJGX*KE]E!P*8G*7FF"*+&7%8<%2_?="N0S1`A3C83(#[23V8-`A%+T%"#^9 M@I5!PB-1VS'_?Z9"V\04C!$,BRS!BRC5!@H3*C[+9!E[*TBU?/RB_YS"9"2Q M;1R/;N#I[.&,?%P_-PI]=D;&8&AW`17XU#U+Q:&WDA`T7:(%`KO):@>11,8H M$77W2CDT+T9B0\E_!Z^U)5='S6&]GL@%UAP\@)P!GRED4^9L8/BM%X?9X-)% MV:`&0L8C3TS3,D>C&QHN)0^(,SC%*_VO?N"/#IUEMDK)(WNE&.VT58#VG18, M.".B'GO#B$%KK]E$)A0\CYTN,2YZ!+D]67\4?Z4BFP`%27@::)[9C*E\)RI5 ML:M$8J1#)8\8Q!X?8XZ,M74"%^"%Y2]VR,!6&#Y+(5H]LR!<8C<,I$9G+`_R M+W,FU(!P`7<]]`*`(\PKFZ]J654M;\6&19^NO0&D1_#T,_5I4;.H]UL">0[X M4-`*VSH=V%WX7P\2-?65/%2'T/C`,4HF$?FLZF.LK0RY(1+"9,6G#Z55^K MZBO*4NE?I&/WUA)!H%V'LW!3NW50UOO-&"U!Y53"(!F^;04.1G^L+`OAL$CX ML/25YU4Y/:[_`_/`GZDCLZCLGUXA^HJ96N0%&`&,+"BJZ8D?/HT*_O>*/_,H MG<@H2VI(^F(%5!WK-T$QIX$+C^$2YFH[Q"!ZGZ(?&H)!8-GU46%6!G^M[SLF M_Z+M:%/J`R)8#$NC3F^J.B@"F_7FR@(E4XF?6K@4,\'WVR/J:0<%],#^L10$.:P- M%5!.\`/8\,P9&>IECY(@!IYD!I7/"P=`P`!*.%ARYI<:\U@`77@(!)*D_G"M M;ZE_"-@,(*5N4BH7E(!\\6ODVD5BM&+ZF`U/MSPB78R6^IL"/6;0VZ9"H.!D MN8@61*-:B7"1(1^;J MKC^%K\OY/.#$2ENSSQF<5O"[2\E:I@)/<\N*\-O`>M]ORXG@=X(W0,Y508;I MSTX:Z5RB,.`^U4<#T"QX42Q?/7WES.1_$L&(D^4E*%Z!L;Q8KFC?JUHD.]I, M92J9%XWKO">GOZ4..]BHF[MY``I0UBG8(T!!)9)A,IM#9J0M22AWKA4>J9:D MZV7S4'X[ZY(98]($PWQ(,<_;6-K[89*_W@!`*RYG9N1^HT+N)[3WVI%-G1:% M\S6OJ:KM:8%T$SYGE3XDUFK=LLR1IR<)M!<4ZMB5BL?K[WGOR+15'=^UR`+B MFVKEZ<=`+QPR*5S[NEXUO-.Z4FZC"['MXGJQ5\@250"!FQ=VGF4!'T@$T(Y\ M=M2*;BX>+JAM;2[S[B4U#@UM;0UNG0\&Z:G/%HAXF$?].PAT'D0W,/7X(R[( MO_V&HOME;I8Y?^2&8N_+E-'#T\\_#^]_Q1W%A_$/-^/K\6AX\TB&H]'MT\WC M^.8'$K$+R;RI1G_G#YC+<8$%AFXB:'ZIU2U#"3F=I,,R;I0.L66 M`I#&/1`L;U3):]91D`5X?(E[G3-]?@GW`3T/=P#45H?:1!`*J_KC)HK^4/WY M4TJ^>7H@/PR'=]^JQ$[5A'QA@.>*KRZV*>Z0>LKQJEH.*N#T;S-X3`KMKLT9&8$'I%P4)9K./0CQKW#A;+T@\=?+5JI$N>J43#A=34/1UNH)4P]! M@U`/H/:.$@C,JE&//1*99'OE,I?`U]2NLM\9IUJZY")M><$=.E,+IE*\=8E7 MQUU@;H0J@TUST!@P3>SI^'@\0SUPJFCP2/D!U6$&S@*U"RT-U%45",8`R'6@ MKHS0D&#EE]K;D2GE,EAM*!SBY&EO3+6\E-M8%X*ZKO/P\Y;3('S)NQF9N6<; ME)E+T7]',,J88J/IJW95;V!G:Y")-9YCTPW2^W@>$2;09_Q,)5BR:ZO*PE$- M*1'&^9)SM0ONJ^^(/><>M'1MAR&L:&:J+/M0-$]T05SN5 MJ>O_,9OAVBYQEJD@KT!BJK!*96FG^_\UFOG(3+6B[+Y>CJ_:_LXYW)/."CZ! M,T17&96E;SIRTFQ;HHXK?L\<3#+5JXZ,H('N>4$_,\*R^:1;&I!<+;6-ZC;W M=,J\.+5DU')L'BS4JY$JBURG6&9254P[LK-=,!'DO&N,YN*K79SI[NP$Q^V" M([,SS/@0RPYP^^N-_G4O7X<+R+K6701#%GKN`'VITC=(6#"`17@V23DWD%YJ MDJGL!5HW!*)%YC<@=8QS%QGPA5J:.#Q-,]1<1_STXQPDIJ^I:$XQ'NLW4I4; M\=-W4C.%V%ZJ)-):H-HKF.-C"J:_9&7N0I5OA0R]6'=]M:/VE%?U.2R\U$V= M>!Y&AJ)\]33O[&GNUL:N=F`SU[%9,QYZ?`><58'.HXZ2-5R5UG"]^>;EUE?> MM:_;GM>#OO'@8:;.?`6KT\+QVV+5@SL:D6'#*AULY2=O#>570"8TH&KK8UW` M,+1.D9W;\TQQ?U7U=U;U8<'192_?D^SM^\T8.Q0;KA&RO51/L&F0*Z-:^NXIC,U7("!JLH-PY!><9Q1!T47.\+#2".D5+YJ&B@5X!5'5D M,V5Y9K9O"CFB/J^L@(!B^=G65]FC'I11X0+WQW!NJO3!FAJ4$@($CU5\B;(V MB%0N&>;(HWEYK0XZ@>6ES:WC20+ M?G\1[S\@M'*L'0'1!'C;W1,ARW(_O;4MKZ2>WMDO&R!1E#`&`0X`2M;\^LW, MJ@(*),!+/$"JYK`MBBAD9>5=><"*5AW!;=1!*S_'7%OYP)'1#JP(%H!I>$/$LDE+\BVS%%_9 MN0N48\FB*E7(4.-F[H2L0;YP:M`^(]W*S.5J1+]>`(2 MVT%WCFA&EC%119`S^,D5N(QAYM6Q\:=`3IQ2+]U+H'5)NE5`* MVCY4*8_JX/@`*CB@+`55Z4E1%(<9B&E2:FQ`O7)*'S8%T=$U$]A;9E[JIOIC M+/JGDB'(F\5F\04JJ/E%XLNE6+?Q2!`[:!V87PIJ@T(<:9C:3',GTXBI M[W#RPA!GE"!58S3PF1Z,A2B.F;J/6NFV*3A!@4VY!YD2GT']$J!EEJ<1I4&D MD&>ZDK%:!&SNU?QK`]Y<"X-:CX[G$YR8+@*"WW>BW$XURVV7Y;+&+\OSFQ2T M;HCI+F&"`2E0Y.E"ZN^$=9I!_Q*TD1M/D/8\I5`(J![!H&*94O:],X*?*]R:U''O%,K\R5Q=)8K/A5/@=9 MK8$J28G.SZ#AGF81]:CR&AQ-$C0S1Z9>#,G]YR_].49YGKJ):)!4E)HO#.78 MC3BKL$`JL0I`_IM$)N3'Z/=ZO)6?$'N!R)#Z/ MW@LZ5\Y]D.U9)*9+']Z6MWBERD+?3:YB9U!5.I_*Z M4@Q9`KY)<3:'B'Q!(MX$4*%\:*[@8N8?QI]3[%P4K[[!;%2685/Q%\ MG(5GBHBEZ`Y!J5S!5>A.'A!$Q3;9MGB8CLR1J43B.*-;U`:0E[,K+GPU+%I$J@5GB@8>B="4RS>^&S.MK\%8 MI(C/9D(SHV&5@R4)>?EO\@D<'_'44"IG[P$M2LRL;R>Q%%$EV M"3PZ`)7)&XO$_#FRVD#6D3CI8ZVMDCKGAD^`8Q#BU$TDX0$EM4I%W#%'#"U0 M$\Q:4L0C9`XR;P9@TH#]*F4L11=354!\H/`X;]YP?GMA=*U6(5_=>G1;M@J$ M'K>S'4SW&T\21=`Z_D!F&,IK]-Q!$SO)"CW%SJ5DJP`7[?.D&0_`!OPI4"$Q M_V)SKS"P!)_J`51@^8V%Q^4#27E"E`S*3J,31<`D\:DPJ`QY.:]#&O!NR78_ M>5C!"=KXJY/@[8?Q+729GV827*5$RR,-WSC1E$^Z'HN':#T)58Y>RJG%`9[RGH9:OJ^,_AY%@\>0HR3CW"K M1R\8-]E0ZHL@RT^$QUN!QW'D#2C$B/@TY25<%LC@^K4O*$FN(=0&)6CLLJ)'I=<78@NO%A;PI3[H(SEH:_6#5LJR-BJO*E__5H3" M&R_^>39$_9:[9=@J^U264WIOMD:J]5K#>F.<&?!W=VZ&X:H+O]FD!GNE)U/? M\8EH":2@"ULAN7@7\.PQW]6"9\/D_?W]N980VT>A9FD%8=AS?X"^]6.(83(, MR6B^WC!1-MNUUILS^%.;$Y4ZET:[5G]SUNC49EU0;53L7@+YWI"N"$7T#B-_ M6"4:OTYY1*&`15'"N0%%\?A+CWU#[K\X5GV8AW^8/7&69X:]+H?J?CLON8N9 MN5>1%\13US+'?;A>W\N\DH->XUXFP72-I\@9_W["_SY9 MX>!G!5D%2$&[9/JF:0_W&5:+WS2U=QV"T">SB5#\YH2@EG?Z7NN5,Y-&H99' M6A[A\_I2;@>7F%/-B<,`:/F9;F++AD$ND)6:V%]( M[+?4)?H3M1M!(F-PK@L&TN0[*5(-^!GO5S)0%BAJ0CK3*29C,*5>6]!;UG`H MF^B%_E65)N[#PAF$#O(Z#WB9C!P]M((O-27P,^G8KU"2[*^IDO9L$PB5L64K8"(^/F]4+J)V?,A728N6-;FL MG.E7*ODYL3K"%NC40:TDWR(78[]8-/!X?]>4%0U>\I\-:1:=5J9.Y"-0.TUD MH!ZNDS'O<9.R=-KQ*Y`BLNXAD MVC._EL!&6=3^RV":S9XVEBWK2\OJW0R=JW1V?&):`FD$[DJ M=LND4:@;%.A2F\/IFYX+::M98V*"H@?61^DDY?V4HG MCK-9*M(925/(#<;QD(G(?*$5(78\8PJ0[WU_P$9_<-[,<3NQ.BJ=)?7," MYY[/%^@SWV./ZKR=8C!$&@`-9RX9:^"R<1A[8AQ8N@HF=5"?_MR\"`/O_@W' M&'F!-YJ,Y/!FO#Z?&DOI\"$.>!0Q0P(=?^"'-:P$<\%P/.6)Z=7Y8QK(] M7F&B1<@2(N2;\T\<:9=.'C^;(='D*13I:A.CH((3^M+AN+`"S2;KVA MY]O6&YD#$CN8<)".!BI-!U`FL18,7S6^+$XHX"OP;(8D3(#S^;LQY0TXDE&J M3)JY>VXT;0YL^M$GPVZ\H:\[43;Z9-$;X<_B-URB8VAF/W\QK*;Z\Q^&-0N! M57]3FI6#PH(FV` M/BMEAI@7.9KY(BCF/"L7\4$IJW54UCHWK!SK71A6[O>?D!7SK/?9L*PW96^4 M\F!)R.>)A.Z42&C!SR`)&E/@65/@_1=^I%E6L^RV6#:>C,=@0Q>:!60.<,.7 M=&'^@:4,@P:GYUZ3#(-LPON+#8-2Q9AM:*>*<7L%7&OT^ELF)G(DB:YKNL3? M66)\1?+Y`4*65\M,%8-]I;D=FEE/B M+HVO%^GM64:ZJ0Q632FY>+WQM*2EN M2@JE."M84Z?U6MW*CX",E5'`V11&P2-$AIP$)2OVB6T#8.\I&EPB-7T*V.(! MP:Y+I6T8&C)S<)0%EF:$@YBOJDH&!+!AMNR>V>UU"(!6V[2Z/?E=!H?(7-/H M3Q**)^&)B#G$T]9SF<;4;+7LX%P>0^"()])'ZN0%LE3KDPE529EF;IKM](SO MX:R878,:N?PEJPP+-&)=1['>3TU`>LY&2YS\4:H&N]R>C@ M*B_VOL5E=C@(D4*"WT_:RW9VL.V%Z?SK[KS2WG`1KE-9LI8[O.5VN-6GOW6B M*+I.:_.\;R]->T=;RK/@^3EU717C^LKF,6FZ/V"Z+RAS>^5T7_64UT9[ESFO MO)O'BY)<5;@(WH78JG#29A7:GZV=84K8WTR1@-GL-LQ.:W8"[U$UFM-$O']@ MMT?$C5=`P5J;J8C[2\0=M3JK$(E60!(TS8Y5-QO'+@PT$>\?V"VJ,[MNUNNS M8Z6/BH2WI<_FN)Z'IN0NIB_-=JWM*N'&KR0]%MUZ[)OJ5Y(NJVQF<]*G93;J M35"A!8'4HP\9:7;1[+(JNW0ML]59JM#YR)AEK@:/PJ?I"/YFM'GS4+4YSZHI M2R[(;OHX3QKE6-4N%_)/@#(<^+KA&"S36-N&&:7^,_&%<^!+QH'4SW: M.U:>>LF^K@+CF_,L:A4V,QO(*Z<)X\\QC>7)#P?ZDA4PN?^S M%P_\$#\R;OAL&;Z(%_")&7^-@"Q=E\7'D`;5[($WXFKSH[@EL+3%MS67Q(/+Z6/R: M%IG.O"';"V*&'P`^KT[>B>AWXC#PEUZ`,]PXY$X_G"0EAT@C9C)<\,HLK`-4 MA[+T&7`LX=<9)EC5#D*2*A"M%J],%Z3@$BZICLI))PH9WFCL8)%A>0T3'BJ& MD6@R4-9B)T[@`XZ&;',3+&Y<2C8LW:EH\W+O2,TO$*G_/0F8*E-!1*9B$4@H M$W%`&7C4$7M@P+%`$52AEL*(G!('>3SQ>B0CD!-)` M\!)OH^#TJ%PQP<)!8%-8?`3I$2:('-!B+ M[_-2O!#9G/=B2&'U4EA9!BH76_!0_YD+A0E7$GV&7Y[F-CF"S:%^4`&./9IE M0,135,:&_/6.*R8DD3R!M\9"\KZ`0S/$41LKCX,!IS?QDY@7`"\N=/_M_20^ MNW><\8=;+QU%F6F('R`"!AZ+[X!T/R&I_^T__\.`__PFG_KJ@6!TX:`SG99^ MEZ9%P0\W;/C[R1NH=W:'`R$Q?L/7ANC,U[LD&;?)AO5L3]9^#A3[<)3=4$T0F6/3YJ-4#.OT$;4:5\S)(X-=(?`)O\ M%[[']:7'6P322#VT2)WH&9N:1-SD[N/NP/RO&><%)?>SE?W441''N3KQ@PG` M@Y7[D\!WQA[>S;@,Y+U'O2;R35Q.6Z:-5?[UNDD+`;XFHXGOR$8/'$E3SUA- ML]%MXT.B^X-'MC)BFBQ>V#2NA5[(`PX"/+7:#;/7[)$SX3Q'(2`K<7[E<$$- M+IX<--/'CN<*A-.Y/[-$S#D$J]E+$J6/F_.+B&"2/(017X?T-_A#.+TY^-<$ MJ"??M1'GI>+@8PHS9%_B+19P'RJ`0X`.VROP7:8:GY]#O5LSKO",N?U#SDN( MI#BA4NYI"J(QD6-&7)A5G,N'A?G%`/(;#SPH2&;F./3VJ; M3F2`(,*9(?[A:(C5X?1H;B7-['0\Y(MXTD?;+D%1A8'ZI$0L8!,41,9\^B!8 MXV5DH1L*IYG:4Q"PCOO/29RD\0DBK!$?^$QNN@_B*'/ZD:$S\:02"6U@!-33 M5XDN?J!F+NK&X/>38)E=:>]N!3V8RBB*A]!1@J\5$?62O^5%()V1Z`;RL(3S MX.7E$!\J/R."))LXR-M].7Z71K'RJ:#4!ICO6+*X[/(K_2-J(3STPR>A4\!1 M0\KI,Q+$(FCE9J]*6ZI02D#"/4.7`;>DLBPO&Y"C0(V3=$!.$^O*5883PHQ8 M?CP!T3=`;PBT_R.-LY6KFG`2.,WM'GX?,9]+B@=O3.$,[D12IOU]%NOALM:) MX"4)QM0`D]AQ#%Q/0G"!N/QH/(1/@*@HQQUNR.+,U<,@F2>84[1Q\B(4TA%7 M?&1MQ),AQV8B.)>X--NV$(UY5&4"3$@K3A/X*VH]G&F+5!`].I[/17,@;"/. MQ2P:8:>3"*4=&$Y\5C5N>@@/"%R0W$N%-"F*@#&7ILBC@"`C9)H44^%`BJI8 M'^2<7>59H0*G3C_=C\OX%&E6^LXB,?ME$N'AC\*(F07DF>%,R,&T-Y<0K-AH M&K5'7F-/1=2R3!BS@.!-PQMF1V'2F[S@,?0?4=4!V7H#T0T,6)#WH*'1X<7T M3*METCH]J&FFX8O@N[(QYU/Z*N+VD`0C M#\&27US/R3)J4T"./_HFQ-QAP&@>4MJ37^GX"XH.Y1&_VAEP5<*=`=4*9]&C M-Q#]Q[F!GZ#!](LF!?3#B-M1I!Q.+;/+_9K2YM\H\B(TW]BO,;DWH#2N`8K, MQ\1(OVP[IGBP0H_RB+3#6XR11TC_P#9YL9+4/&.,BH)V-QI8;6*$)KP\*DD_'F M(7I$)R+Q?&[;RE>`\QI/37N8AK<4H:"_\"+!E>OS@0^36'1ZQED/W/(#O>JB MT9CVK*5X.AA]019]/AUX4)T:C;KBX'[4?X-B?Q(;U M'L@5<&SQ)[A5JWX+#7_Y>,WX,QB$OL\&0MO-'`=N4P+1Q^RQ)?>`7#&'+M"0 MX8,MI.$E>OM^8?UH@M8&O_@XGVE42"ZHI*JT>2GG,=DF])'Q\2`(_TBT&0:X M3]M-L]/MB0C0$_6<'(*[:CCW.,0DH9@$+2F6*PA0-WHEDCQZ#%T"":F\)/SMMX\6ZC4OIF^3OD1L2&+@.EOT4K49E#%M4U+FT$+ MP3%"243B*D@V$E6#5T\"M['J+N4)"K$GO]\%Y M1(41A!CPX!DP-!\*;3%,J,&)2]CCG_'[`LR5H2>YF\T%.SRE:+!+!]0"Q3?$ M<[.OS;Z,[BY%8>B!K'4WA]C$'"`X#4?TS^;+H,:#'QY#?JT4/E%#?&$-#>1W MR2,?,U*<9#V@2_XH_649DO)\AE<:3IQ%*T1"@H+YHJ.;Q3^I67D'D3TL#479 M3+9N(K)+3X2WFA5)(Z@\,YM#!VM72,4YG]P#`PN$J^8YTA.V;\Z\#0SI3WR> M[G(?,9Z^)WP+\3LP.I"E1,H*VG4L)CL%;W-XC%/&?%(KC5OUV0+3(:@Q"V+^ M1-IU7NU5/$,7:&Z9AC)J+8NP\67P3L),0XEB+>EA9027ZV$_=:^5E87A=NW6 MF[EM]$W.-T-B&A&?33$XSZN2*&4^'X9+(7'T])C,6RJJ5`,"0U9#TR^/P(4N M`"CR@;@TY49FEAO(]^\\(3?S2\S3;KMK=NPFM>MML=\F!X)OHD]>3.W3AB,0L,^O3P1R",'G2Y=2U)KJ<\O(UGNW(+F'` MJ7=!+"Y<14X6OU=5;Y1JQF?^3NX>\-7;O9;9:]3+2(80YU++>*O3,'M=.R>S MA&>CG+)TN@2&)1CEN6.2LA5+)E3#FK#;,(K._6R\U"!:_?`3VG: M7+WP.#SB*NW>7MPI/W__+&Y7P>=%9(&N)WS#M7MPP(L'G@C MJ+=>8_+6@<[PZ=66+@[8I/.QV^E0&\/6S>77\SMP/7ZWYQ M=W7]_;9R?D@ULMV.J]YDX?/T5I<-A`/TP9C`1J*TS>Q%9J.=2PM#IZFO&9?_ M[PGH-I$C56(<6VT1K)YG'$=$R-NS!T7!_W2U2J:AYDUDRZ/YL5IV[1;=0ZR_TPQRZ*H)Y7\S)I3 M*@;`F\2$..$XRQWB%44_?"S+=PCAIF<@DA>43J2 M"AUR<4%D-&8B7",=C\'L-D9R8C2D:1QXODSFM MU^Q6-A`K[S9&2&HNB5V1B"Q$FM7L48[3`A=R\2"C;4:.9EV@%7R;:;?H(LO% M.@_<"\H3NN(%IZHGTG>!GSH/A!KY!%@E8[NR)#URF5SL!-^K!O>`:F"OWF36D%S2= MQVIF>6GWR!`E.FYL]::TM+A*O"H*B,UH-6AJ"*M!"/*PPGF>>"Q\-PKA(E*A(5Y M1\:A:@82%)VFV6VIEN!"*Y!RLHNMMGK=FC;;RFX/@#CH_:=6SVPV&S*:[(PP MS(T9+*',0\=+F_19B<&/8J`LG#/OP5!H();:@MQR)``0+R M5XNE)IW5GEDB$#`(/9YFBDR3K MY>G]:6JX8'19O)X2<=8RPXN*N)WYHJYB'MOSY@(2\`'\3:5J7.HX\0-E&2I\ M`P#&LL+0RZH>8<<\):%9Z_7>S'/.BJX:^3TEYE%R>2#F7!,0E$I9,ZX"0]$` M,S$=@>M"Q]$RZW;=M*S&TJXCO9C?_BUT$9V(%E!!:]=]M>[7$) M+347VS8+DB+RR=C!3*@7/DF2,`K8,QV1J-\V9,82R_J)<.L$?B>K.$E2R<0) MQVC46O4WT@BBHC6*H@2S8A#+9TD.B$CPR/,QZ2)@Q?%/7IZ9?8GSSHC1XKE\ MV"QE.]V4&FIJ31DNR'@BE3M=QFJ*I!Y5E.!P]FZ[O2G+8\;PD'(8@5W.-*)B MZXQ#7\*@=@>LFE9C>9-"&'(1&_,V-O&\U`O-RKMR.+^R^XPYM<^Y9G895:+R M(OW9IA#3QHS/('P*@I)05F5C`<*9>3>`7GJ8E) MLQ<"QGEJUJ/=PZL7L/T`>M_P=YX"\*Q!26!F+E[VW0MW6U1+Y*N-80&&S>D& MC&>HA@F=3XE!*G)9B<-+OP2$XC+@C9](F/AO(V:#2+87*'L*53-5M%"GK0@K MFO`<^`O3_BU;D-LO3=7.!YYGH3E$B2.2]&;M-C0%J))*=,;@6EG*"]ZFT!$E M.>IMC<*< MP0,:,+#P]?E5E@\YU\:%;M&I^G!\8<2Q^FF1-^`%$K>1H=G4LC[_=E2*=L2B0@B M!;+TK("I0VP7(@YK"(9PUE7IMH:M3JEP'0Y]$H&`_1Y2G7U@7&#>/)C!GI-] MI_^,A?E1"&X[IJA+Q,4?C"]@>!H77C0`;_;6\5%-X>F:QA\1)>(;E[_0X(N- MKU\O3.,V85[09V!=7N#FGXT?XF3Y,_!KD-/G_@AKVA.^'F'^4Q0"G8`R,(W/ M8""?!V[$GF+CBT-M$+[`"QZ`11)LHP0_PZOHJ?\]8?`NL8O^A*SVB[`F(2RG M3844.25.'4*O0X=`D=/,$6("6.G%S'%+,@Q22$#2-W:O\+W9;@6%*\VE?\[X MDN2RMY$31)0&I(!.`[];;A!5R4AU2GNG[;9";:A8\%'^-:ZG5%F0DMBWD##P M+`_Y=D*M&2-.:DA,-Y<&W01CRJ]([%U*:.0.)F:,^'KJ?G9N/P_/RZ_WU[R7(+KN_^ZO#$N_KRYN?Q^ M9WR].O]T]?7J[ACS"G36=0%)K):#*AI$2S-B&/H^]?%ISP"4BIPJ MZP$Y_&?[\_N,6;RN/'ZI`E,&$XR&^].S!,L`GC\#UXM12[E1GGG7;U+>-"LIC(/KBR)/GM]S!A1N_= MIKR*92DF@JNTEE9I5:+<"D@(T0;EN"6$)N']`ZM)6"NY3>'MAQCR M(YHOR8$_-'R(+OJ,M^=:TU6)?"L@)BS3[G3,1OO(K6%-Q/L'=IM$;#4LL]71 MVFXM;3*M&*$IGE%\\I2N^FTL'[X%?+*[I1X=&4S4,,>L-G0_;=N0]X@ZT( M?@VXRCZ)4W&9VPIO;$$;$K/!<>)GQ"/$+K8_&(F136%$HUZY<%::RF>MY(LV MMSS+OX0`9W5/J7:85B-7@'@\M.LAC=4!E21[1WX)HUM1@7L=75##E&55BS$) M//ZE/V\_GQB_8N]#X/FP(5"`)\;[C<-@*3!8Q3"X;."-'#]&)?8W^%JGU\ZP MM1(`$GJ7>1\N@?J2YPMJ/$6/WE*'JNMLC1U#ZSN@J(_#$5RJOO M7T[^9EGUAMWJ-7Y[O]S+IA'[F?63EW;W'DMJY/*'"#$CO/$L`6=VA&HW3-L5 MLW;$M*U0YI6`TP;F`2?L#7EPOC:M1TI? MT.NN]89,'GR_OKN\-7Z<_^/\T]=+T_AZ??Z=5Y9^OKRY^OOYW=7?+].R4E%5 M*N!25%NFZF;T6WIP`D@;@!2=E>:"*34-G'21"U)PXM-OJJ_Y)LRSS/)0:'1= M-@;%4XLL886`43FE*\9O\PZQHLXR+BFT7`+V[6%I);XHU]'38*S!0=Q5G\=$ M:"B\8(6"6JN9U4H+G;)FEML$<<^;5#WDS4)9(%J.B8X* M@W-6K05L)BZREC^$M&[SH(ALPQBP-/EMAZE5Z&3=+C_VL)SRE[P:W;'_(#&MANZ)[ACW5R("E+F%- MVZQWVMA9JV"^WFF[85I6$W\[$R)_EZ9M+^.[6$70KWP,"Q<[7=Z9FH/.F:NR M5J]G-GM+:)[=[O8@4->RS%ZGN[7=[D08YYE)`-*J?S3$>#3LA4GN8CF?->IF MO=4HX[-6^MLB/OM4=8V\G+&1$46SVS:;K=:![FI[>&DTNZ;5J%=:'Q6_^B(, M:"GDCV553Z/1,IL=JXPGFI;9;/?*>.)B)SRQAN^RBW>4TH]EFRV[=QA<<6"X MM>VNV6P>HO=Y%R:.O[<3M6LVHEOF(JUM?*RU>-EA6F:C!\?9.1`5=$B(M8!/ M6LT-RZ`"/CF*^P=<:S)C8=);)^G&]1W"*K=PS?&O%>@5?=BR`>QKV73ETUIF MC[BBQ'UH1]ZQ5SIRK[";][KRZBJ0K;KK-/'<"USOT7,G?%`)7O&[4\/(C5.; M-P'O,R?B$UZR]N9MI;MY<==QFO^93A'U`@SA>H]B3(GR=MYTO&147K:>O7#6 MNM5L%XRZ.K5JV*@]G6JU<'P>^S7V^%@R97X9C:LL>?(^"N-8SH1)00NP,PYU MPD^'7@D'PS%<=#%QLY.%2(!H&E>+(Z9CFN M\ECC;?YE8I0IIL92+JDH/Y6`FF)DH&U:3>%RV9;9;98%*0J29,7,(4";_\QW MDTU*HFPIG$"&,P"2K"U^Q,0L#\)'[EQK+Y:*W=6%8FEZ_*N7DYL5E.K!*SA>C"Y,N2P2`_):JL`TUN(`>%VKW2H,-/`5.00T MX4&.W_AO)TAG$+Z<;+4R7Y](-TZEZ6#(1E$M0$:E+=ZN;T:`BS%`),=QWID< MY7@^N9\`X?*9G38?O49S-WCRICM+VU:>N.>K?I_1Y+!4[1?-[5;&7TH"5BH> ME/&7S99M-EI-Q2Q89]0E'\_BQV$&U=![G`+*S$$U"9C1J"\!TK+3-JO,FYOR M(E7%Z_`2$#''A6Q"D6HJ->T@"]42)-/T"]*-SQFEAXB:SV\OC*[5DCMRI35\;C;8 M:XK11C1'4QFCG]PRHW_A-Z-PG+!;/ M:LWPO0E;EE-;JR5LIL`!*6G3K+KQS`.;6MGMFT6^(.M-]#1\JV'2G[M)](V9SK]BKK M]D.CAGT'T3*A9M?K7=.X!"V-PON;DSS0V&74&R,4ED\!B\SRX!IHF70V<,0 MSGJ"LP0BVHQ4<33D5'B_#OD#9*E;7?ZBU6,_-($1A["*`!!_IMKF^K&S]/8\ M:4$GUO0T=:S`!#>[V^J:K4ZIMPDVSVD2FYP>WPZ3>CL#IM-\VNW11]`U0$9AZ2`3YR=$]&'H>A[W";=H2F+Q]N M*LU@EP^@7L8$MXIL.SX@=!I0;L^9W?K2X>-IK*X9.M:2HP*28^/FP/4@"?ND M>Q7*00UJ&M^`#1SF`TIB((4'QS?!'P962,*<69"S"83_3:S>H']/^Y0))LGP M$;W\"SD+@I>,YVR(&?XM,B%:RU@0_''%;LAQ#X=:#8S5IR]>BD6M"&^$XT3, M.L>?'D+?1?.I0`[WL$]DLU$FA4M$:JMC=CN][!9-C#:?DJ\SX@(?[9CU7OGU MWQI"5GD[1G'XKF?.B4_^+A*T.$F[9R\(+^":"V7L!D(-6I[M3YX];EJ<*3?> M==XY*&58SM#?PBCR8J`@=&T#*C?^^O7">'OW`(B*TU^;T@NZN+RF92X>@$T` ME9)'/H5.1-2+/_P`RJ9^%>_F^4N*:.2^4[EHM&=]JZU*QA1MTI$3@]OCPN"V M;78Z*VI8JXB'%^NT2@2$5*3V5>>IE^7<]![YB=;E/D573,9B=S MT#D,*^=6",JFUC&I4R[T('!UL0B9[YKS4.SR]K4.L&Y/ZVQ6Z7SF7A[1FR!V M>0$F;6MA)H+5`M00/C,V)30-/W2"`HW1!F>YU<4OLG5&Z9TA$**4Y%B>AY-6(.=NNAM],5$+=XTY#"]$U:852@ M7""*V$#=;$MYV`)JZ#1?.]B*B-APBE+)(9CGG/E+H3<$H*,>6F*?QX M)87!&.'@Q#,W8(/!MOLY0%_$66G_`N32ECU.2*[A7$Y8#: M!`C8Z2&D^W%"/^<<[D67VH@$`AJ]<4X,X?5KEO0SDQ]$V`EWV0C,U?T>=NZ&6?NZ`M_WT0#)I9SH`4'3/AV!1K(^<9 MI:LX;TD)M,"$9`0\.ISX`#N_FJ!TP>#,B6,6Q\2+!)47Q$DTH6MY4\B^]P`I M-D.+10-6(<"%XYX"7XC@&760)YC02F>Q::T4%@7*;TE-XTG4.771( M[JR6GHSQ$XO\N2S!>W&:-EF7Q9E5-:L^E=OU2-(=^8C`&SCQ0^JJ94D.R`WX M[4'H^U**BW1PU$!3(J`YK94%,D\[K3L)4SSZW;,EMA96_Q[-0)99:_T&OSFG.T6 MNA^KY]6VE-""W6V8O=[:N>7GLY>.LSV:R2%*SA6-O M,)5"B%OVR%4IR25$-'D*ZD!KJ_I<)"4J*IUG%G'[O,]`#8Y'`=(^X202DO&A&+\TBATF:\F?BU(8*R57"<629!, M0<&>`N0,`#YUW4F?*KM)D^#20Y(2!R4I\$6GR85>+B61`%6"6465,^3"C3"^ M_F\NZ\BG+,H)S%+@ MI:+-FS&]10)_=X[MG3,-OT6U;+?+9>87X$TU'2P>@5?,@R5*]>::A=$P/,%?=(FF1,/]_!DI;4Q/R@NXU*JU+', M9KTMA,Y2UN#\&\"M)1>O&%4!#NG9!2U4-F#HK%W3OJJAL\8-Q)'*[553H*]`3")]PM`!\YKO/,5\[N MM@M4^XR[/X[`&`HG,:#*P%7P05(,55MG,@(+[%$EF8]]!L\YNK=.5`,Z!Q8,H?*(T2#;`J1GA M),KY@'U@(JYNN8!3BO'%C9F:B"ZY0-3I9/1VRJ,T`C`18X2W=EIFI]5=([QW M6JOW>@O:*0@`E72XE>%K-/;4;JAH28WT&2N4Y]S%8H3":\9QQM+R/MQJ ML;1/V&;L['8`*IE-!=!,Z;]E%!FGT"P7@S->%G^;C1KFPF[YK)FYFU?#;MQR MVF38+<7*3.C-F`F[MX0T9\EDV6UE;*C74UMU4U9S:P8J( MB+L!O+^#,`Z*"T!D;CJ%K)[I?MDD\U-HZZ*T&&[6K!0.PPX1K24Z5TG4P/$/ M)J*8OE!:]%D`G@"-85,$QY!10O]R(J],?JR4'3]79I5?%93*JRY/!M[R+<&L MI++,1J.QM*0JKR!8V>CJFMVZZ(35-=O=?33"TM5,%1#'&Y?'/&G'GE<%Z="U M7*O;72*R`AP.X'J8!DA/Y^+S\-I2CIBW]')7(V^]=SGH(\>T+2_B M(^#C"#@1_O'6@Y6P<^)"-A95U66)0$M%?`K$_IQ6'K-I4AOOX:'LW!82EFQV MH>)X;33)P/0Y>9F2ZB4_)-0[*R%_1CJMGOZU4ALJ#'2=%=]US7"%S$67O8RZ7UE;"'9=MMKUV+7"SKQK1&\!5<&9$"SECG>YT;,[IYM`G.]X M&ZLXW5QTR/ZDJWC@!,F>O.G<$8IV0&NEN93:KNVZ8KSFNL466J\$P]IY+@7. M-I>YTH:=EVJW3?^Z=-C;+NYH=6/5W9277HNVB59KOGG9XG<"K\B\Y&AIJCUJ M=F%,OL18W)T9N#$S;IKX%"NNU=E@NI+]\EL5P0+:9-,FFS;9JF:RM?9KLN'H MK%6ZD^I[D<,JB$[SFQ:825:]9W9M>P-V$M?HN=1/S"?";!VEM;UH')Q/.TF) MET">&QZKFM$ELJ2+E>@VRA&W:-:5)$]LRF[*4Z.:YFW6>UW3MK=A.6TL_F4! MU*W.TFTGM36EK2EM3>W,FNJUS&:OLS=KBK]^[P$P79!PX/TAU(01>UYS"*RI M!HN=*PY,__5]D0/LSI:(40=3M0I;:3^@]*^1Q?,FY[_"8FZEFG_9#%%1RI\U M>IE]=\99\D7%HRA*$ZFI!PRW2H4-Y`5H>!!^^D[P$Q-MT@U)-DUW)4%(FRRL ME@<+%B-L![-ZZV\R(3B5&$ZLP,71WJ:M6 M;&1YHQ%S/9[3B@(-QU%8IMU:8^+=$DT1,F.4ER'FVXEW90TB=EB85QUARXCE MJ^^T41A6/6V4=7]8J1'"NET-.AW3MGI%)7>+4ZT=45^!E-,510YIYP+TN[*" MD93&#\WF1?&]]'O@O_C0\H9O06F\L)_FY5QKR[=*EF]VAELQ?1M-<$RQ4_2> M;%^[9;::+VYP4,QG*>,(GLD>_>W])#Z[=YSQA\^PE<^P$S_$KFYW8*E]\D&' M_>T__P,-K]^N;_ZX^'"+6NV:G_AYX/XECB#],IX`VG@W;/C[R1=0Q@CH6=V" M_R4A_W?CK&&=_`T!<+U'"1_9A1Z6/2<$Y$?$Z=AWGG&P.*PK6?_,9T/Y#?%) MQ*T_^D@U+_&;Z5Y1SLAWI2M[`=J/'XUR@YF>[ZH)Q[=WUQ?_R[C^<7=U_?W6 M./_^V?CK_.;F_/O=+:$4ETKQ"_N;%7TK;#J%OA\9[_/"^Z5+[Q.?"Y]?4%-, M-&@((A3"M6M;UD?CDMHKDJWZE27`\?$7.?VQ+ MUZK($@+8&2()DXV!BFM: M6/4D&*NF??$%>LTD5&IK.EZ3S*=)MD\B*5 M,4=XSP*X0[)3TM-VND7-JALP)*0)<3L9``T;P(3X#_[BP&'<6_(#X8.B//AQU-?7TZRI__,0VK3P?]^V&2A*./\#=X MP]%9$H[/Z)L?,);'\G M]LD1["8(GR)G_/L)_WOACJ99Z"#V>/BGI&E.T]S1T=QN#"FU/.:%^/N+;K*9 MN\"HT42OB;X:NSEZFI.WIJM;RY6S?:M,[(='NE43?M4_7:V--7EI\LJP<K2U)5BXX::1,N\6$U?%:*$>/BG>W!J[%*4?VDMILEK"^1U$>(@H$$R<7Q-89K"MD!A5T!@7A![@]=` M7^M;:A\-D=AWQG_^8-CC7Y4SWW8!Y4:9)KT-EO#V<2`"0FU0ZOR!,M4M57_L M@Z.J0@&:3`^`3']@.;6F4DVEE:;2.Q:--)%J(JTTD?Z=JC9?*Y4N8U?/`EZV M19$5V++?S-G.?+C/T[EDMOIK?B9M8K0BW:3:-A=EH%I/9BB:0<4R6%D^:5'?#*Z3&PB(6= M(C2':`[1VF2A-JEUNYI3-*=H75*RB;-7R!W:#5R(S3^PI]Z:=2=:\F@=O^ M2Y:5Q<@:7;1N6CS<]$:!>)8,XAFD&IN9G^J@6:C7Q:N+5Q*N)5Q-OQ8#5Q*N= MAPT@3M3;R5!583KR;>ZJ)6$^]A.0]'E':FU!]]Z:(91.N3)8J/;%VFISE% MJY**.'R5(*UEO,!E+XPV!K6Q28ZH-+,>E-K:#M>M!NWAQELTR6J2U22K25:3 M;"50K4E6DVPU4+V[BYCFH5[$B+H0I^]7\C*F>8@A`0#:<,,)H'3_+/#RX$#9 M;C;9%Z#3ZE;A.F:OU*899GL,LXL@VO;YI`H7,II%CI1%CDRG5.%*1O/*D?+* M<:B3O5_*[(&X%(_P?8).3_ZW.?=F#5EE,75'F/H.F+K),+7H M>8+"98,POPA'HS`P;A,`R/C+B;!Y7&S<3D;@KCY_F,5^ MN>]8+>1.N>#U;7G@16%.(N`4(WE@\/^(,0/0GCS$!H,] MN%->NN$$+GWSF3F1^,9,4W?#B<#!CP$8WP^?XH*SVO?QS.`UE4(4G!@PWQ<" MY/>3^@G]'(^=@?Q9+"4%4+W^9I[`!KL6@CZ/B+X3M>5M]:G=.J M'$#'3C[GL!OGGFGJJ0+UO&+5L7[*F28T36BOZ_2TDM'4\XJHYX:-'"\`9UG3 M3Q7HYQ7K#FVD:$$U!QW?)Q2W#(=:4&GZ63^A3=M)FGS60<=7;ZA)1Y/..NBX M"I+("V)O<`3T\Y+BQ>W77FZBBK$B4"[-%(M*=P^4:602P>9YIC)'?!A0OG9" M_!%Y@RUH_LJ<[V%`^=JI\"HP_L&<2(O#?4/YV@GQ[XX_.5IQ6/7N[EO+/YS3 MBM&T^RV"@J:-)'MDLB6 MDFW688JV@CJ-;18P'RHG6JW:BTJ]JTSJ&K:MP-:K,&Q5QIN&3=.;=F`VJ^7_ MP`#R-G+W#X(S*F-('K>-U#([W8YI][13K&%[I2Q0K[VL(U253U'#ILTV#=O! MPZ;I3;L)BQ)#M:.@K:0M6DDW,M;<4ZE01Z,V56EK,[-F65O&W;=K-=?E'.U M1N[0\3#_.\WTFND/C.FM;JU;T`K[==/MP0%<64;;$%=5$?:#))2#`_A0J4-3 M=G7=S8,T+DL+<;:KO:M,I0=F0!ZF@=@RNVW;M)HZM4V7XNA2')UC]QK9\(!A MTS<8&C9-;T=W8W:06EZ7XE3"D#QN&\DRV\U&\;A@36:O&;;7PP+@)C0T]6O8 MM-FF8:LH;)K>M)N@2W$J"-OKL9)T%8*&33.!9@(-F[;@-&R5ATW3VTX\AN/) MQM>E.(>64JFS\G=MEAT@]1X',"593==,*`!UI1]8+!7A5!V MY^XU#]3=2^MCOCG1X$$6QVPW77H.]JI*S(6,"%`;;CCI^^PXS-'I_1R:/=HQ M6_66V=UR.^D#I-YJ`;Q6LXL*$>SAEN]4"HT'5-]3-0XZ1H"UACT`3FO4K+;F MM"H#K)6K5JZ;-:J;3=-JO`;]NDRP8-GH&XZL)69;QIV#2]:=BJ M#YNF-PV;IK=7D))XJ'=4HK+)`1]*WU/I*-KAN]3ZGNH0`-:A-!U*T_=4KXKE MM88]#D[3]U15!U@K5ZU<]3V5OJ>J1@SF*<34-FZ:WZN--PZ;I3<-6?=@T MO969G>\3O(O)_S9G9J_A/*3[Z4?&^T5+K_N273EZ=X3K[X#KFQ37=P\,OII$ M7A![`^/1\2?P-%".Q/ MEHBGPR']XB('KP!@_&DQ,;I_6:73?& M+#+B!R=B!GP$*^7OU4S#"5Q:G8FV@L88UDO?^>1$V)4\KBWPM[9-"(=U_,/0 M]\,G\!\-8B!`*8L!UAC6&(;1R$D\((&(<6I(PA3+AI-,G<^'ZN%]!F&I4*.] M#ICO"^_Y]Y/Z"?T5;O?YFGO3BOSN+O7\S_@7QP=`9>3[LJ%#8 MI0#->,V#$&$)?C]IGRP2P-5IY#"`M5BT$3WPER2TZTD2)\#Z<"IK15*"\"ER MQK^?\+\7(G,V"KC]JN$-*.%J`*F)5A"MDA_R:HEV;E`PI11[P>;V0,4O1'[5 MA,,^Y8`^77VZAR?%&;YCS7:#FKRT\*C,Z6H5K+E(GZX^W8-3P>>P&^=^+[Z3 MIJZCIZX]>^>';`4LKI5)YS:H)51-JI0GU*C#^ MP9Q($ZHFU&H3ZJN7J/JFK!H"H[UTZG5K"X2Q;>2N)0%6;_.P\?JPS=%$M5"[-P+N-,UNJZ`#G*9@3<&' M0<%63=.OIM_#I=_7((&K;&<>%K6`P:GM32WM#I9^FRW;;+2:FH0U"1\J"5NU M;D/3KZ;?0Z7?5R&"M<6I+4XM[BJ$VOWYU[V6V6T7].'6)*Q)^#!(N%'K=C7] M:OH]5/I]%2)86YR;LSCMUG'3BA9W^P=VB^(.QZIU"V9`:!+6)'P8)-RLU;7% MJ>GW8.GW58A@;7%JBU.+NPJA=F_TV^JTS'K]R).(-`GO']AM6IRVOF;2]'NP M]/LJ1+"V./6MNA9W%4+MGI.(M-.D2?AP25@[_9I^#YE^7X,(UA:GCG%J<5/_`;M7F[&GZU?1[J/3[2H2PMCIU@R0M\:J$VGU* M/+MN6I8N^=5$?+!$;.L>29I^#YA^7XD0UF;GYLQ.2PL\+?`.EGZ[KR&;2)/P M_H'=ILW9/G)UK>EW_\!J$:PMSDJ0B[8XM;@[9/JU[%<@[C0)[Q_8;5J/[#:XM3T6VG4:A%\@!9G M)498OXR&MK>%W4=#*W82R*`6W[SN#GPBT$8>^Y^Z?]5=B MCU4VL]'4IH9EVKO.SZL8K6EVT>RRK,6]XS[B%2,SS2F:4[1BT29_Y4S^U;9P M9`2GY;.6SZNVJ#9;V*2Z]QKELV87S2ZKABIKEC;\-:=H3M&*94N&?_5):SOT MLE7#O>I(W0,\@]"/QT[P^XE57X`^?;PK\/O[Q.G[+/];UWO,/I"?PHH% M+D-X`)R/1@IKWP\'/S\:(R>Z]X(SW)OXAOB$^$]\I&)A`&NQ:&4\W!$>O@,> M;I;"@]C9;^^O;_ZX^'";`+#7X\0+@_@\PYI(]F:'@?A-'(\:>Q8?(/3..61=Y0 M'@&\B^N[FO'E_.K&^/OYUS\OC6^7Y[=_WES>;ONMN)97L%$O/:(MOOS\]L+H MVG5#O+O9^8@G:M"1&M^8@P60Y0-=#I/+AD"(L3'$IQ_Q:=-@ M,3*2%S_`YXXQC)P1>PJCGT"LD3&BI4''*T_0*R+VKXD'ZQLL>'""`7.1D>1+ M#:QT]8;.R@7/3&#N$Z(7"4S1FND[":<0>?WB:` M)R<"\>\[<*(>BSG$^`3[-0"LW\_*SOQ(!O=15<(`CQ;Z"+!%YU%H_9`#8_4+]66Y9;['59 M=6>B2/*ERD.(VF'H^^$3\LV#QR(G&CP\&Y.8$S9BDP"990U^`K_@.%V^CF"S M/'>%0WZ^_.OR6)'`Q%JND3NT#_O'-ZEJ4)4^6D(#P,OO)V`+X<_"AZ"?!332 MYZC713Y9NDI49IXDX3C[*FJ^O"DH5FR\457P>\MJO9F_T:+=*0;)2B^Z`%#[ MD6<:_\7\1X;0PTN`.<]FWM1M+/^F7G.M/7UEC\PW+*E/6O6/QE4PG@!)`94: M_YJ$"1`1R:.8Y",(GT"A#85'(&D1/E-(,4-:*O0NPA$0]K,!XH5^ MEM((Q)8S@!?%-777BJV7V7XS!E_U*9B?SAE*5'Y$FR=IM"W/'ABW3Y$`Q#N' MSLCSP?K<&HDO>O$62?[E>^8L8)>P0`@4"D3./R`2=B+XM!^SZ!$I`)*"ED2<"^1.9`#&3"WC!P)^XTXR%;!1[`*\3E0GT6=X#YGDB)1_G88PG M@P?\T$-O!-21$8%&YPL^>PQLI,$D>F2%>T%M,0A'HS"`;0@0:1G0'IHI-5/N MG"D;!4R))#L)%*+E=&\*WD)3:YI;G4<'>(M_%Q@MF3CD+QM/P#;H/N"?8,\" MJR7(T!Z85<&S*4UKXCO43\BFW!;S'62-U+9.#>I*\\BF3-VK`-`(9FZ`HHNC MT$OE)7E7POI4W86AX_L$"'OU*V"M9A#DK^8*+<9$-D9Z=WE M/"HN],=1^`@X$:9DL?8<.%'D,9?[TT7Q""(/!V,'DXBB'$`S'NE8.+QO2(%& MPS(-C('QP`H;L%$?E*[X%/Z$PX*S0!4-$N[`'*WR<.0T&&NX9&I$NUAUS*B+ ME=7>"U;(@O+-%!^%UW=6K07X$1=X!1JN)!9<$I^;`U%))'Z5/1;HGL,_('LK MYR,\X.V>QV$BQ=9(F45*0R-%1-!X>%5X MV+9HRN_OGY,X\8;/M,)GL,]B"\1&B@91<'@,L$ M63ZZLG2%`(T@C6"2V'L='MFO=75 MV#T*[.[3M)T*KN]:><_5I4L<[TY$4M4L'HVT*B/-:K7,KE6-V*7&V-'G".!% M+4CNNN$6ABGHBKXX1Y5`F<1TOPN+?,+8]-GMX"'T,>&5%SI0WA1^8Q2ZS#>- MIPIG,H6Q%?*$B>D$`-O<`)!K0_!3MI#H^"(@)#7;O@ MZE[?P._[3F2K-U3YO+7[\1:E@[#-@ ML`"-`,RY!*X+W0T$=`XA.K386]G+;@\!==TF8*ZWM9>"JG/#>-D?F=\PZ>D.N#>+J?#_ MFF#%QF0,/P["`-X?XV]`*P1APH[L/,\.=#_;P\C;=MOL-MKOCH7$O[/$F`01 M@U]A0\<+WAE^&,<8_%`"2UD0!4MTHLFB5/.-'$<9@=B=KFFW M6X=!]@>&V[>VU3-MJWXTW*=Z&"QP5_$MMG0P=LW&DW'#2=]G+S"7UUI\_0OJ MJO-4)=&ZM&=7)6:J@G%0Y8O*@U^A`K&F)2Y*K>5ZKBBA6?BOM60CL^)KI9EN M:.FCO[U?J@F;[-@&V/GY81B&"7HL7^$'XQ=]E#R/X37P;8:!ZA/Q:13BRQ^2 M9/SA_?NGIZ?:KW[DU\+H_KU=KS?>XZ_?XQ=/Q/+R!?#&W+KPLY.$D5SV(<)6 M7GOM-G_N\GXO/_!T^=&.]?M+2UO:7M[2W=V-[2S>TMW=K> MTNWM+=U996G)..=1_A5.-)#+P#\7<(WXQGLLMC^3*\K'AU$XF@)"O"CD'^.7 MS^I`UV0-_'YBE4.9`Q&$03B)!FP5UIX&3D%1"L:OD0^?X[4S"\[^O#WY&][P M\W8O(+RP_6/\X%#3ODGRP%LGF(87QQ.\=$>S=Y)@UP?JL/'@@+/9Q_YSCHNF M,N_[`.?ELT%B.(9=QY\M^`1#+\R(Q[Z7R$2-)R!_P3?OS_4$L#!!0````(`$PPTT"H'8B; MJPD``/U?```5`!P`;W)G8RTR,#$R,#,S,5]C86PN>&UL550)``,O3N!/+T[@ M3W5X"P`!!"4.```$.0$``.USB0:4!/X%ZG.O:;$9_QF-<$@NT#5A1."(BY_1+0X6ZAL^H`$1J,?# MAX!$!/[P.O$%ZIZ=^ZC9U&![2YC/Q=2Q4K;S*'JX:+6>GI[.&'_$3UQ\DV<> MUV/G\H7P2,J+BWOO:[O;[9RW.^=GSS,0OH\C^(/ZW&I_:'4^3L[/+]Y]O.B^ MUYP@PM%"IA.TG]O+?Z_#/P>4?;M0_]UA21"@P>3%LZ27C16UGKIG(%CKO-WN MM/ZX&;K>G(2X29E"Q2.-9)3BDC6N\^G3IU;\UX1TB_+Y3@3)'-U6(D[*&?Y* M"^A7))'T0L;B#;F'H]BI2J=!N13J4S,A:ZJOFIWS9K=S]BS]1F+\V(*"!\0A M,Z1^@G.DLP(KS*B'@X`J"2GSP#7"EB)K`52+D+#(8+[)(AJ]*-Q$&(L-JL1\ MYX+,+AO*+9K*!91KJ,E_T!D;O3Q`N$BJO+V!6GO+V^/,)TP2'WZ1/*`^>*9_ MA0-%Z,X)B[)E+ M[QF=`17D#\_C"T@@['X,MO(H*95V-RZ'UN&:PR2`K$=$:8[,HCVT//T%F?`! M]F"=49JRMTD/+UPH^^R'.SV"4W[$0 M$)/E@5P\[-!2.B10F1AJ8_0R@9DD1().<2H;=_A*%(8TBFL%6`72ATIKT)-H MI$:-H8>6%C*O6!#??'Y0-4]-:\/"0_060BU!DJC0D'UG1H>O3G>2_+F`RJ@)DI&K/X* M_2UZ'8[6QA]!`?UE>:K%.8B>KJG@]Y0%6N6!EDQ0S`7]<\KPPH<<[?^8-$^) M7@'WUG0)5/>V65*7JL0MV@S+N[A/6\CF/<8/K;A!)D$DDV]B;VFV.\MV[8?E MUU\-*4DDEWZ=3!#@.Q+$TWZUG>O>!DVK.FG58E7E$OAA_KF`8A?$V27J0;9^ M@>P2%Y@<+33';FJWXF.&\!`7/A&7C4Z[G4R#A;?F6]M]\Y*B)=5:43%J`NIA M,GXF>)AKZZ5=^(Q52YX.(E'X=U$CWS=RLS?Y9"M;,Z]!H/F";+BV1UH9.+M4;J M8?2N,HQV4+]VT+U*65@I:U)$,I/32=AX97U='`U9A#6H;LN^O&15E4-_D MVSZKR&5K6CN'BO.+.^&5W8+E>0!EI+.*/&+ MD=N)@QZ0[ZL%\@TVJ1VN\0;UG`=@3ZDZ_^@E![XLPFI[G97G*D4[-)F4%2^' M\JV^T=#DZ5@[/U+;\IR5@K%-5O':1P^)/.UJ!X/A^U1IC(,QM,(6Z^$'>_ M'[&YXLFCKGB]HP=*B:ZUP\8A$::,^"863"V<8;VV"!=QV>B3&?5H7N74&5CQ MRD:%>JS#NNVRMKKW55K&`JE#%SZU-#8?P MN0:/%[./RZ7/&KMO>M:XQO3'ZIZCEARC2[5\IZ?E=W:(S]!WAC5YN'HMN)1C MP6>Y!6.-HM**]TC8@N1MB'W_<\5),,.BZV5K78W:%:<>E_%IF.1@2>[B>Y.L MXLQ<8O<\M3+LWZQX)_@U1[![BT&F(D,N!LR@K=O\"Z5?AR$*K;I'P^D)* M`$YC^"%E5$8BWFE;NE!>OBP;57&7L?AA5GCQT1WM=PM:L)(Q*5EN4-FJIC,DOBM6>Q!06ACBUXJ4+E/GHZ M;7?Q>U!I,_K^+J+[)7K5#W9UC0:YPG'9#52767@/9?&Z=0USQ(Z[]<"RV0.T` M>WT^]QME?M)`Y#VKSR"L^,G6?D#E:UX[D$ZP9?K+SO_LF67_BAZJXH;:"+F( MZ']CP]FS/KF+^E3&IW7'@H1T$>8X@<8X/:P_U!-K;;N<0+QOOV.D'=E90_5P M_:F>N.YBG1.`-GE_*;\/*QFC!^;'4P$SPQXG@.+R#:?^\EA@YIM.VO#J,=/# M_=.IX+Z+!4_`(39>F-DY7:?CM/SPW3`KS6#^L76Z%V M[NE`)7Q9/J;0@"V?O)X[HIJPE5FA?IWXJJ.MOY.IND^-H,L:5,_=T#>$7KY% MZOD$,?=>PO0YX0=U@Q&57L#5!6?P861,IHZ)[`&ZFKK6R'3=HYR\W?%.PE3^ MGS;E=Z/1U-K-$U&MM#JV>9Q]$K\P;#5/J/ MF])?VTK"GCWJF<[H.'=?9=QIF,KW:5.^_M1$$QL-C-[$=HXB7\X5AXF(G?:F MB&/'')B.8_:1.[%[OQU%R)UO-DS%[VS%GSTQ730VOAA70_-?:&@;(Q<9HS[J MFXYU:TRL6Q,-+>/*&EJ3(_EP_C6(J1KGFVH,#,M!M\80_.7&-%Q(*4?*(R57 M(J82=[<2A_(69(\GEKVT^.^&XT#N.([@I9_;-C36Y,<'.L=$A]ZDL;8Z.EJ)WOSD*9<:8`A?G'V!RYYJM*]N17TT&]*20EJ$1)\!Y+O=Q;%E,M,FKHE6O^9ZJD M-6_--`*6JQCUG[I-';[Y'U!+`P04````"`!,,--`FFMBLV4%``"9'P``%0`< M`&]R9V,M,C`Q,C`S,S%?9&5F+GAM;%54"0`#+T[@3R].X$]U>`L``00E#@`` M!#D!``#-65USHS84?>],_X/JOK0SQ?ACL]UXD^X0C%.F-KB`L[M/'1GD6+,@ MI0(2Y]_WB@2MXX]@9PE=/R0&[CWW'.GJ7B2??5@E,;HE(J6Z[4X+$1;R MB++K\];,UPS?M.T62C/,(AQS1LY;C+<^_/'C#P@^9S]I&AI1$D<#-.2A9K,% M?X\CZW=U=F_%;?,?%E[0=\L/@?)Z+D"@L+J[#?SK]?K?7Z?;: MJP60'^(,'LAKO?-6[[X+>KW!FW>#_LF!`3*6M-UEV_#<3T7J?3U3]-QGZX)`G6*).S$I)6Z251=OEU3T]/ M]>)I:;IEN9J+N(S1UTLZ"AF>1IER6#<^T1\>KIO29Z#72*=TD!9*QCS$69%_ ME8S07@MYI95FFKRE=7M:O]M>I5&KG*=BL`6/B4<62/Z'/%)1`0HS&N(XII(A M92%D4:)+,QUF-4\(RPP662RCV;V<8I$4M$%*@;L49''>DAFDR6R1622#_WR( M;W9_`RLKI7)AM)#^S7Q-SB+"4A+!EY3'-((DCBYP+`W])2%9%>F#`1IG/L4" M!G-),@GPS3)VHC6B218&(O,B=1?NC2R5D`_IBP0]#]6X&A.GRU',[[Y=S!92 MW5H<*,Z"N(N+/*6,I)6,]]G7SW?ATVM&%V`%]2,,>0X%A%U/8:Q" M2BK9'H=2MX9+#D%@9D,B*FOD+MNZ^0QS$O`1#N&5I+)D;YO6S68*H8D0,M]Y M^*6*T&[KVE<#ST@ZQ?=X'I,QQRR%EC4D@MY"0;DE8XKG-*99==X=BU.WCA&F MHGC?FA"X%HW6ZB\(B>1M;J1/4^& M=>'%0YBYD*\@Y:HX@/O10/5WIWE*_LTAF'5+#DG?/?;/\<(B+*GM,EX/N&=/ M4&Y-Y&;@I."Q!`@1YG.B112F/BU>P!\#K6M7*)1E.ICJCS;Z3H#7YZV":1%/ M,#V2]+9W`XR+2%I"DCD11])]ZOKZ7"'%CV-8.+P^+\8SXUAJI4^C.4D6.(^S M%R=EZ?Z4,]RFC,KV,8;+)[S)*B.P<8A*YA*PMET\W)9HG4ZGBS14>JQ_Q2Q" M#^[HB?_K\S]\4ZY$]("YVE'!=P6!UC'0(P@J4-`O,X;S"-[0HE^_"UF[-^E* M8_]%&I^`_G\Z*_;N2N2;PT1^A4-\@;X"?A=S^OS67DD]>8E4B8<*P*:E[CT3 M4(+>RO)!TS#F>1R@Z/^^2=^?32:&]UGR M]^U+QQ[9IN$$R#!-=^8$MG.)IN[8-FVK$5D[SPX4^7>;Y"]=2=!T'=/RG$:Z MSH[#!$7O=)/><&:AP$4CPPQXX62H;=SB;#J6>-+,^SAL@/7/.O1I;8 ML0<*BGUW:^FY@>6CJ?'9N!A;OZ&Q:S@^,IPA&EJ>?64$]I6%QK9Q88_MH)G\ MW7_XH%3T-E6,#-M#5\88DF5B&3X4DV8J2,4YA"+ M!U6C$=Z5!Q.*^)M-XIXU-@+(]:GA!9]1`)1]6)I213-MM/J80G$_V>1NNI.) M'4PL&.5BR*'HR>IL.4V5YN-/*I28K9X)W<6;P418GZ:6XUL/BMS@3\M#Y@S* M$32@&UL550) M``,O3N!/+T[@3W5X"P`!!"4.```$.0$``-U=;7/C-I+^?E7W'W#>K4I298WM M\6TVXR2;TLCRK"H>R2?)DTUM74W1)&3SAB(IIXV&@T@,9/OWQ91^@))VE(XI^/SEZ='B$<^R0(X_N?CVX7@^%B-)D< MH33SXL"+2(Q_/HK)T2]_^\__0/2?G_YK,$!7(8Z""W1)_,$D7I$?T=1;XPOT M#L-&&?4*NP@@G:$36CQ'.,/TB_^$+=/[J=8`&`XMF/^`X(,GM M?%(U^Y!ECQ3>_WAZ?G[V^O3L M]:LO*PK^TLOH%^SO)Z??GYS]L'S]^N*_?[@X_XOE#V1>MDFK'SC]?$G#GX]J9GT^?T6!G;P^/3T[^((Q9 MK_CXJ-1BK7/"ORU%!TCP2@XF2I(3IG\2XWO:V0'[H3?LA\Z^9S_TI^+C:^\.1T>(25+Z M*>UZTVBK4#IQ#?8&)R$)QO%NJ-O:/<&G[TZ2[6%`7=^Y"4N2>=%.X.N:SF%/ M\6Y/?*OG_DG3403O]J1KFDW8$?OPFOZI`1Q_R>CP@X,2.FM+X^#X3W&_6[1= MM4[\1KL1I5GB^5G9$+?BYZ,.>B=MI*R%85+"]1+?8',A<>(3.B`\9H,H?[JY^BHA MZTYPBH=$.BA]C.ZJW\N?+H6D,*PAEN"4!P.=.K=N7=>G72!=1U23A5LX'MPN MCOY6JB*JBW)E5-/^Z63[8[O0JC"(&Y-B_]4]>3H)<'C"(QSZ!TZYP>E9,]`]+P$D'*P8#)]]G(U96#S98TM+3G7_2Z%V29`0P@4$V3( ME)3(A6D($?`D1A_L&%(@`0-S%7GW$KM:W[MB@Q16R8+&ER!Z7X:HW>N5#&)" M??3U:),D#&.8^E[T._82M3-0B[IB@`EL20:5'`A>&,"U*5*(HUP>,85>G4,> MK/R&H^C7F'R.%]A+28R#29IN<"(QUR#O-IPTP&Z&E0IA$"2R0=AFTB0M)Z8> M8IJ#3TP5E;HH5_ZE/U)](-$FSKSDF:\XI$JS!3FW)%+`;)*G)02(-')D.K)4 M&HBK],B0PAG.\2-)LC"^S]=IU-,OA;CC.:P6=&LJ*Y4%Q!XM0"6)ODE1I5$L MKJ&BI1[9Q-D\HN/H/4G4&9"6E%ON2"$V*=,0`<04&2Y%YJ-882YD^R/$S>8N M"OVKB'CM9+Q"QBT9)/":5*@)`"*"B$I!@UP0<QQBR7I-XD1'_T^+!HX]C MMLGX3@KJN]1N4:OD>+RQ,*`UZF@T`!')`J8JM*?B8+9S2RKG-Q2KCM?)P@"()))G3*O%PQ_R[2[(?T#2!IJ-F$T$W5!;-V,891K8M>[]S;`6R;C)4J(BM4*:-2&_VS MU/]?&.0OQF^]_0%Z&WE-K']#YV3$_7X(\MAA+VUS?X:3\]`P&*R?Q$WV92/*L M)F-3Q"4'9>#JU*M_#X9Q$E#"HD"D,=@K M;+72=,F8#J;4B62A!H9?]EC;M"LT$2MRIGIC??,9J6&F$@AW$?V0`Y8 MECYH2H(AD1:>,H'PF$O#(`^?'RP>2)(M<;)^2Y*$?`[C>U4`I19W22`3Z#J% M5+)@2&0`*"P2;S#*"%I13T42&!RBS$XV.!!=JOJU4%CYA:[+I55SRS09\G7(Z>3"LLP`I>+!*!1[! MIB3#Y7`^QQ&O*N,EW*;(2]-P%>)`S[=.+;BDWPZFU=G801T,.;MC;G.5MU!& M;&S<3?)FZ$=)->?D3C.M5H.",,TC/1B4MO:4??M'.Z_8LR\T)M"LW6`SA0K. M$[(MSV&VYHOI<3`B,3M[@V.?`E2MQ.LTG.Y\,$-O['=0BX/Q9&:,0KYBJ\&= ME%_7@4&QSNE:*`G:;BG9KR`)VSGMJDJS`DF)W="V,'6L>3Y9MW%+*NEX45H% MM;4(W18#PQXU-LDB1ML@>2A/_"P8_H[/3X])3_ M'Z7YB9OZMX/30?EQR`Z>!WDHMCV3@SR^\>;KV6U3.YZDW6HHB+D>6V4@VP-J M708,417`9$,GB4N*_OD59>`9"_ASCAY38FJ82;\^.SX]?WW\ES?G!R/H,9UW MI(_89Y/F",A:UC`(^$D`+[KQPF`2C[S'D$:TJNR42MIIQD\/N9'ODXN"H;(> MGY#KJZ01V^0S"&/DYPHPN#3'F1?&.!A[292$`6Y)`SNB;&O=9#<]ZS#;K8!*S^BQ"?/CZ2-B48` M=S^'=//*CGM>8&TWVF6;$2S.6:*5,_#KVF$T+(\B7)'DLCB((!YS,*S/=FO# M:02WBWF-N*Y+`V!&W5U0"P.P_I`*#/HV4PDW7C)+^$'D@,_7;MA&"3JCLLI# MJ)7[2^^8#%)G?%2:8"C:":XQ+U3-MB'2,J__,JRF_%9/1%3JCX8J`]3T:VL` MI9T"II%N0A8'+NUXE_(RQ0K.\AJ1\A1H8,MICU2^F`(OK MA(J`QJ!.J]$3Z6S".8TX1))9!G)-<@&-X@2SM"&<4KI7VV)HP6!8Q[L<,IL"S7XMLDO(9>=9`%(/EH]0`VRRJ)%%$A8`0AAWQS)$; MYD%22>?%,>10A;H833$PWD>-3>`*KU?P;E+P*\&40U3^S3H.$&SI^&M',Z.K;EA\9N`WNU`5@Q?8R:$(E%4H+./%\ M>7RIW+SPUDM#G\YV+\-HDRG79HU:+@EC:4*=0@85,*&='+%]B@\&\WW!X_T#!#9^H9[W'TPT[Z#M;<3MK*X=VA-RU,9<\W<_@.GUW M:PD,J_>"WR9[V1CR\M90S)MC(9Y?K"X+R\IH@.[:[PB,EZ)V3QV[D^LS$)^6%!/P5T:0>D>""_:\81C\WR;-JZHMR1RS[@GYK6%;2Y;D,-[E97[*;;F5 MEWM8S5HMA_\=,&_)"QHG5HFI?BHO=5K\&$_I\+D4_93]V6?N<$-_A>47._M" MAVGV--VP$\\TR&9;+6E0_9N7)!ZU[XHD"YP\A3Y.9\DH\L*U,K/>K0VGR?1= MS&ODS[LT`.:-V`6U;@=N69Z+'8M/"W48_"V3'SB@>%DNU6-%G%01NT+8Z51( M"[@Q"9)*@N&8%IXP\6'"@SLFS2;?E3@,$N7UP7X-XZ!<"U78+!-T>I93";1Q M?%.0`D,:)32QJG@\X&-H6,C!8,IP39(L_!?G[FQUB>^RRZ*4^4V"U^%FK0I1 MS'I.PTY;,QHQI$D)#,MLD0K174T/T?^59>I9MB8F&89U+Y&X(%[%LT6I0_-Y M%.L&^MT!83),O^-!I0V&KYTAR[RX=W()IHL%FNR?EHRU7X) MJS9&3U51#S!)E6`M+H:'RL+R:G'U'0X&G7YY)X&O)UQ-P2G3GG!R1U+<;<.7 M"!;XS?"B"<4=XI=%"1+I+>36S\.NL7X9V<5@/55M6H+/X0Y6?.7WSZL'C.*^ MJZVT*<>=+/" MIUP6#.D,`,6I42Z>$ROF5]+RQ"?Q8F"QZ9Q.XI[Y#I+9RH);:G&W98#TH)ME M@>2RT`X4&G"*%`NILWKD]T/E:FR)"-ZR4/W-X3F%Q0-)LB5.UFPAS.)UDRGU MYZ>`<=[W%BF#W#XI3'8/6=4['#*@T?>SXO,2S*=,ZKADLXH!^@. MWXP3MM`#X]\[@!7V$-=4^=:\B*2;!-". MIGRC*MOBJES=J(OT4<2J#DY6P8I]#X8K$E#*VE5L81P&#TI63VFOT#^R'2DI M3_['@21^OJQX;/!7^S?K.L8XQ$-HCY_[M`F&UP6D:KD*_VI5?5EFK+>W?/I)X1.C[D*1T^=BGUAK:*_*K9\CS'"Y&=G[G,[]!Y+7L4S>^= MT5$&J^)7_4L8A)$@$J*_XIAKO:0//ZZ:$93B+&/GLATXMQK2AD-K&:KMYLTC'&J2C489)T1P02W(H5*$`9!#.B$ MQ#`71[,5*A5@S`]+,XI=8216+HE)!)TN?2F!-I:X!*G>V6*$)E!EN+R=C]'L M"KV]74RFX\7BI4:*S7KM)<^SU2*\CWG@$F?%#FHZ);LA4>BK-\SMU(*[T68G MT[;C42?UWBFV.V9QULX;87ZJU@S:MH/*AF"X+ZVM2_PE>TM__),J^VNI[#3M MWLF@1N+=2K-WKNX$5Z#I[?OWP_GOS$S9@W& MDBN^I4[G2Z1B[G+2:I#;A+0HTWO?&X#)-C@N"27MV.TG*&KX6@YF[]0I]\DQ1GKO`:>YCU723KK>#W4JNOE8C`Z7XM- M6L+J=?L)!&[5X/ODP7$X^C-'U9/AV]22O;.%RMX;;HP><054*D!P^=4AFRI;TP3&W1<^A\K^'4OI%7H MG5M=4`H4&T[FZ,/PFD[=WH^'B]OYB[D='@+.'OF27:UVN79=S*3B=MN%&7QS M)X9:OG?*=``I7G?$-F<4:CPX*A7=$D>;\S'K]$T==2[(I`":/,8E)S:S0[.; MY616A#Z_#>?SX72YM]LY5"&'B)48N/&2['E)+4K9CFIFHGXCOUG-;6$'.R.: M!1[T.KVSKB-0<6,I5T-<#]45P5W4IK+0?I;7J04(S+2<#790!\]7^UGC?'P] M7(XOZ;QQOOP=+:FW7`Q'W(&^T(C+;HD)\PN1J&L?$;ZI`,>F;4Q6:L[&W0Y& M5$.OA4[OO.H(5'8#4*')@[>&+@S_IS'.W@5V;<3I0;J=#&P3Y?LQC1EY`#F:\;U*X^D+;E0JZI`6A9W3LK+S**]!6COJHO./.S3B MS%ON;&#E.SNWT#LK]X*MJE1;-L2=*V\*%6VA:VB5:EO5H,6JO.73J'VT?4\+ MLTR.^-`_XO1*I1=Y0(W[EP[Z"[V_4B]JEO#*C4;S6QH7C_]Q,YXNQOEH,%O^ M?3Q'H]OYG`X0U6+*`4:&0Q4WN4OQ'QMJW?C)JJ")2MQM$1,]Z&;A$KDL&&H: M`(I;^4MQE,N#2Q>T#3+NUU?+]TDJ_:Y\E3!86IGWWK]=C/_GECFI\8>Q(?_Y MDD,MP:<.U'7Q/MF\]\\>>!1`%.TO$?FS![ECIM00K0 M@]>`DZYX%J+?H%P8#;,L">\V&=\HEA&VKM!??S0#:[O>,>D`ZBMKJ)I7AE>. MS\5[ZJ1W"4G3FX2L0JF;JGT-Z-'+4`F'>Y@,RH5Z>K;5;2R3V"=K?$T!R9ZQ M1`S0L]:A:S_S2A;EPNA;)OY=3X]?O.&IVHLT6]W&#SBXQ[7MN).83J`V/`TL MZZ7=6P/4F0Q0"@/J?#-&<>/Y5J-ZI0LE.&_U7C?1PND>.YR6 MKU]-%4P_.;Z?%7+/=C+`LLO+.UN+QGAHF2_U#(U7M3KEP4$N-87YO?E/D=VDYSAE:WR[Q@_Q[DMC0X?6>$*&Z@W5Z1MD*-@Y*PWKC#7^,$ MI]=V`-WQC:N:ZO^-T]ZYTG^!4RDD!\9X^:_A9/1O#BCJU' M;L;8?O[+!QJ>K_.JZ"M>0%]:(9V%$AXKJ-^JIY]M-VR_ZJ/;H%0;!T6`_0V1 ML23I6'F<79O4K#[NY1>'`J62?:5P4)TM02;KO15+@CZ52="\@'3(M5A_B+VQ MO2BC[\XPE/&&VAGG_SZ=L7N%+E"=HT$HZZ3693)!_4K:_MZ)@QZ4!=4]EF@M MNBI_H4AQ`ILE'S\7C3_`5!+`P04````"`!, M,--`Q')]^7\0``!AU0``%0`<`&]R9V,M,C`Q,C`S,S%?<')E+GAM;%54"0`# M+T[@3R].X$]U>`L``00E#@``!#D!``#M75]SV[@1?^],OP/K>VEG*LNRD[O$ ME[1#2Y2KB2RJE)3A.CDW__ZZU\,^N_#WUHMHP]!X%\:/>2U!N$"_6J,W"6X-*Y!"+`;(?RK M\=D-8O8)ZL,`8*.+EJL`1(!^L7[PI7%Q>NX;K99$MY]!Z",\=]F\WPXEW#Y9N"X8,%0^>NB<_I$_)-4^8D&,0J``Q8&^TF-8_M4VI4;0L\-`L@XA*%'36/99F1M M"E6\!&%DAKX51C!Z9KCA9<(V%27I]QZ#Q<<39A8M9@+,--C#?Y)I&SVOJ+L0 MR*S]Q&@?S&\7A3X("?#I+P0%T*>6Z5^Y`2.+4=C;=Y&)>3M@=D'LA;UBXQ^U!U)+H/*NOKLT79?<]P/T>+@PN9Z:EF5$ M1UP,[,553&`(B)!C'GW3?$WBY=+%S_9B`N]"N*!4=/SP/!33`22\&U-=>1`( MN:W62],R7"/Z$(JL![!PC"RB;9J?7@RFJ.]Z=)TA'++SI$US,Z:/!A@S>T?> M5Q%#Q=2->P.*`!F[S^X\`$/DAH1.63V`X0,=4![`$+IS&,!(;'=5^VE:CKX+ M<;*(N@$NH?XJ9)C;H'&_9O#9JV1\IDKYXF),?5+LR.7-FN;2`0$;B>G<&#U/ MZ9,(]029R4G4KOF9:+F$43)74*W0X8,-:S0FD1@:)9HVS2T=>7$,?.MIQ>8\ M]EB;+CQP-\9L"9)ZA03OE3MJ?G::$_`MI@^S'H",^7+HR_A:42^DM,E29D@_ MR#0!3Q&-[8"?=L2X:FP=3S]FO=&XJV.TC+3%[J\TP#76S8W=]AO^4PD"Y&68 M#EB8(YY[;.>Z>UO&ISDG$::>E784N',0)-W?LK9R3=MUF-TH.`F\"/!.[]!# MVP>PG42\])=$D-999Q-V_40_NEWSX(`[R!X=1BS4Y7!>3+K/Z:YAF-BC<;@/ M,(4K[=3%7L8<\J'BAJ*]2M;^+>\>!EM+6F"TK*K+C=Z02))=_5(>OCL(72H) M=H,!]9RG3^"Y%(4TS7 MGHB*X+,$G4#M>[22^K_04O^%<0#8HY%4_!NM%%\HIPJ% M;]:"?4CH.NAWX.)RX^>32\+P5BL81-*KFX*_@"#X%*+'<$(#310"?T!(#'#I M5,QM(XG-SUIA(Z4'=0!]1D%,58B?D_TG4@I,CE82D%\T!(0CM\+%ZMJ'';!" MF,7FZ\VQ\C4KIXDD+.\TA*5<"^K02:RD2X?4.X3+`XD]2DDLWFN(1:',ZB`8 MQ_,`>OT`N;Q,0`&==!2GH?X+!%8X/*'E$H5)7G9R3P4G=APEE0_42#JYCHC[]C#>9E-#+PJ-G.,Y5@'I4V")='I,=:EE$]`S0 M.<(7X/&AG1-O2#_X#BES^4J0;=[\W&@9VVU\^ONV"V.W#V/3B9'T8OQ]%KJQ M#^D7_ZB52=\UPH5+Y@F>,6G=N>YJ;8D@B$CZR;Y);CZ^W;)M+_HPI.Q!ZC&( M0(G$NUS3@QVLOFPF(2`B`BGVB52FWZN`D4G#%`K:Y"AW*`B;=;T4%CE:I:GX MPS#AR*T'-*S:B&T&TQ_6MQ@^N`%@V\-1U\7XF2YBD@H!7@9-KJW2='Y=Z"KI M10\H-U5.Q`%T-GM@=2@CP/6R8EJEF?_:7E8FMQ[0#$)6`T!#:#XB61*E.P%U M@2B24@_]CS%8N3"M'DF+1S+#,P<6J99*-PSJHE5!)WJ`*`-7/6!>9[>@D55# M`02KM"YRN):=RVK"9X0B-T@H-0"O%#7%>PF'P?6CX+1324>'A"2Q=8\"JG;" MED'1LV#U+M]<:5*\+M95M:/'P+G#M5P,5M9`;3:]`>"T#L?2M>RFD%PPV7&( MU2;4#UW&%XNN!SS)$FERCW`T!7AYA3!&CS08Y,UK?'*U2?6Z$(G$UP.D3:EX MWN7Y;L2C5YMI/\"3RA6@!T[YTS%"J,J;R**E5]0LHP8]`-L]XK1S[(6Q&[B$ MP`4$?CE^E7J0A5.OL+J&DO1`5]H)#W$]O2)M*8<[RC!.XJC7?C*_K(4LO*]3 M3E8[AR][WDVUZU4.LQL(K,_U"M".)9;.'DHNVQTKI)0%1Z_0K$1H/5#9*<,J MW;#,D+1O:C+QZU+#2:Q5[EPNN! MD`,B%X;`MUP)'A#FYTOII8(\ M1'I%5GR1CWVU+MI6J+G9(@^TMF%9J3H:A5WC8M/B^[JVE:<7M2I/,YW^67WZ M2DNA($"/3.M]A'LHGD>+.,B7*PG2T]7Z.,K:U3IJTF,>SH9&U*ELG&C!3Q;F M8[9=0M4F%2+R&Q]E\6LUS>B(YOI$CQE']PC#/UY&]E(4\XV.LOY53A/ZHI:< MK:Z"6-K@*$M@Q1K0%RGQ(4)AJZ.LEI74A1[`[62<*LYQ4BV/LH"V@DZT`U%R M:BMM<93%M1(ZT!2LTAF-2WV4);4"V34%2#R1-7(.7K\]UAH'X#7+M@@N$]^F M6M[(I5I>NC/0PGCI4)/SOH.0:@-LF10D6;C42CJK'J8^;[]9@9@CL6$JH?-4G^P)5+H,=>%`6#..(F=X6MU)Z4 MD@144G8]YM@O`-[=4Z[,!SJ$W(%1O)P#;"\2QGU,%M;72=Y+PGJ8 MIHXK-9Q_->,V,_RV3F:8]67>NMBTS+):S3D295>%P0]V;:FHK28ZQ^Q160+OB4KH24'O7Y M7TS6)RRGR`$>"CV87+_WPO`4->.%K_,H76KSI`SA-;6MASVQ?7XV+=/U`]M1 MWGGM9Q_A"<`/T`/$QMW`A4MN-J-:'[K4^TE90"W]Z`%MNN9GJZLE"\0S[Y_< M7U1PB'4I]),"JUQB/5!9'U+\!$,_37ER$"DBU*5J3PH-OJ1Z('&,6=U7+^V3 M&Q3_S.[>FDOVKJ0_$H#L10_,HQXDR0&:,09+&"]YJRIQ.UTJ".662+)ZT-7I MMTNUS<%Q<7&6=`>ZU!?6=&J19G1%-'^031K+HJ:ZW)M:$T6^-G3%+[W5G']U MDJ"--C>FUH2L0`&U]V$>`)XC`M1/F'DQ-_>A]S;B%-Z++FT`R!H_J>(GY0S/ZZI-C?,UD>>HX[C!U]^ M8^3@G2.-+J]M>,_H1RG=X$B\.2QU^'9B:4?:7*]ZB'%(J$J/&(`R[@'@DS[5 MPNYUOKS4*)=<;0%'Y0RI0&P]P''HDO-Y4X\A`0Z?7)L[;:7`$8E]_"G,7?/+ MOFB`I?$D?*^HD2S(>J1+Y%2@AQ_*#_('SX,:W6G<\/SWHRR.$G&3=VSO1P@< M\,L::',GKQ388M'U\%?&9PD8&MVW*ZWV@[UGE>!&'XTC/7RH!*#;:^5KD"EPKJT&,03$L_6#$( M-VVW2R(+B!X17)%X>B@^97^$0H_^RK:42)(G"OV"91';LP\0B;'H@._AW`T)0:#S4**JJ70'UVL0&:<7>;UEK8H41DSB.6+LC4`I%RD5])SP[P-N^2 M\K:5+@4O$9NM4-A%U$8P28@8A]PTR0$]RB*FQS9F`\I[)5B3FM[U56?GO&5$ MAD16\7I$2D7BO;XF+\2:O)#7I![!3Y%X6IVD&[D1G77LQ55,8`A(P7FYGXV6 M\3(_T3]&YG3F6(;=-ZYFD\'(FDQJG8/C&,0^0Z(]&BZYRHS;AJG\!74<[G<) M51Y($RD_DSOC"JF5@4_BY=+%S_9B`N_"9"H)HTT1!%V"C5$`,V^9VYK]+_MF M/YG=W)C.[\SN)X/KT:`_Z)JCJ6%VN_9L-!V,KHVQ/1QT!U:C[B#'OC"DK=:) MRL"]C,,IM8(K^O"O/#DE&RL]\UD+T,R<4DE%6CGC-6)5P30D`CC,N]R[?9>[ MMIE;=>U1UW)&37K5+A\"WRDF5?H*HF\Q]&'T_*(JD5^4-U'I#65`9%\T)!9: M*TOOQ6"*^E2:%R-X,?3W^X;>FUG&U#;Z9G=J.TT:^@X;`CLOI&PTY?#R`)&] M%I.JM-,2/69R#"4R:F6>V5<:Y"RT<[9OH6/'ZEN.8_6,R=3N?FK21K.\",R4 M1ZS-JS)$MLVE5FG>Y1#PWX6AMY'OYOF&R`W9!<+Y#%+!XK_3R<6\]M2:&&/S M=_-J:/W3&-KF:&*8HY[1LYS!9W,Z^&P9PX%Y-1@.ILT&`+)"B.+DRMTH]*CT M-*#DZ.)8&+E-`K](4M5R^J$\;!@C8J_4((RJX#2,FNE1LDLZ*]2M)A.W=^ MY)WA(I=>8LLJPQY/!_9F:OEB.HXYFC:;3BKF3WASF*!5XSL"^8<)V[K0$(/6MF_`Y(7<8]='#U/*;^$"E?X@I;.FWT'<*RA.:7QQ=ATIK\; M4VKZ$QH.,V]0>,T>3QZ!PXB;*:W++V9.?L55J0>5;B<+7W;7N;)ZM')!]IXG MN+Y[C`X;792DAT%8N,O1>;OOA5W[YF8PO;'HO)-,0ET[V=NP1DUO;)2P*2HE MDFFI^'5C'/[D7:QJ)RJ]K`*4^R\DJZXGK7QMIY^\_[KHJ.V6\_+ M;:N;W:XSH_.?]=O8&DVLM?O9T_]8CM&=.0[UR&V&H6%7E)9"=/%C]7Y47L24 M/0F?/QZ=\K_ST0M@&Z%$;MST0U2Z>6TSR5S[]"I:UVI0F,1S`K[%M&.+7<=2 MX/L%M057$^N_,^;CUF>K;LS75.E\EGUA;0&/7&GY?Y8I8?#(IU=;*U`.1;;$ M7R!R)1_9?,/^F[L$T$_^#U!+`P04````"`!,,--`F8B116@'``!,-```$0`< M`&]R9V,M,C`Q,C`S,S$N>'-D550)``,O3N!/+T[@3W5X"P`!!"4.```$.0$` M`.U:67/CN!%^3JKR'Q`])56AJ&-F,M;:NT53E,.*+"HDY=UYFH)(R$8-!6A! MT);_?1H\=%"B3'D\%6UD/[@H]('N_AI@@XW+7Y;S"#T2$5/.KAKM9JN!"`MX M2-G]56/B:89GVG8#_?+S7_Z,X._RKYJ&!I1$80_U>:#9;,9_0B,\)SUT0Q@1 M6'+Q$[K#4:)&^(!&1""3SQ<1D00(V4P]U&UV0J1I-=3>$19R,7'ME=H'*1<] M77]Z>FHR_HB?N/@6-P->3YW'$Q&0E2XN[H.OK6ZWW6FU.\WE#(SO8PD$]5MO M?=+;G_U.I_?A8$$LLD7DW06K;ROTS\,@X>R!PCB#N+KQH;OCQUFV"- MWFFUVOIOMT,OY6MDC+UE1-FW?>SMBXL+/:46K#N\,Q].4-R?H"@^M MU=:Z[0T1P2,2[Y5)*7N$&&]W-Y1"E\\+H@.3!EQ$T&`E][+0M@#8H(;W M6Y=2]ECGN#?F2@!X,:,!CB*JXD]9`$D^3Z54PL)"C"Q*`F%1K"0"Z8LU0( M@>M!$ATGLS9EKT@^4,3\.U$P.0L)`^7P$/.(AK#OA=`R$R@^)EMFH\ M.@""V@])#LA*%]I4AG)M*%6'_C9A.`DI$/[^CM#AT(^Q`*\?B%0*:L*U+5.- M7?=5V&UI?\=O#Q:KF,;.S%FHB@F,B0^`5R%0C=R'>LBM]2(^0VO-[PNP/H`F MCA\&$7^JB]^:OQJ^CZ^!3RE&J>9W^%;PC:`2%\2972`KB>>/;(\[\Q#["7S.1;/SLRC]PP*SP!#T18$/(%J MB]V/(5L#2O+`U^2MAN.?93B\R>VMX7Y1>'CVS<@>V*8Q\I%AFLYDY-NC&S1V MAK9I6^<.TPV'",/V$1"15]A;(]4A_UP.^8VCPFHZ(]-R1V<>U7Y"?#[`@>0B M/[9L#%3']*(VQ&7)![C9SR-R)!C%L/QND\$?02;'\F0XBF-H&XHWI-U MN:OQ:.^\/QW?\M#8^&)<#ZU_H*%CC#QDC/JH;[GVG>';=Q8:VL:U/;3]L]^T M!YB*]"OB+<$J?CDNN\/5`'3*``P,VT5WQA!VG%O+\*"8.?&ZW]!/@3=@U>LPN',0V_R^9S*]/`(60U5 MH"K`"5N7ZH<8J@'X6`;`=&YO;?_6@F1/,Q_*1E656Z/WDER'DX](2&@M%^IP MK\+LR`B.H?ZK+ MZ)(92KN3/=7SNFK$5+6"&_G8`Q3V5PW5@]6*]M-7<*VYG$<%BU)]H#N9(E.. M1CYQH0*+8$?+3O<4E/`%$6H%Z87QA0))I1(?;TR#U#R0`OI;N!SAZ;$N@PB) M?J"O0Z7_39V$[#O6R5+"_B!7S?4L;^HP+)UC'=Y>;3_(W_YJDDUW\P:OON[P MYK_+7>!+<)P+B=A.8_G0W8'LUL.0!ZFJ`R+JEU;(:6I(:W>T;KNYC,.UI<<8 ML0[#<4849\A+5N0W1M+" M1=TU^7KHGH4QC:6`4U*\$3Q9%(P46`ZZ"!67:C$X M;/.#ULJI*NH19F>T:=8(OVH$@H14;GLSYXQ(+)[?P!^7!!&.X[1_HH2=V>Y' M.=C])PO.X-R67^US9LJ]PNGO4W&RD4D_UMAQ#,>D3N%J:>R/8'MWC^W=4[:] MW%`M;QS5])/;+.JU*,L.'BMU;M*--SFZ_]F2AXPW,WN[-E4-?13VYZ-=M=NWL;4?+G9SK._VDLH\' M&$[.F8J&SM;_7E]U]A>#_T/E+ M/3NAPN-_`5!+`0(>`Q0````(`$PPTT`9ZU"1E&@``#8@!0`1`!@```````$` M``"D@0````!O`Q0````(`$PPTT"H'8B;JPD``/U?```5`!@```````$```"D M@=]H``!O`L``00E#@`` M!#D!``!02P$"'@,4````"`!,,--`FFMBLV4%``"9'P``%0`8```````!```` MI('9<@``;W)G8RTR,#$R,#,S,5]D968N>&UL550%``,O3N!/=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`3##30$[^@*O2&```&T$!`!4`&````````0`` M`*2!C7@``&]R9V,M,C`Q,C`S,S%?;&%B+GAM;%54!0`#+T[@3W5X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`$PPTT#$`L``00E M#@``!#D!``!02P$"'@,4````"`!,,--`F8B116@'``!,-```$0`8```````! M````I(%\H@``;W)G8RTR,#$R,#,S,2YX`L``00E#@`` ;!#D!``!02P4&``````8`!@`:`@``+ZH````` ` end XML 31 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Statement of Cash Flows [Abstract]    
Net loss $ (930,833) $ (1,172,990)
Common stock issued for services    201,796
Share-based compensation 89,587 388,945
Non-cash interest 22,892 11,762
Change in fair value of derivative liability 278,265 40,572
Amortization on discount of note payable 110,012 24,694
Accounts receivable (66,436) (187,727)
Inventory (19,073) (8,978)
Prepaid expenses and other current assets (8,967) 2,263
Accounts payable 16,393 (397,229)
Accrued expenses and other current liabilities 135,285 365,508
Net cash used in operating activities (372,875) (731,384)
Proceeds from notes and loans payable 500,000 566,926
Principal payments on note payable    (38,262)
Due to factor - net of repayment (31,158) 201,267
Net cash provided by financing activities 468,842 729,931
Net increase (decrease) in cash 95,967 (1,453)
Cash - beginning of the period 5,852 1,461
Cash - end of the period 101,819 8
Interest paid 95,967 20,607
Discount on notes payable 362,977 137,703
Reclassification of derivative liabilities upon conversion of note    44,852
Issuance of common stock to settle notes payable    274,507
Issuance of common stock to convert notes payable    $ 5,000
XML 32 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
PREFERRED STOCK
3 Months Ended
Mar. 31, 2012
Preferred Stock  
PREFERRED STOCK
5.
PREFERRED STOCK

The Company’s articles of incorporation authorize the Company's Board of Directors to issue up to 10,000,000 shares of preferred stock, having no par value, in one or more series without stockholder approval. Each such series of preferred stock may have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as determined by the Company’s Board of Directors. At December 31, 2011 and 2010, no shares of preferred stock were issued or outstanding.

In August 2010, the Company signed a one year consulting agreement with a consultant to provide investor and public relation services. The consultant’s compensation includes convertible preferred stock which, at the final determination date, will be converted into shares of common stock of the Company equivalent to 25% of outstanding common shares, as defined in the agreement.  The consultant elected to receive the common stock equivalent directly as compensation.  The Company calculated the fair value of the award to be $868,724 or 4,169,638 shares of common stock. The Company accrued $506,680 of stock based compensation for these services during the year ended December 31, 2011, which has been included in accrued expenses and other current liabilities. During March 2011, 695,930 shares of common stock valued at $173,982 were issued to the consultant for the settlement of a portion of the accrued compensation, the remaining 3,473,708 shares of common stock valued at $694,742 have not been issued as of March 31, 2012 and is currently due and payable.
XML 33 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 7 84 1 true 0 0 false 3 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://organicallianceinc.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Condensed Consolidated Balance Sheet (Unaudited) Sheet http://organicallianceinc.com/role/CondensedConsolidatedBalanceSheet Condensed Consolidated Balance Sheet (Unaudited) false false R3.htm 0003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) Sheet http://organicallianceinc.com/role/CondensedConsolidatedBalanceSheetParenthetical Condensed Consolidated Balance Sheet (Parenthetical) false false R4.htm 0004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://organicallianceinc.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 0005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://organicallianceinc.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 0006 - Disclosure - NATURE OF BUSINESS Sheet http://organicallianceinc.com/role/NatureOfBusiness NATURE OF BUSINESS false false R7.htm 0007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://organicallianceinc.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 0008 - Disclosure - GOING CONCERN Sheet http://organicallianceinc.com/role/GoingConcern GOING CONCERN false false R9.htm 0009 - Disclosure - DUE TO FACTOR Sheet http://organicallianceinc.com/role/DueToFactor DUE TO FACTOR false false R10.htm 0010 - Disclosure - PREFERRED STOCK Sheet http://organicallianceinc.com/role/PreferredStock PREFERRED STOCK false false R11.htm 0011 - Disclosure - NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES Notes http://organicallianceinc.com/role/NotesPayableLoansAndDerivativeLiabilites NOTES PAYABLE, LOANS AND DERIVATIVE LIABILITES false false R12.htm 0012 - Disclosure - FAIR VALUE MEASURES Sheet http://organicallianceinc.com/role/FairValueMeasures FAIR VALUE MEASURES false false R13.htm 0013 - Disclosure - STOCK OPTIONS AND WARRANTS Sheet http://organicallianceinc.com/role/StockOptionsAndWarrants STOCK OPTIONS AND WARRANTS false false R14.htm 0014 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://organicallianceinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R15.htm 0015 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://organicallianceinc.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R16.htm 0016 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Sheet http://organicallianceinc.com/role/AccruedExpensesAndOtherCurrentLiabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES false false R17.htm 0017 - Disclosure - SUBSEQUENT EVENTS Sheet http://organicallianceinc.com/role/SubsequentEvents SUBSEQUENT EVENTS false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Condensed Consolidated Balance Sheet (Unaudited) Process Flow-Through: 0003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) Process Flow-Through: 0004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 0005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) orgc-20120331.xml orgc-20120331.xsd orgc-20120331_cal.xml orgc-20120331_def.xml orgc-20120331_lab.xml orgc-20120331_pre.xml true true